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S U M M A RY
The metabolic activity of cells is crucial to their growth, survival, and quick re-
sponse to shifts in the microenvironment. For macrophages, changes in metabolism
have been shown to be implicated in their ability to shift phenotypes as a re-
sponse to multiple cellular agonists, including bacteria and other pathogenic
substances. Two specific metabolites from the TCA cycle in mitochondria have
been found to be involved in pro-inflammatory macrophage activity, itaconic
acid and succinic acid. Itaconic acid is a antimicrobial metabolite produced in
macrophages as a side product in the TCA cycle, resulting from agonists such
as LPS stimulation, while succinic acid is a metabolite in the TCA cycle which
accumulates in pro-inflammatory macrophages for the purpose of increasing
cytokine expression and glycolytic activity.
In this work, a combination of metabolomics analyses and other experimen-
tal techniques are used to investigate the regulation of these two metabolites,
with the goal of understanding how metabolic changes are controlled both
through cellular mechanisms and environmental cues. To do so, the metabolomics
extraction method from our laboratory was published, with the goal of in-
creasing standardization in the metabolomics research community. Extending
the investigation of metabolomics studies in the lab, a comparison between
primary macrophages and a common macrophage cell line was made, show-
ing similarities in cytokine expression patterns with differences in scale, while
the changes required to create an immortalized cell line make the metabolism
under inflammation not comparable to primary cells.
Through multiple studies, itaconic acid is found to be increased in macrophages
not only through LPS stimulation, but also in bacterial infection and anthro-
pogenic aerosol exposure. Glucose flux into the mitochondria, thought to be in-
hibited in pro-inflammatory macrophages, is shown to be constitutively active
in basal conditions and increased with LPS stimulation. In addition, succinic
acid accumulation is shown to be regulated through an itaconic-acid depen-
dent inhibition of a TCA cycle enzyme, controlled in part by the gene impli-
cated in the production of itaconic acid, Irg1. Finally, the antimicrobial activity
of macrophages through itaconic acid and pro-inflammatory cytokine secre-
xvi
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tion is found to be linked to SIRT3, a mitochondrial deacetylase active in the
regulation of multiple metabolic targets in the cell.
The combined results point to a tightly linked network of metabolic regula-
tion in macrophages to promote antimicrobial activity and increased cytokines
through the interplay of SIRT3, Irg1, succinic acid, and itaconic acid. In addi-
tion, the work in this thesis shows that the TCA cycle is extremely important
for both metabolite production as well as regulation of cytokine expression
in pro-inflammatory macrophages, showing a decoupling of central carbon
metabolism under inflammatory conditions.
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I N T R O D U C T I O N
1.1 the role of inflammation in innate immunity
The innate immune system is the first barrier in protecting its host from pathogens
and tissue damage, serving as a non-specific defense mechanism that targets
foreign and local sources of pathogens. Cells of the innate immune system
recognize foreign pathogens using transmembrane protein receptors, called
pattern-recognition receptors (PRRs), that bind to a wide variety of pathogen-
associated molecular patterns (PAMPs). PAMPs are structurally-similar molecules,
such as proteins, nucleic acids, or lipids, that are unique to microbial pathogens
(Akira and Hemmi, 2003). The binding of PAMPs by PRRs initiates a signaling
cascade that allows cells of the innate immune system to combat infection and
induce tissue reparation after damage has been done. (Medzhitov, 2007). The
biological pathway behind this process includes four stages: induction of the
response through infection or tissue damage, sensing of the infection by innate
immune cell based-receptor signaling, production of inflammatory mediators
by the innate immune cells to help clear out the infection, and finally resolution
plus termination of inflammation (Medzhitov, 2010).
In addition to inflammatory responses induced by foreign PAMPs, endoge-
nous biomolecules, so-called damage-associated molecular patterns (DAMPs),
can also initiate inflammation (Seong and Matzinger, 2004). These non-infectious
stimuli are often result from tissue injury or cell death; they are generally se-
questered from the immune system and only released as a result of cellular
stress. Afterwards, they are incorrectly identified by the immune system as
danger signals, and cause so-called “sterile inflammation” (Chen and Nuñez,
2010). DAMPs can be recognized by the same receptors as PAMPs, and have
been seen to lead to similar inflammatory response pathways; for example,
the TLR4 receptor can be stimulated by ligands from both pathogenic bacteria
(such as lipopolysaccharide (LPS)) and products of cellular damage pathways
(such as heat-shock protein 60), leading to the same cellular response (Seong
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and Matzinger, 2004). Thus, there is some dispute as to whether PAMPs and
DAMPs cause distinct mechanisms of action (Barton, 2008).
In the case of dysregulation of the acute inflammatory response, or improper
removal of pathogens, the state of inflammation can persist, leading to chronic
inflammation. Chronic inflammation has been associated with multiple dis-
eases and disorders, including obesity and cardiovascular diseases (Hotamis-
ligil, 2006), neurodegenerative diseases (McGeer and Mcgeer, 2004), and vari-
ous cancers (Grivennikov et al., 2010). Thus, the process and critical regulatory
points of inflammation, as well as furthering the understanding of inflamma-
tory dysregulation, are important fields of study for human health.
1.1.1 Macrophage activation and polarization regulates the inflammatory response
One of the main cell types implicated in the inflammatory response are macrophages,
a phagocytic innate immune system cell. Macrophages are a form of differen-
tiated monocyte which arise from hematopoietic stem cells in the bone mar-
row. Both circulating and tissue-resident macrophages are found in the body
(Gordon and Taylor, 2005). Under certain conditions in damaged tissues, fully
differentiated and mature macrophages have been seen to complement the
tissue-resident cells in order to aid in tissue repair (Wang and Kubes, 2016).
The role of macrophages consists of the constant scanning for danger signals
(PAMP and DAMP), while being primed for an immediate response if necessary,
to return damaged tissue to homeostasis as quickly as possible (Murray and
Wynn, 2011). Specialized receptors (PRRs, including Toll-like receptors (TLRs),
nucleotide-binding oligomerization domain receptors (NLRs), and integrins)
recognize these signals, and recognition stimulates signaling cascades which
initiate the macrophage response (Taylor et al., 2005). Macrophage activation
can be hijacked by diseases or stopped from functioning correctly; dysreg-
ulation of macrophage activity has been associated with disorders such as
metabolic disease (Chawla et al., 2011) and tumorigenesis (Grivennikov et al.,
2010).
Macrophages can be stimulated into a variety of activated phenotypes, all
with differing phenotypic differences and activities which are necessary for the
different phases of an inflammatory response (Murray and Wynn, 2011). Typ-
ically, macrophages are classified into two phenotypes, “classical” activation
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(also called M1 macrophages) and “alternative” activation (M2 macrophages)
(Figure 1). Classically activated macrophages have a pro-inflammatory activity,
while alternatively activated macrophages are involved in wound repair and
have an anti-inflammatory phenotype (Murray and Wynn, 2011).
Figure 1: Macrophages are known to be activated either towards a pro-inflammatory
or an anti-inflammatory phenotype. While there are different sub-activation
phenotypes thought to exist for the two classifications, the activities of a
macrophage polarized in either direction remain conserved.
While this dichotomy of macrophage phenotype naming is still in use today,
there have been experts who deem that this classification is too limiting, and
instead refer to a continuous spectrum of macrophage activation states which
are able to adapt to specific situations required by the tissue at any specific
time (Mosser and Edwards, 2008; Wynn et al., 2013). In this thesis, I will use
the term “pro-inflammatory macrophage” to refer to the activation state that I
was most interested in studying.
Pro-inflammatory macrophages have a phagocytic activity, and are heavily
involved in the active defense against pathogenic bacteria through phagocyto-
sis as well as chemical means. These chemical effectors include nitric oxide
and reactive oxygen species (ROS) production as well as the synthesis and
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secretion of pro-inflammatory cytokines which coordinate the inflammatory
response (Dale et al., 2008). Inflammatory cytokines are small proteins which
act as signaling molecules and support the coordination of the immune re-
sponse (Duque and Descoteaux, 2015), or directly induce the destruction of
pathogenic bacteria (Jayaraman et al., 2013). The main cytokines induced in
pro-inflammatory macrophages include interleukin-1 beta (IL-1b), tumor necro-
sis factor alpha (TNF-α), and IL-6, are induced by different signaling cascades,
including nuclear factor NF-kappa-B (NF-κB) and mitogen-activated protein ki-
nase (MAPK) (Barton, 2008; Shi et al., 2009).
1.1.2 Pro-inflammatory macrophage activation using lipopolysaccharide
In vitro, LPS is the most commonly used to stimulate pro-inflammatory macrophage
phenotypes (Mosser and Edwards, 2008). LPS is the main component of Gram-
negative bacterial surface membranes and is recognized mainly by macrophage
TLR4, but also TLR2 and CD14 surface receptors (Hirschfeld et al., 2001). Bind-
ing of the ligand to the macrophage surface receptor induces a myeloid differ-
entiation protein 88 (MyD88)-dependent signaling pathway leading to NF-κB
activation and expression of the cytokines IL-1b, Tnfa, and IL-6 (Andreakos
et al., 2004). A parallel signaling pathway activated by LPS/MyD88 signaling
is the MAPK pathway, which co-regulates NF-κB-dependent pro-inflammatory
cytokine expression as well as regulates anti-inflammatory macrophage re-
sponses (such as IL-10 and STAT3) (Bode et al., 2012).
1.1.3 Anthropogenic aerosols as a source of inflammation in human health
Air pollution from anthropogenic sources is consistently associated with neg-
ative health outcomes, such as asthma, cardiovascular problems, and cancer
(Sydbom et al., 2001; Wichmann, 2007). These aerosols consists of particulate
matter (PM) suspended in a gas phase, which enters the environment and the
air that we breathe. To link pro-inflammatory stimulation to human health
and environmental factors, anthropogenic pollutants have also been used in
macrophage exposure studies. Since the industrial revolution, there has been
a steady increase in the amount of PM that are present in the air we breathe,
and these particles have been in particular associated with higher levels of res-
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piratory diseases (D’Amato et al., 2005). A major source of PM from vehicles
and certain industry, diesel exhaust particles (DEPs), have been heavily studied
as an instigator for inflammation and immune system responses (Chaudhuri
et al., 2012; Provoost et al., 2010; Reisetter et al., 2011).
The Helmholtz Virtual Institute of Complex Molecular Systems in Environ-
mental Health (HICE) project aims to investigate the mechanisms of human
health effects influenced by anthropogenic aerosols in a comprehensive biolog-
ical and chemical approach. To do so, a novel experimental setup was devel-
oped and applied to different aerosol sources. Experimental campaigns were
carried out, each focusing on a single combustion aerosol, and a large team of
researchers applied state of the art techniques to both characterize the aerosol
as well as to profile the effects of the aerosol on biologically relevant cellular
models. (Oeder et al., 2015)
For the chemical analyses of the aerosol, a combination of online and offline
measurement systems were applied, including gas chromatography coupled
to mass spectrometry (GC-MS), high resolution mass spectrometry (ESI-FTICR-
MS), energy-dispersive X-ray spectroscopy (EDX), on-line photo-ionization mass
spectrometry, particle size distribution and number measurements, and others
(Oeder et al., 2015).
Parallel to the chemical analyses, multiple cell types were exposed to the
combustion aerosol using a novel air-liquid interface (ALI) system (Mülhopt
et al., 2016), and the biological consequences were studied using “omics” tech-
niques. A549 human epithelial lung cancer cells, Beas2b virus transformed
lung epithelial cells and RAW 264.7 mouse macrophages were used, and ana-
lyzed using transcriptomics, proteomics, and metabolomics workflows.
While multiple studies have investigated the effects of PM emissions on lung
cells (Chaudhuri et al., 2012; Bhavaraju et al., 2014; Shaw et al., 2011), most exper-
iments utilized submerged experiments, where particles are dissolved in the
cell culture medium at specific concentrations, with no gas phase or combined
aerosol exposure. While these studies have contributed valuable insights into
particle effects on cell models, these exposure types do not accurately simulate
inhalation of combustion emissions. Therefore, studies utilizing ALI exposure
systems (such as those in the scope of the HICE project) represent a more bio-
logically accurate exposure situation for lung epithelial cells.
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ALI systems are a complex integration of technology allowing for simultane-
ous automated control of both aerosol conditions (such as heating, humidity,
and flow), as well as cell exposure conditions (such as temperature, humidity,
and accurate particle deposition). All materials must be compatible with bio-
logical exposure (and cause no confounding effects), and there must be enough
exposure chambers for comprehensive experimental conditions. For this pur-
pose, an 18-position fully automated ALI was built for the purpose of the HICE
project, specifically designed with all of these features in mind (Mülhopt et al.,
2016)
Additionally, ALI studies are able to discern different effects due to the gas
and particle components of aerosols through the use of in-line filters (Steiner
et al., 2013). ALI validation studies have been performed previously (Knebel
et al., 2002; Seagrave et al., 2007), and multiple studies have used ALI technol-
ogy to uncover novel chemical and biological insights, including more accurate
particle deposition efficiencies modeling (Comouth et al., 2013), the study of the
response of co-cultures of epithelial cells and macrophages to waste incinera-
tion emission aerosol (Diabaté et al., 2008), and discovery of specific aerosol
constituents which contribute to toxicity of epithelial lung cells (Dilger et al.,
2016). In general, ALI systems are preferred compared to submerged experi-
ments for cell exposure, as has been discussed previously (Paur et al., 2011).
1.2 central carbon metabolism and the importance of the tca
cycle
Cellular metabolism is an extremely complex network of biochemical reactions,
and looking at the whole system is beyond the scope of this work. There-
fore, I focused mainly on the tricarboxylic acid cycle (TCA cycle) of central car-
bon metabolism in order to understand how macrophages utilize their fuel
sources when challenged with a pro-inflammatory stimulus. Central carbon
metabolism is a integral subset of cellular metabolism, and supports cellular
processes required for cell survival, proliferation, and many more critical activ-
ities. These cellular functions define a large part of cellular homeostasis, and
perturbations to these systems can lead to cellular dysregulation and disease
(Metallo et al., 2012; O’Neill and Hardie, 2013; Hiller and Metallo, 2013).
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The two main carbon sources that the cell utilizes for metabolism are glucose
and glutamine. Glucose is taken up into the cell through the glucose trans-
porter GLUT1, a process which is conserved in all tissues and cells, including
macrophages (Fukuzumi et al., 1996). Glucose is then converted into pyruvate
through glycolysis, a multi-step series of biochemical reactions taking place in
the cytosol which serves the purpose of transforming glucose carbon into a
form which can be efficiently converted into cellular energy sources. Once con-
verted into pyruvate, glucose-derived carbon either enters the TCA cycle, where
the carbon is used for energy production through oxidative phosphorylation
via the electron transport chain (ETC), or is reduced to lactate and secreted
from the cell.
1.2.1 The TCA cycle and glutamine metabolism
Glutamine uptake into cells feeds different cellular mechanisms, including
amino acid synthesis, oxidative phosphorylation, and redox control. However,
for central carbon metabolism, glutamine is converted into glutamate through
glutaminase activity, and then funneled into the TCA cycle through glutamate
dehydrogenase (GDH) (Newsholme et al., 2003) or transanimation.
The series of reactions which compose the TCA cycle take place in the mito-
chondria of the cell, and serve as the main input of carbon for energy pro-
duction through the ETC, located in the inner membrane of the mitochondria.
Succinate dehydrogenase (SDH) directly links the ETC and the TCA cycle, through
catalyzing the conversion of succinic acid to fumaric acid while simultaneously
transporting electrons (Liu et al., 2002). The TCA cycle operates mainly in the ox-
idative direction, using glucose- and glutamine-derived carbon as the main
sources which feed a cycle involved in many integral cellular processes, in-
cluding energy production (both ATP and NADH) (O’Neill and Hardie, 2013),
biomass synthesis (including amino acids and fatty acids) (Fendt et al., 2013),
ROS production (Liu et al., 2002), as well as production of cofactors important
in the creation of bioprotective compounds (such as NADPH) (Yu et al., 2012).
However, flux through the TCA cycle can also move in a reductive direction,
based upon factors such as mass action kinetics (Fendt et al., 2013).
There is constant exchange of certain metabolites between the mitochon-
dria and the cytosol, and many of the enzymes catalyzing the reactions in
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Figure 2: Central carbon metabolism. Metabolites are in black, and enzymes are in
green. Circles next to each metabolite represent the number of carbons that
each metabolite is comprised of.
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the TCA cycle have complementary isoforms in both the mitochondria and the
cytosol (Figure 2). Biochemical activity of these enzymes outside of the mito-
chondria can also affect cellular processes associated with the TCA cycle, such
as acetyl-CoA production for lipogenesis (Metallo et al., 2012).
The cyclical nature of the reactions in the TCA cycle create an extremely effi-
cient carbon oxidation and energy production pathway, with many side path-
ways allowing for complete use of the carbon that enters the mitochondria.
Glutamine-derived glutamate can be converted into signaling molecules (γ-
Aminobutyric acid (GABA)), be used for nucleotide synthesis, create glucose
through gluconeogenesis, or aid in the creation of nitric oxide (used for antimi-
crobial activity in macrophages) (Newsholme et al., 2003).
1.2.2 Regulation of metabolism through signaling pathways and metabolic changes
Different utilization of glucose and glutamine in central carbon metabolism
is regulated by thermodynamics of reactions under homeostasis, regulatory
signals which monitor and react to the needs of the cell, as well as cellular
perturbations which modify .
Cellular perturbations can activate signaling cascades which change the uti-
lization of these carbon sources depending on the current needs of the cell,
shifting carbon from “normal” activity to specific endpoints in order to react
and adapt to environmental challenges. For example, cells under hypoxic con-
ditions shift energy production from oxidative phosphorylation to glycolsis.
This switch in cellular metabolism is mediated by the stabilization of hypoxia-
inducible factor-1 alpha (HIF-1α), a transcription factor which upregulates pyru-
vate dehydrogenase kinase (PDK) (among many other enzymes), which in turn
inhibits pyruvate dehydrogenase, leading to a reduction of glucose-derived car-
bon entry into the TCA cycle and increased lactate production through lactate
dehydrogenase, also positively regulated by HIF-1α (Kim et al., 2006).
Central carbon metabolism can also be hijacked by diseases, leading to a dys-
regulation of cellular processes that is used for the benefit of the diseased cell.
While the above pathway is utilized by normal cells operating in hypoxic con-
ditions, tumor cells have been observed to use the same pathway in normoxic
conditions for increased glycolytic rates and production of large amounts of
energy (Semenza, 2007), a phenomenon known as the Warburg effect (War-
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burg et al., 1927). The Warburg effect is associated with tumorigenesis, but has
recently been seen in regulatory T cells (Shi and Pamer, 2011), and has been
hypothesized to play a role in pro-inflammatory macrophages as well (Cramer
et al., 2003; Wen et al., 2012).
Under certain cellular conditions, glutamine imported into the cell can be
shunted in the reductive direction, leading to reductive carboxylation and pro-
duction of citric acid, acetyl-CoA, and finally fatty acids. As with the pathway
described above, this has been found to occur during hypoxia in cells, and is
considered to be complementary to the reduced pyruvate oxidation into the
TCA cycle (Metallo et al., 2012). In addition, this chain of reactions has been
shown to work independently of signaling pathways, depending instead on
the ratio between α-ketoglutarate and citrate (Fendt et al., 2013).
1.3 metabolic changes of macrophages under inflammation
Inflammation-induced changes in macrophages are classically associated with
cellular changes in cytokine production and signaling, phagocytosis, as well as
differentiation processes (Murray and Wynn, 2011). Only recently has the in-
fluence of metabolism been studied with regards to macrophage polarization,
and many insights have appeared which show the integral role of metabolism
in the macrophage’s response to inflammation. While new insights have been
gained in both pro-inflammatory and anti-inflammatory macrophage metabolism,
I have focuses on pro-inflammatory macrophages for this thesis Figure 3.
1.3.1 Glycolytic changes differentiate macrophage activation
Rodríguez-Prados et al. (2010) performed metabolic characterization of the
glycolytic activity of macrophages stimulated to a variety of different pro-
inflammatory and anti-inflammatory phenotypes. Using [1,2-13C2]-labeled glu-
cose tracers, and sampling the medium of RAW 264.7 macrophages, they found
that pro-inflammatory macrophages secreted more lactate compared to anti-
inflammatory and unstimulated macrophages, but with no difference in the
labeling patterns of these secreted glycolitic metabolites with different stim-
ulations. In addition, the fructose-2,6-bisphosphate pool was found to be in-
creased in pro-inflammatory macrophages, suggesting that the glycolytic activ-
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Figure 3: Metabolism of pro-inflammatory macrophages (Utilized from Ghesquière
et al. (2014)). Pro-inflammatory macrophages have been found to have in-
creased glycolysis for cellular energy production (with a reduced oxida-
tive phosphorylation activity), while exhibiting a modified TCA cycle activ-
ity for the purpose of pro-inflammatory compound production. These com-
pounds include ROS, nitric oxide, and itaconic acid. Glucose, glutamine, and
fatty acids are utilized by the cell to fuel the various pathways necessary
for pro-inflammatory macrophage metabolism. α-KG - α-ketoglutarate, Ac-
CoA - acetyl-coenzyme A, ARG - arginase, ASL - argininosuccinate lyase,
Asp - aspartate, ASS - argininosuccinate synthase, Cit - citrate, CPT - car-
nitine palmitoyltransferase, ETC, electron transport chain, F1,6BP - fruc-
tose 1,6-bisphosphate, F2,6BP - fructose 2,6 bisphosphate, F6P - fructose 6-
phosphate, FA - fatty acid, FABP - fatty acid binding protein, FAO - fatty
acid oxidation, FATP - fatty acid transfer protein, Fum - fumarate, G6P
- glucose 6-phosphate, GAP - glyceraldehyde 3-phosphate, Glc - glucose,
Gln - glutamine, Glu - glutamate, GLUT - glucose transporter, GSH - re-
duced glutathione, GSSG - oxidized glutathione, iNOS - inducible nitric ox-
ide synthase, Lac - lactate, MCT - monocarboxylate transporter, NADPH -
nicotinamide adenine dinucleotide phosphate, NO - nitric oxide, OAA - ox-
aloacetate, OTC - ornithine transcarbamylase, PFK1 - phosphofructokinase-
1, PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3, PPP -
pentose phosphate pathway, Pyr - pyruvate, ROS - reactive oxygen species,
TCA - tricarboxylic acid.
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ity of macrophages stimulated to a pro-inflammatory phenotype is increased
compared to anti-inflammatory macrophages or unstimulated cells. The TCA cycle
was not studied, most likely as it was thought that HIF-1α mediated regula-
tion strongly reduced oxidation of glucose towards oxidative phosphorylation,
and that macrophages used mostly glycolsis for the production of energy. As a
result, many studies simply dismissed metabolic flux through the TCA cycle in
pro-inflammatory macrophages, since it could be shown that oxidative phos-
phorylation was significantly reduced; this is suggested even by O’Neill and
Hardie (2013), on the forefront of macrophage metabolism.
Vats et al. (2006) found that anti-inflammatory macrophages have reduced
glycolytic activity compared to their pro-inflammatory counterparts, and in-
stead focus more on fatty acid oxidation and oxidative phosphorylation, due to
induction of PPARγ-coactivator-1β (PGC-1β). In addition, inhibition of oxida-
tive metabolism was shown to prevent polarization of macrophages to an anti-
inflammatory phenotype, while having no effect on pro-inflammatory macrophage
polarization. PGC-1β expression affected pro-inflammatory cytokine expres-
sion in addition to oxidative metabolism, reducing the secretion of IL-6 and
IL-12 both in vitro and in vivo.
While transcriptional regulation is important for phenotypic changes in macrophages,
direct regulation of metabolic pathways can also influence macrophage activa-
tion. Recently, Haschemi et al. (2012) screened RAW 264.7 mouse macrophages,
finding an sedoheptulose kinase, carbohydrate kinase-like protein (CARKL),
which is an important regulator of macrophage polarization through affect-
ing glucose metabolism. In vitro and in vivo, decreased levels of CARKL were
found with LPS stimulation, while IL-4 stimulation resulted in an increase
of CARKL (Figure 4). In macrophages, this enzyme controls carbon flux from
glucose through glycolsis and the pentose phosphate pathway (PPP), which
affects glutathione and NADPH levels, pro-inflammatory cytokine expression
and NF-κB activity, as well as oxygen consumption.
1.3.2 Succinic acid links macrophage metabolism to cytokine secretion
In 2013, the O’Neill lab discovered that the TCA cycle plays an important role
in pro-inflammatory macrophages, and that LPS stimulation of primary mouse
macrophages leads to increased intracellular succinic acid levels, and that this
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Figure 4: The role of CARKL in macrophage polarization. LPS stimulation inhibits
CARKL activity, leading to a pro-inflammatory phenotype, while IL-4
stimulation promotes this enzyme, polarizing the macrophage to an anti-
inflammatory phenotype. This polarization is regulated through CARKL’s
control of metabolic flow in the pentose phosphate pathway. From Haschemi
et al. (2012)
succinic acid is metabolized from glutamine uptake into the cell (Tannahill
et al., 2013). Succinic acid was found to stabilize HIF-1α through inhibition of
prolyl hydroxylase activity, leading to increased expression levels of IL-1b and
increase of glycolytic activity through upregulation of GLUT1, lactate dehydro-
genase (LDH), and other enzymes involved in glycolytic energy production.
Shortly after the role of succinate in pro-inflammatory macrophages was
found, the mitochondrial metabolite was determined to have a key role in
ROS production in ischemia reperfusion (Chouchani et al., 2014). Using stable
isotope labeled glucose and fatty acids to target TCA cycle intermediates under
hypoxic ischemic conditions, reduced influx of normal carbon sources were
found, and a reverse flow of SDH was observed, fed by aspartic acid. This was
determined in vivo to cause ROS production upon reperfusion, showing that an
accumulation of succinic acid is a main source of injury due to ischemia. Block-
age of this accumulation reduced the damage in a rat stroke model, providing
evidence for a role of succinic acid in ischemia reperfusion injury.
Other roles for succinic acid are beginning to emerge, both in macrophages
and other cell types. Enzymes in metabolism have been shown to have lysine
succinylation, including SDH, pyruvate dehydrogenase complex (Park et al.,
2013), and isocitrate dehydrogenase isoform 2 (IDH2) (Zhou et al., 2016). Suc-
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cinic acid signaling through succinate receptor 1 (SUCNR1), a G-protein cou-
pled receptor, is also able to influence and enhance T cell immune response
through synergy with TLR activation, affecting pro-inflammatory cytokine pro-
duction (Rubic et al., 2008).
1.3.3 Itaconic acid - a mammalian antimicrobial metabolite
In addition to the increase of succinic acid, an integral TCA cycle metabolite, a
novel pathway branching off of the TCA cycle was linked to pro-inflammatory
macrophage metabolism. Itaconic acid, a compound used for the synthesis of
polymers, has been known to act as an antimicrobial, inhibiting the enzyme
isocitrate lyase in multiple bacteria species McFadden and Purohit (1977); Pa-
tel and McFadden (1978). More recently, itaconic acid was found to be pro-
duced from cis-aconitate, and dramatically increased in LPS-stimulated mouse
macrophages, the first time this metabolite was identified in a mammalian sys-
tem (Strelko et al., 2011).
A few years later, Michelucci et al. (2013) dug deeper into the production and
regulation of itaconic acid in mammalian macrophages. Using stable-isotope la-
beling metabolomics techniques, production of itaconic acid from cis-aconitate
was confirmed, and its presence in stimulated primary mouse and human
macrophages was determined. In addition, the synthesis of itaconic acid pro-
duction in mammalian cells was found to be catalyzed by the immune-responsive
gene 1 (Irg1) protein. Finally, the antimicrobial properties of itaconic acid were
confirmed in vitro.
1.3.4 Metabolic breakpoints highlight the TCA cycle in macrophage polarization
Through an interpolated metabolomics and transcriptomics analysis combined
with network integration, Jha et al. (2015) identified the rewiring of the TCA cycle
during pro-inflammatory macrophage polarization. They found two “metabolic
breakpoints” which contribute to the accumulation of itaconic and succinic
acid. Using [U-13C6]-glucose and [U-13C5]-glutamine, carbon flux was seen to
be blocked between citrate and alpha-ketoglutarate (α-KG), leading to an ac-
cumulation of citric acid. This flux blockage was linked to the downregula-
tion of isocitrate dehydrogenase isoform 1 (IDH1) mRNA in pro-inflammatory
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macrophages. While the diversion of carbon flux towards itaconic acid makes
sense, the measurement of IDH1 is puzzling, as it is a cytosolic form of the
enzyme, while the activity being described takes place in the mitochondria.
This increase in citrate can serve multiple roles in the TCA cycle. Infantino
et al. (2011) determined that the mitochondrial citrate carrier is increased under
LPS stimulation, leading to an increase of nitric oxide and ROS from citric acid
metabolized to acetyl-CoA. The production of itaconic acid comes from a series
of reactions directly downstream from citric acid production as well, and an
increase of citric acid can serve an increase itaconic acid production. All three
of these compounds are important mediators of pro-inflammatory macrophage
activity, and highlight citric acid as an important pro-inflammatory metabolite.
In addition, Jha et al. (2015) pinpointed inefficient SDH activity, leading to a
buildup of the succinic acid pool from glutamine uptake. At the same time,
an increase in the metabolite malic acid was observed, hypothesized to arise
from the aspartate-arginosuccinate shunt, which is an interface between the
TCA cycle and the urea cycle in cells. The combination of increased citric acid
(from glucose) and urea cycle activity (from glutamine) stresses the utilization
of multiple cellular energy sources towards the same pro-inflammatory cellular
function.
In the above studies, macrophages were found to modify their metabolism
under pro-inflammatory conditions in order to produce multiple pro-inflammatory
mediator molecules, including itaconic and succinic acid. These studies high-
light the important role of these metabolites in pro-inflammatory macrophages,
and solidify the TCA cycle as a vital player in macrophage metabolism during
the inflammatory process.
1.4 sirtuins : linking metabolism and the immune response
Sirtuins were discovered as a conserved family of class III histone lysine deacety-
lases which use NAD+ as a cofactor in the post-translational modification of
proteins (Michan and Sinclair, 2007). Current knowledge has elucidated many
different properties of sirtuins that expands their scope of activity. They have
been observed to act on other proteins than histones, to be able to perform ad-
ditional post-translational modifications including demalonylation and desuc-
cinylation (Du et al., 2011; Peng et al., 2011), and target proteins in different
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cellular compartments, including in the mitochondria (He et al., 2012). In re-
cent years, sirtuins were increasingly studied because of their involvement in
metabolism (reviewed in Houtkooper et al. (2012)), tied to aging related pro-
cesses (Howitz et al., 2003; Kanfi et al., 2012), and associated with cancer (re-
viewed in Chalkiadaki and Guarente (2015)). The sirtuin family is composed
of seven members, with different cellular localizations and activities (Figure 5).
SIRT1 is the most well studied, located mainly in the nucleus with multiple
integral transcription factors as targets, including HIF-1α, p53, and the FOXO
family (Houtkooper et al., 2012). The many links that are being discovered be-
tween sirtuins and diseases make these enzymes important areas of study for
the future.
Figure 5: Sirtuin activity in the cell. The seven different sirtuin family members are
known to be present and active in different parts of the cell, with regulatory
effects on a wide variety of cellular functions. The most well studied sirtuin,
SIRT1, is mainly present in the nucleus and is a known histone deacetylase,
while SIRT3, SIRT4, and SIRT5 are present in the mitochondria and regulate
cellular metabolism and reactive oxygen species production. Not much is
known about the other sirtuins, and there is much current research in this
direction. From Anderson et al. (2014)
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1.4.1 Connecting sirtuins and macrophage-mediated inflammation
The effects of sirtuins on metabolism and other cellular processes has been
seen to impact macrophages and their role in the inflammatory response. In
2004, SIRT1 was discovered to inhibit the transcription of NF-κB through target-
ing a lysine in one of the subunits crucial for transcriptional activity (Yeung
et al., 2004). Since then, SIRT1 deletion was shown to promote inflammation
and metabolic dysfunction in models of adipose tissue (Chalkiadaki and Guar-
ente, 2012) and metabolic disease in the liver (Purushotham et al., 2009). Fur-
thermore, the interplay between NF-κB and SIRT1 is thought to be an impor-
tant part of the progression of the inflammatory state, through the control of
the metabolic response to inflammation (Kauppinen et al., 2013). By targeting
AMP-activated protein kinase (AMPK) in macrophages, SIRT1 has also been
found to have a role in bacterial infections, therefore mediating a metabolic
switch between early-stage infection (with a Warburg effect-like phenotype)
and late-stage infection (with more oxidative phosphorylation) (Moreira et al.,
2015).
Apart from SIRT1, other sirtuin family members play a role in inflammation.
SIRT2 knockout bone marrow derived macrophages (BMDMs) show reduced
expression of inflammatory cytokines, and diminished production ROS in re-
sponse to LPS treatment (Lee et al., 2014). In LPS-stimulated monocytes, SIRT1
and SIRT6 were shown to positively regulate both glucose as well as fatty acid
uptake and oxidation (Liu et al., 2012). While more links between different
members of the sirtuin family and inflammatory macrophage activity are be-
ing hypothesized, these enzyme deacylases could be tightly involved in how
macrophages behave under different stages of inflammation.
1.4.2 Mitochondrial sirtuins target cellular metabolism
Sirtuin activity affects many cellular activites, but most mitochondrial sirtuin
targets are implicated in control of cellular metabolism. Within the mitochon-
dria, three sirtuin family members are known to be active; SIRT3, SIRT4, and
SIRT5 (Figure 5). Over 20 confirmed targets of mitochondrial sirtuins exist, in-
cluding IDH2, GDH, and SDH. These enzymes affect important metabolic and
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regulatory pathways (including the TCA cycle, urea cycle, fatty acid oxidation,
ROS metabolism, and the ETC) critical for mitochondrial activity (He et al., 2012).
While the study of sirtuins is an emerging field, knockouts, chemical ac-
tivators, and chemical inhibitors have been used to artificially target activity
through of mitochondrial sirtuins. These studies have identified sirtuins as im-
plicated in mitochondrial dysregulation associated with metabolically-linked
diseases. For example, SIRT5 has recently been discovered to be highly ex-
pressed in the heart, and knock out of Sirt5 results in increased succinylation
of proteins, decreased ATP production, and reduced long-chain fatty acid ox-
idation, all of which can lead to heart disease (Sadhukhan et al., 2016). SIRT5-
mediated lysine desuccinylation has been shown to decrease both pyruvate
dehydrogenase complex (PDC) as well as SDH activity (Park et al., 2013), as
well as IDH2 (Zhou et al., 2016).
In mouse liver, Sirt4 knockdown was shown to increase the expression of
Sirt1 and Sirt3, while increasing fatty acid oxidation and oxygen consump-
tion (Nasrin et al., 2010). The role of SIRT4 in negatively affecting fatty acid
metabolism was validated in fibroblasts, where SIRT4 repressed glutamine
uptake (through GDH), cell proliferation, and tumor progression (Csibi et al.,
2013). SIRT4 regulation of GDH activity was also shown to affect TNF and
doxorubicin toxicity through the opening of the mitochondrial permeability
transition pore, with suppression of SIRT4 leading to decreased cytotoxicity
(Verma et al., 2013).
The most studied mitochondrial sirtuin, SIRT3, is an important regulator of
mitochondrial metabolism, and is hypothesized to connect phenotypic aspects
of pro-inflammatory macrophage response with the metabolic changes seen
under these conditions. As I focus mainly on SIRT3 for this thesis, I will briefly
summarize what is known about this mitochondrial regulator in the next sec-
tion.
1.4.3 SIRT3 - Current knowledge
SIRT3 has been seen to affect multiple aspects of mitochondrial metabolism
while being associated with different disease states. SIRT3 is a lysine deacety-
lase, modulating multiple metabolic pathways, including oxidative phospho-
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rylation, fatty acid metabolism, and the TCA cycle, with over 933 possible acety-
lation sites affected in the mitochondria (Sol et al., 2012).
SIRT3 has been shown in multiple studies to play a role in tumorigenesis
through a series of interactions with important regulators of cell growth and
metabolism. SIRT3 associates with Complex I of the ETC to modify its activity,
thereby regulating levels of adenosine 5’-triphosphate (ATP) without affecting
oxygen consumption (Ahn et al., 2008). Deletion of Sirt3 in fibroblasts leads
to increased ROS production and genomic instability because of hyperacetyla-
tion on mitochondrial antioxidant manganese superoxide dismutase (mnSOD),
a mitochondrial protein which detoxifies ROS (Tao et al., 2010). SIRT3 inhibit-
ing ROS has been validated by other studies, while at the same time inhibiting
HIF-1α (Bell et al., 2011). As HIF-1α is known to modulate glucose uptake and gly-
colysis, Finley et al. (2011a) discovered that SIRT3 destabilizes HIF-1α through
ROS detoxification, inhibiting its activity and reducing tumor growth through
suppressing rampant glucose metabolism (Warburg effect).
SIRT3 targets several enzymes in the TCA cycle, and can affect the way that
glucose and glutamine are metabolized (Figure 6). SIRT3 was found to directly
interact with two subunits of the SDH complex (both in the TCA cycle and in
the ETC) (Cimen et al., 2009; Finley et al., 2011b), showing that deacetylation
activity can target critical junctions within energy metabolism. In addition,
SIRT3 can deacetylate IDH2 for the purpose of increasing levels of NADPH
and glutathione, protecting against ROS-mediated damage (Yu et al., 2012).
Most research on SIRT3 has been performed on tumor cells to elucidate its
role on tumor progression, however, there have been studies linking SIRT3 to
the inflammatory response in macrophages as well, mostly with regards to
ROS regulation. Similar to the study above, IDH2 was shown to be a deacetyla-
tion target of SIRT3 in macrophages (Sheng et al., 2015), which suggests a role
for SIRT3 in macrophage-mediated ROS regulation. Palmieri et al. (2015) show
that the mitochondrial citrate carrier is a SIRT3 target in pro-inflammatory
macrophages, which is seen to have increased activity under glucose starva-
tion conditions in order to increase both fatty acid production and NADPH
synthesis.
SIRT3 knockdown also affects cytokine expression in macrophages, increas-
ing levels of pro-inflammatory cytokines and mediators (such as iNOS and
TNF-α) in RAW 264.7 cell line macrophages (Xu et al., 2016). Conversely, in
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Figure 6: Selected SIRT3 targets in the mitochondria. SIRT3 has been shown to af-
fect multiple enzymes in the mitochondria, impacting carbon import, ox-
idative phosphorylation through the electron transport chain, and important
metabolic breakpoints in the TCA cycle. MCT - Monocarboxylate transporter,
LDH - Lactate dehydrogenase, ALT - Alanine aminotransferase, PDH - Pyru-
vate dehydrogenase, FA_Import - Fatty acid import, LCAD - Long chain
acyl-CoA dehydrogenase, AST - Aspartate aminotransferase, CS - Citrate
synthase, ACO2/ACO2_2 - Aconitase 2, IRG1 - Cis-aconitate decarboxylase,
IDH2 - Isocitrate dehydrogenase 2, GDH - Glutamate dehydrogenase, GLS
- Glutaminase, OGDH/SUCLG - Oxoglutarate dehydrogenase, SDH - Succi-
nate dehydrogenase, FH - Fumarate hydratase, MDH2 - Malate dehydroge-
nase 2, I-V - Complexes in the electron transport chain. Created using Omix
(Droste et al., 2011).
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primary human macrophages treated with LPS, SIRT1 and SIRT3 mRNA and
protein expression is decreased, lending more evidence to the hypothesis that
sirtuin family members play a role in the macrophage inflammatory response
Storka et al. (2013).
Interestingly, the “metabolic breakpoints” in pro-inflammatory macrophages
put forth by Jha et al. (2015) correspond to two SIRT3 targets: IDH2 and SDH.
While only IDH2 activity has been confirmed to be affected by SIRT3 in macrophages,
these findings were integral in motivating the studies described in this the-
sis. The current knowledge of SIRT3 and mitochondrial metabolic changes in
pro-inflammatory macrophages point to an important role of mitochondrial
deacetylation activity in the regulation of macrophage metabolism during the
inflammatory process.
1.5 experimental and cellular tools for macrophage inflam-
mation studies
Since macrophages are an important aspect in understanding tissue homeosta-
sis and disease progression, a large body of scientific studies focus on primary
macrophages, cellular lines, and in-vitro experimental conditions established
for this field. The majority of macrophage studies are done with RAW 264.7
cells, which are a Abelson Leukaemia Virus transformed macrophage-like cell
line, widely used for in vitro studies of macrophage response under inflamma-
tory conditions (e.g. Tannahill et al. (2013); Michelucci et al. (2013); Meiser et al.
(2015); Cordes et al. (2016)). RAW 264.7 cells are easy to grow and handle in a
laboratory setting, and are seen in the scientific community as consistent and
comparable between experiments and laboratories. Much of the knowledge
about macrophage activation and their role in inflammation has been gener-
ated using this cell line, and many of these findings have been shown to be
directly parallel to in vivo activity (Berghaus et al., 2010). It is important to note
that RAW 264.7 cells have been transformed to be continuously proliferative,
and this must be considered when drawing conclusions about in vivo cellular
processes based upon results from these cells (Berghaus et al., 2010).
As a step closer to in vivo systems, BMDMs are used in many studies to serve
as primary cells that can be used in an in vitro laboratory setting. BMDMs are
differentiated macrophages obtained through the culture of mammalian bone
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marrow, typically from Mus musculus. Monocytes from bone marrow are dif-
ferentiated into mature macrophages through continuous exposure to granu-
locyte macrophage colony-stimulating factor (GM-CSF). Differentiation is per-
formed using either pure GM-CSF, or conditioned cell culture medium from
L929 mouse fibroblasts, which produces GM-CSF and other factors which pro-
mote macrophage differentiation (Francke et al., 2011; Boltz-Nitulescu et al.,
1987). As this cell model comes directly from individual animals, and is not
transformed to be proliferative, it is considered to be a more applicable model
for translating experimental results to in vivo cellular processes (Chamberlain
et al., 2009). However, BMDMs have a restricted life-span in laboratory settings,
create inter-animal variability, and are much more costly to obtain and work
with.
Since there are critical differences between RAW cells and BMDMs, it is impor-
tant to understand the similarities and differences between the cell line and the
primary cells, as well as where they can be comparable. Previous studies have
compared RAW cells to BMDMs with regard to cytokine production, cell surface
marker expression, and culture ability on different biomaterial surfaces. These
studies revealed that RAW cells and BMDMs respond differently to LPS, with
different cytokine response profiles and surface marker populations (Berghaus
et al., 2010; Chamberlain et al., 2009).
A large variety of cytokines play a role in macrophage differentiation and
their function in vivo; there is a strong polarization of important phenotype-
inducing signals and secreted cellular signals between pro- and anti-inflammatory
macrophages (Mantovani et al., 2004). In in-vitro experiments, macrophages
are stimulated into a pro-inflammatory phenotype by effectors such as LPS (a
PAMP), and interferon-gamma (IFN-γ) (a signaling cytokine), and into an anti-
inflammatory phenotype by compounds such as interleukin-4 (IL-4) and IL-13
(both signaling cytokines) (Gordon and Martinez, 2010).
In addition to the classical laboratory activation compounds of inflamma-
tion, some studies infect macrophages with live bacteria to provide a chal-
lenge which is more similar to an in vivo infection condition. Bacteria used for
these studies can vary, but the most common are those of the genus Salmonella,
and have been used to determine effects of infection on macrophages as well
as to uncover novel regulatory factors in macrophage metabolism (Shi et al.,
2009; Michelucci et al., 2013). Salmonella enterica serovar Typhimimurium (S.
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Typhimuirum) is a gram-negative facultative anaerobic bacterium character-
ized by an induction of pro-inflammatory cytokine secretion in mouse models
(Zhang et al., 2003). Simultaneously, S. Typhimurium can modulate host cell
metabolism and induce pro-inflammatory cell death through virulence effec-
tor proteins (Robinson et al., 2012). There are multiple cellular defense mech-
anisms against S. Typhimurium infection, including phagolysosomal degrada-
tion, ROS production (West et al., 2011) and itaconic acid production (Cordes
et al., 2015).
1.6 metabolomics - measuring the metabolism of cells
Even today, metabolic activity is estimated based on the abundance and ac-
tivity of enzymes (Moreira et al., 2015). However, enzyme abundance can be
affected by transcription and translation speeds, while activity can be modi-
fied through post-translational modifications, thermodynamic properties such
as cellular pH, and other changes arising from normal and perturbed cellular
processes. These changes can obscure the ability of protein studies to inform
on actual metabolic changes, and while new knowledge has come through
these studies, measuring precise changes in intracellular metabolite pools has
been elusive.
Through breakthroughs in technology, high-throughput approaches target-
ing the different levels of cellular regulation are now possible. Transcriptomics
and proteomics give valuable information on global changes in mRNA and
proteins expression, while metabolomics complements these analyses through
the measurement of intracellular metabolite pools. In this way, metabolomics
provides a snapshot of biochemical reactions occurring in the cell, and provide
a tool to study how these reactions are affected in response to different per-
turbations of the cellular environment. Metabolomics data can be applied in
the use of metabolic profiling for different diseases (Hiller and Metallo, 2013),
biomarker identification and diagnostic aids (Weiner 3rd et al., 2012), as well as
integration into mutli-omics networks for a deeper understanding of cellular
systems (Bordbar et al., 2012; Jha et al., 2015).
Both targeted and non-targeted metabolomics approaches can be applied,
depending on the scientific question that is asked. Non-targeted metabolomics
is mostly used for biomarker determination, as well as global metabolome pro-
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filing (Hiller et al., 2011), while targeted metabolomics focuses on the analysis
of specific compounds (Michelucci et al., 2013; Tannahill et al., 2013; Fendt et al.,
2013; Cordes et al., 2016).
1.6.1 Analytical pipeline - From quenching metabolism to measuring metabolites
The metabolic profile of a cell can change on the order of seconds, so cellular
metabolism must be quenched in order to both halt the function of biochemical
pathways in the cell and to minimize the effects of experimental handling and
sample preparation (Ewald et al., 2009). Metabolic quenching must be a quick
process, and a mixture of ice-cold water and methanol has been found to pro-
vide the highest extraction efficiency and minimal sample loss (Lin et al., 2007;
Sellick et al., 2008). After quenching, cells are lysed, polar/non-polar metabo-
lites are extracted, and analyzed. One advantage of metabolomics extractions
is that proteins or mRNA can be extracted simultaneously, which minimizes
the amount of experiments needed to obtain biological knowledge as well as
minimizing the variation that comes with repeated experiments (Sapcariu et al.,
2014).
Commonly used techniques for measuring metabolites include GC-MS (Hiller
et al., 2009), liquid chromatography coupled to mass spectrometry (LC-MS)
(Ewald et al., 2009), and nuclear magnetic resonance (NMR) (Lin et al., 2007),
but for the purpose of this thesis I will focus on GC-MS. In short, for this tech-
nique, metabolite extracts are transfered into the gas phase, run through a
capillary column with a stationary phase to aid with separation of different
compounds, and finally ionized and measured on a detector. GC-MS analyses
are highly reproducible, especially when using electron ionization (EI).
Metabolite extracts must be derivatized prior to gas phase transfer, in order
to maximize volatility of compounds and therefore increase the amount that
can be measured. For the work in this thesis, two types of compound deriva-
tization was used, both of which replace the hydrogen in polar groups with
non-polar derivatives. N-Methyl-N-trimethylsilylfluoroacetamide (MSTFA) was
added to extracts to create trimethylsilyl (TMS) groups, and N-tert-butyldimethylsilyl-
N-methyltrifluoroacetamide (MTBSTFA) was added to extracts to add tert-butyl
dimethylsilyl (TBDMS) groups. The different derivatives are used depending on
the compounds of interest in the analysis, as TBDMS groups are larger than TMS,
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some compounds (e.g. glucose) become too large for the detector to measure,
and therefore cannot be analyzed.
Finally, EI is a hard ionization technique, breaking the compound into mul-
tiple fragments before hitting the detector. This fragmentation pattern is re-
producible for all EI measurements, and acts as a fingerprint that allows for
the reproducible identification of metabolites based upon a library that can be
created through the measurement of analytical standards.
1.6.2 Stable isotope labeling and metabolic flux analysis
Through the utilization of stable isotope labeling in cells, metabolomics analy-
ses can be extended, allowing for the inference of the movement of metabolites
through metabolic pathways. Labeled carbon from these tracers is integrated
into metabolites through normal metabolic processes, and the labeling patterns
of the various metabolites are measured and interpreted, in a technique called
13C tracer analysis (Buescher et al., 2015). The application of this technique is
growing in metabolomics studies, and can be a very useful method of under-
standing how metabolic pathways change under different cellular conditions,
such as inflammation in macrophages (Michelucci et al., 2013; Jha et al., 2015).
To perform these experiments, cells are cultured in medium with a stable
isotope labeled tracer, targeted for the scientific question. 13C-labeled tracers
are commonly used in these analyses, and were used as well for the experi-
ments performed in the scope of this thesis. Once the labeled carbon source is
taken up, metabolism proceeds as normal under the experimental conditions,
and the labeled carbon is metabolized throughout the pathways utilized by the
cell. Depending on the differing metabolic pathways leading to target metabo-
lites, labeling patterns of the compounds are different, forming a unique mass
isotopomer distribution (MID). These MIDs can be measured by GC-MS, and
changes in metabolic fluxes can be inferred based upon the result.
For the experiments in this study, I utilized two tracers: [U-13C6]glucose and
[U-13C5]glutamine, allowing me to understand how carbons from these two
main cellular inputs distributed to metabolites in central carbon metabolism
under different experimental treatments.
GC-MS analysis, as described above, can differentiate between labeled and
unlabeled compounds, as well as compounds with different amounts of iso-
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Figure 7: An example of a mass isotopomer distribution (Based on Hiller et al. (2011)).
An differentially labeled example two atom compound is shown, as well as
corresponding spectra which depend upon which atoms are unlabeled (black
circle) or labeled (blue circle). Each labeled atom will shift the mass spectrum
by one unit (left side). It should be noted that it is not possible to distinguish
(in GC-MS analysis) between different isotopomers (i.e. compounds with the
same number of labeled atoms, but on different positions). A mixture of the
same compound with different amounts of labeled atoms will result in a
complex spectrum with all labeling patterns mixed (right side). With this
data, the MIDs of the compound can be algorithmically calculated.
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topic enrichment. Once the mass spectra is measured, MIDs can be calculated
for each metabolite (Figure 7). Each incorporated stable-isotope will shift the
spectrum of the compound fragment by one mass unit; for example, labeled
fragments of [U-13C5]glutamine will be shifted by five units (compared to non-
labeled glutamine).
It must be noted that stable isotopes are also present in the environment
(around 1% of carbon in nature are 13C isotopes), and these natural abun-
dances cause the formation of isotopic peaks in GC-MS spectra not containing
artificial labeling. This natural isotopic enrichment must be corrected for in
any calculation of MIDs.
1.7 objective of this thesis
The initiation of the pro-inflammatory phenotype in macrophages can be caused
by a variety of factors, including environmental pollution and bacterial infec-
tion. Many aspects of pro-inflammatory macrophages are well characterized,
such as cytokine expression, transcriptional changes, and phagocytic activity.
Upregulation of cytokines such as IL-1b, and TNF-α through NF-κB and MAPK sig-
naling pathways define the classical pro-inflammatory macrophage. However,
the investigation of metabolic changes of macrophages in the inflammatory
process remains an emerging field.
It is thought that macrophages can change their phenotype during the in-
flammatory process, leading to changes in metabolism which play a role in
modifying macrophage energy use and antimicrobial activity. Previous metabolic
studies have uncovered a glycolytic activity increase in pro-inflammatory macrophages
(regulated by cytokines and their effectors), as well as the increase of two
metabolites linked to inflammation: itaconic acid and succinic acid. While the
regulation of itaconic acid as an antimicrobial compound was found to be
controlled by Irg1/CAD activity, the buildup of succinic acid is due to a modi-
fication of TCA cycle activity.
The aim of this thesis is to follow up on the idea of the two metabolic break-
points leading to the accumulation of itaconic and succinic acid suggested by
Jha et al. (2015), in order to understand the connection between the important
metabolic players in pro-inflammatory macrophages. To do this, the following
questions guided this research:
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• Does environmental pollution lead to the same metabolic changes in
macrophages as classical bacterial infection?
• Is the pro-inflammatory macrophage phenotype comparable between pri-
mary cells and cell lines?
• How does the TCA cycle operate during inflammation, and how does it un-
couple from its classical activity during the response to pro-inflammatory
perturbations?
• Is there a connection between succinic acid and itaconic acid in pro-
inflammatory macrophages?
• Are the metabolic changes in pro-inflammatory macrophages regulated
in part by SIRT3?
Using classical and stable-isotope assisted metabolomics techniques, com-
bined with the analysis of gene and protein regulation, the multiple studies
in this work attempt to answer these questions as best as possible in order
to probe further into the changes in the metabolism of macrophages under
pro-inflammatory stimulation.
2
M AT E R I A L S A N D M E T H O D S
2.1 cell culture and reagents
The mouse macrophage RAW 264.7 cell line was obtained from ATCC (ATCC
TIB-71, Manassas, VA, USA). Cells were cultured in Dulbecco’s Modified Ea-
gle’s Medium (DMEM) 5796 (Sigma Aldrich) with 10% Fetal Bovine Serum
(PAA or Invitrogen) and 1% penicillin/streptamycine (Gibco, Invitrogen), and
stored in an incubator at 37◦C with 5% CO2. Cells were grown and cultured in
cell culture flasks (Thermo Fisher Scientific), and split through scraping three
times a week.
For BMDM experiments, bone marrow (frozen in Fetal Bovine Serum with
15% DMSO) from C57Bl/6 mice was obtained, and cultured for 7 days in
Roswell Park Memorial Institute medium (RPMI) 1640 VLE (Merck Millipore)
supplemented with 10% Fetal Bovine Serum and 20% L929 cell culture super-
natant (Dulbecco’s Modified Eagle’s Medium + 10% Fetal Bovine Serum) to
differentiate cells into BMDMs. Medium was changed on day 2 and day 5 to
promote differentiation, and cells were seeded on day 6, discarding any float-
ing cells. Cells were detached by scraping, and all cell seeding and experiments
were performed using RPMI without L929 supernatant.
The following inflammatory stimulants were used to induce pro-inflammatory
macropahges: Escherichia coli purified LPS (Sigma Aldrich), recombinant mouse
IFN-γ (R&D systems Europe). All concentrations for experiments are given in
the text, and follow commonly used concentrations. Honokiol (Sigma Aldrich)
was dissolved in ethanol and diluted in MilliQ water for stimulation. The max-
imum concentration of ethanol exposed to cells was 0.5%.
2.1.1 Stable isotope labeling experiments
For stable isotope labeling experiments, cells were cultured as above, but were
seeded in a labeled medium 24 hours before treatment.
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RAW cells were seeded in Dulbecco’s Modified Eagle’s Medium (D5030,
Sigma Aldrich), supplemented with 3.7 g/L of sodium bicarbonate and 10% di-
alyzed fetal bovine serum. 25 mmol/L glucose and 5 mmol/L glutamine were
also supplemented in the medium. For labeled glucose experiments, U-13C6-
Glucose (Cambridge Isotope Laboratories) was substituted, and for labeled
glutamine experiments, U-13C5-Glutamine (Campro Scientific) was substituted.
The pH of the finished medium was adjusted to 7.4, sterile filtered through a
0.22 µm Steriflip filter unit (Merck Millipore), and stored at 4◦C until use.
For BMDMs, RPMI 1640 was used, which contained either no glucose or no
glutamine. For labeled glucose experiments, 11 mmol/L of U-13C6-Glucose
(Cambridge Isotope Laboratories) was used, and for labeled glutamine ex-
periments, 2 mmol/L of U-13C5-Glutamine (Campro Scientific) was used. The
medium was pH adjusted and sterile filtered in the same manner as above.
2.2 stimulations and exposure
2.2.1 Inflammatory exposure in vitro
Cells were stimulated for 6 hours at stated concentrations, except for the time-
course experiments, where the time points are given. During stimulation, cells
were incubated at 37◦C with 5% CO2. All experimental treatments were per-
formed in biological triplicates.
2.2.2 Air-Liquid Interface Experiments
2.2.2.1 Cell culture
The mouse macrophage RAW 264.7 cell line was obtained from ATCC (ATCC©
TIB-71™). Cells were cultured in RPMI-1640 medium supplemented with 10%
(v/v) Fetal Bovine Serum and 100 U/ml penicillin, 100 mg/ml streptomycin
(Life Technologies, Darmstadt), and cultivated in an incubator at 37◦C with 5%
CO2. 24 hours before exposures, cells were seeded on PET Transwell© plates
(3450, Corning), and placed in an ALI device (Vitrocell), which was connected
to the engine. Cells were exposed to two treatments for each fuel type: un-
filtered exhaust gas, and exhaust gas filtered for particulate matter. Control
cells were placed in an incubator next to the ALI. For stable isotope labeling
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experiments, cells were seeded 24 hours before the experiment in RPMI-1640
medium as above, with 12.5 mmol/L U-13C6-Glucose (Cambridge Isotope Lab-
oratories, USA) substituted for unlabeled glucose.
2.2.2.2 Engine and exposure
A four-stroke single-cylinder direct-injected diesel engine test bed situated at
the University of Rostock in the Chair of Piston Machines and Internal Com-
bustion Engines was used to generate aerosol for the exposure study. Heavy
fuel oil HFO 180 was used as a representative fuel for ship operation outside of
sulfur emission control areas (SECAs). Distillate diesel fuel (DF) according to
DIN EN 590 was used as a reference. The DF fuel represents a modern, sulfur-
free distilled fuel as used in inland waterway transportation and SECAs. The
engine ran at four different operating points: 100%, 75%, 50%, and 25% load at
a nominal speed of 1,500 rev/min. A detailed characterization of the aerosol
composition at the ALI exposure system was performed, (Reda et al., 2015).
The duration of each operation point was set in accordance to their weighting
factors as described in ISO 8178-4 E2. The total cycle duration was 2 hours, and
this cycle was run twice for a single exposure. To obtain comparable particle
deposition doses for the experiments with the two fuel types, clean air dilu-
tion ratios of 1:40 and 1:100 were used for the exhaust aerosols of DF and HFO
emissions, respectively. Based on a post-experiment gravimetric filter analysis
of PM 2.5 and assuming a constant deposition probability of 1.5%, which was
determined using previous measurements from ALI exposure systems (Co-
mouth et al., 2013), the particle mass deposited on the lung cell monolayer
surface was calculated at 28 ± 1.5 ng/cm2 (DF) and 56 ± 0.7 ng/cm2 (HFO)
for the 4 hour exposure (Oeder et al., 2015).
2.2.2.3 Air-liquid interface exposure
An automated ALI exposure system station (VITROCELL Systems, GmbH,
Waldkirch, Germany) with 18 exposure positions was used as the interface
for cellular exposures of the diesel engine exhaust (Mülhopt et al., 2008). ALI
exposures were performed in a custom built mobile HICE S2 bio safety lab-
oratory, placed next to the engine hall. Diluted DF or HFO aerosol was led
through heated stainless steel lines from the engine test bed into the ALI sys-
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tem. Exposures were performed as described for ALI exposures of BEAS2B
and A549 epithelium cells (Oeder et al., 2015).
Cells were seeded in fetal bovine serum supplemented RPMI-1640 on trans-
ferable 24 mm Transwell™ inserts with a 0.4 µm pore polyester membrane
(Type #3450, Corning, NY, USA) 24h before exposure at a density of 1 x 106
cells/mL/insert (2.1 x 105 cells/cm2 growth area) with 1.5 mL cell culture
medium provided beneath the insert membrane. For cell exposure, the culture
medium on the apical side was completely removed and cells were placed in
the ALI exposure system with RPMI-1640 medium without FBS, supplemented
with 10 mM HEPES, provided at the basolateral side. Cells were then exposed
for 4h to the diluted and conditioned (85% r.h., 37◦C, maintained by the ALI
exposure system) aerosols with a controlled flow of 100 mL/min for each in-
sert (Mülhopt et al., 2016; Paur et al., 2011). Cells were exposed to both the
complete aerosol (with both particle phase and gas phase), and the gas phase
only (with particles filtered out of the complete aerosol by a high efficiency
particle membrane filter). All fuel-specific results represent both the filtered
and unfiltered treatments, unless otherwise stated. Cells kept in an incubator
at 37◦C with 5% CO2 were used as a control treatment. Metabolite extraction
and GC-MS analysis took place as described for the other experiments.
2.2.2.4 LDH release assay
After exposure, medium from the compartment under the membrane was col-
lected and frozen at -80◦C for later analysis. An aliquot was used for quantifi-
cation of released LDH, an indicator of plasma membrane integrity. An LDH
detection kit was used in accordance with the manufacturers‚ instructions
(Roche, Mannheim, Germany) with slight modifications: the dye solution was
diluted 1:1 (v/v) with phosphate-buffered saline to slow down the reaction
time caused by elevated LDH values due to the high cell densities used for ALI
exposure experiments. After 20 minutes, before saturation was reached, the
reaction was stopped and the absorbance of the reaction mix was measured at
490 nm with a microplate reader. Cells lysed with Triton X-100 (Sigma Aldrich)
were used as a positive control for cellular toxicity. Absorbance read from the
samples was normalized to the absorbance of blank medium. Statistical analy-
sis was performed using an analysis of variance (ANOVA) test, followed by a
post-hoc Tukey test for pairwise statistical analysis.
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2.3 cell counting
All cell counting was performed on cells grown in 12-well culture plates. Cell
culture medium was removed from the cells, and 1 mL of fresh medium was
added to each well. Cells were detached using a cell scraper and then trans-
fered into sample cups (Vi-Cell, Beckman Coulter). Cell count and viability
was measured using a cell viability analyzer (Vi-Cell, Beckman Coulter).
2.4 metabolite and mrna extraction protocol
For all inflammatory stimulation experiments, cells were seeded on 12 well
Nunclon coated plates (Thermo Scientific) two days before stimulation, to re-
duce variation and cellular stress due to handling.
The extraction protocol used in this thesis was published in 2014 Sapcariu
et al. (2014). Cells were washed with 0.9% NaCl, and immediately quenched
with 200 µL Chromasolv® Methanol (Sigma) at -20◦C and 200 µL Millipore
H2O on ice. Cell extracts were scraped and added to eppendorf tubes con-
taining 200 µL Chromasolv® chloroform at -20◦C. Tubes with extract were
then vortexed in a 4◦C shaker at 1400 rpm for 20 minutes and centrifuged
at 4◦C for 5 minutes at 20,000 g. This results in a three-phase separation of
the sample (Figure 8). 200 µL of the polar phase was transfered to a glass
vial specific for GC-MS analysis (Chromatographie Zubehor Trott), dried in a
rotary vacuum evaporator (Labconco) at -4◦C overnight, and stored at -80◦C
until analysis. The interphase was washed with methanol and stored at -80◦C
until RNA extraction. As an internal standard for unlabeled experiments, 13C-
Ribitol was added to the extraction water at a concentration of 1 µg/mL. For
labeled experiments, pentanedioic-d6 acid was added to the extraction water
at a concentration of 1 µg/mL.
2.5 gc-ms analysis
Derivitization was performed with an Gerstel autosampler directly before mea-
surement on the GC-MS. Dried metabolites were dissolved in 15 µL of 2%
methoxyamine hydrochloride in pyridine at a temperature of 40◦C for 60 min-
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Figure 8: Three-phase methanol-chloroform extraction for biological samples. Hy-
drophilic phase was used for metabolite analysis using GC-MS, the interphase
was used for qPCR analysis of extracted mRNA.
utes. Then, 15 µL of 2,2,2-trifluoro-N-methyl-N-trimethylsilyl-acetamide + 1%
chloro-trimethyl-silane was added and incubated at 40◦C for 30 minutes.
The metabolite extracts were measured on an Agilent 7890 GC containing
with a 30 m DB-35MS capillary column. The GC was connected to an Agilent
5975C MS operating in electron ionization (EI) at 70 eV.
1 µL of derivatized sample was hot injected at 270◦C in splitless mode. He-
lium was used as the carrier gas at a flow rate of 1 mL/min. The GC oven
temperature was kept constant at 100◦C for 2 minutes and then increased to
300◦C at 10◦C/min, where it was held for 4 minutes. The total GC-MS run time
of one sample was 26 minutes. For relative quantification of metabolite levels,
an alkane mix was run with the experimental sequence in order to provide
retention index calibration for the experimental samples.
The MS source was kept at a constant temperature of 230◦C and the quadrupole
at 150◦C. For relative quantification of metabolite levels, the detector was op-
erated in scan mode with an m/z range of 70 to 800. For analysis of stable
isotope labeling, the detector was operated in selected ion monitoring (SIM)
mode.
2.6 mrna extraction and quantitative real-time pcr
Washed interphases were dried in a rotary vacuum evaporator (Labconco) at
4◦C until all liquid phase was evaporated, and then brought to room tem-
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perature. RNA was extracted from the interphase of the samples using the
Qiagen RNeasy minikit, and RNA purity was checked on a Thermo Scientific
NanoDrop 2000C spectrophotometer. RNA was reverse transcribed into com-
plementary deoxyribonucleic acid (cDNA) using Invitrogen SuperScript™ III
reverse transcriptase, and stored at -20◦C until qPCR analysis. All treatments
were performed in technical triplicates on the 96-well plate for statistical ro-
bustness.
Analysis of cDNA was performed on a Roche LightCycler 480 II, with iq™
SYBR® green supermix including the fluorescent pigment and the polymerase
required for the reactions. The program for the qPCR was as follows: activation
of the polymerase for 3 minutes at 95◦C, 40 amplification cycles (30 seconds
denaturation at 95◦C, 30 seconds annealing at 60◦C, 30 seconds elongation at
72◦C), melting curve analysis, and a cooling step at 40◦C. Comparative quan-
tification (using the ∆∆Ct method) was performed using LibreOffice Calc. The
primers used in qPCR analysis are shown in Table 1.
2.7 metabolomics data analysis
Analysis of the raw peak data for both relative metabolite quantification and
MID analysis was performed using MetaboliteDetector (Hiller et al., 2009). This
software provided chromatogram alignment, peak matching, and automated
compound identification (using an in-house library). Raw data was exported
from MetaboliteDetector and processed using either R statistical software (R
Core Team, 2013) or LibreOffice Calc.
2.7.1 Relative Metabolite Quantification
All metabolites identified with MetaboliteDetector were verified through man-
ual chromatogram analysis of characteristic fragment peaks.
Normalization of the metabolite raw data was performed using the follow-
ing methods: First, all metabolites were normalized to the internal standard
added to the extraction water in order to control for variations in extraction
amount and GC-MS measurements. Where applicable, normalized metabolite
signal intensity was further normalized to cell count as well as to the control
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Il-1b forward 5’-GCTTCAGGCAGGCAGTATC-3’
Il-1b reverse 5’-AGGATGGGCTCTTCTTCAAAG-3’
Tnfα forward 5’-GGTTCTGTCCCTTTCACTCAC-3’
Tnfα reverse 5’-TGCCTCTTCTGCCAGTTCC-3’
Sirt1 forward 5’-GATGACAGAACGTCACACGC-3’
Sirt1 reverse 5’-ATTGTTCGAGGATCGGTGCC-3’
Sirt3 forward 5’-TCACAACCCCAAGCCCTTTT-3’
Sirt3 reverse 5’-GTGGGCTTCAACCAGCTTTG-3’
Sirt5 forward 5’-CCTGGATCCTGCCATTCTGG-3’
Sirt5 reverse 5’-GGGTCCGGGAAAATGAAACC-3’
Il6 forward 5’-CGGCCTTCCCTACTTCACAA-3’
Il6 reverse 5’-TCTGCAAGTGCATCATCGTT-3’
Il10 forward 5’-GCTGCCTGCTCTTACTGACT-3’
Il10 reverse 5’-CCTGGGGCATCACTTCTACC-3’
Irg1 forward 5’-GCAACATGATGCTCAAGTCTG-3’
Irg1 reverse 5’-TGCTCCTCCGAATGATACCA-3’
Hif-1 forward 5’-TGACGGCGACATGGTTTACA-3’
Hif-1 reverse 5’-AATATGGCCCGTGCAGTGAA-3’
Hif-2 forward 5’-AGGTCTGCAAAGGACTTCGG-3’
Hif-2 reverse 5’-CAAGTGTGAACTGCTGGTGC-3’
Casp3 forward 5’-TCATCTCGCTCTGGTACGGA-3’
Casp3 reverse 5’-ACACACACAAAGCTGCTCCT-3’
L27 forward 5’-ACATTGACGATGGCACCTC-3’
L27 reverse 5’-GCTTGGCGATCTTCTTCTTG-3’
Table 1: Primers used for qPCR Analysis
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(or t=0) treatment, in order to provide a standard basis for comparison across
experiments.
2.7.2 Mass Isotopomer Distribution Analysis
MIDs were determined from samples cultured with labeled tracers (as per Sec-
tion 2.1.1) using SIM measurements. The data was corrected for natural isotope
abundances using MetaboliteDetector software.
Weighted carbon contribution for labeled compounds was calculated using
the following formula:
1
n ∗
∑n
i=1Mi ∗ i
where n is the number of carbons in the compound of interest, and Mi is
the ith mass isotopomer. Glucose and Glutamine contribution was calculated
with samples from the same experimental replicate, and contribution from
other sources was calculated by:
1− (CGlc +CGln)
where CGlc and CGln are the weighted carbon contributions from glucose
and glutamine, respectively.
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simultaneous extraction of proteins and metabolites from cells
in culture
Sapcariu SC, Kanashova T, Weindl D, Ghelfi J, Dittmar G, Hiller K. Meth-
odsX. 2014, 1, 74-80. doi:10.1016/j.mex.2014.07.002
This manuscript was written by me, based upon a laboratory protocol
that is used in our lab as well as in the HICE project, in order to utilize
the same experimental sample for multiple omics analysis techniques. I
organized the preparation of the manuscript between all authors, and
wrote the majority of it. The section on proteomics sample preparation
and analysis was written by T. Kanashova, and the figure was created
by D. Weindl.
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G R A P H I C A L A B S T R A C T
Three-phase methanol–water–chloroform extraction for biological samples. Examples of components
available from each phase are shown. These different phases can be then used for a variety of different
analysis methods on different levels of cellular regulation.
A B S T R A C T
Proper sample preparation is an integral part of all omics approaches, and can drastically impact the results of a
wide number of analyses. As metabolomics and proteomics research approaches often yield complementary
information, it is desirable to have a sample preparation procedure which can yield information for both types of
analyses from the same cell population. This protocol explains a method for the separation and isolation of
metabolites and proteins from the same biological sample, in order for downstream use in metabolomics and
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Method details
Washing cells, quenching metabolism, extraction and separation of phases
Materials
 Living cells, cultured on petri dishes ormulti-well plates. Cells can be incubatedwith a labeled tracer
(for example: 13C or 15N) for downstream ﬂux analysis
– Cells should be conﬂuent in the wells, with a consistent cell number between samples. The
amount of cells will vary depending on cell type used, but we have found using around 1 million
cells in each well of a 6-well multiwell plate gives good results for both techniques.
 0.9% NaCl at room temperature
 High purity (MS grade) methanol at 208C
 High purity (MS grade) chloroform at 20 8C
 Millipore or equivalently pure water on ice
 Cell scrapers
 Eppendorf tube shaker at 48C
 Centrifuge at 48C
 Note: This list does not include generic laboratory equipment, which are assumed to be available.
Themetabolic proﬁle of a cell can change in as little as a few seconds. Therefore, themost important
step in metabolite extraction is the quenching of metabolism; this ensures that the metabolic
pathways in the cells do not continue to function, and that the cellular state at the point of extraction is
as close as possible to the desired analysis time point [1]. This quenching must be performed quickly.
There has been much discussion as to which extraction ﬂuids are best for quenching and measuring
metabolites [2,3]; however, it is generally agreed that a mixture of water and methanol provides the
best extraction efﬁciency with minimal loss. Both ﬂuids are added directly to the cells, and should be
kept as cold as possible (methanol at 20 8C and water on ice).
Once themetabolic processes have been quenched, the next step is to lyse the cells, separating both
the polar and non-polar metabolites from the other cellular substances at the same time. While
methanol and water will extract the polar metabolites from a sample, non-polar metabolites must be
separated with a non-polar solvent. Therefore, we use chloroform [4] with the methanol/water
mixture to separate the polar and non-polar metabolites efﬁciently. Adherent cells quenched with
methanol and water are scraped from the multi-well plates and added to cold chloroform to allow for
separation of polar and non-polar phases. These extracts are agitated to complete cell lysis and
centrifuged to fully separate the layers.
proteomics analyses simultaneously. In this way, two different levels of biological regulation can be studied in a
single sample, minimizing the variance that would result from multiple experiments. This protocol can be used
with both adherent and suspension cell cultures, and the extraction of metabolites from cellular medium is also
detailed, so that cellular uptake and secretion of metabolites can be quantiﬁed.
Advantages of this technique includes:
1. Inexpensive and quick to perform; this method does not require any kits.
2. Can be used on any cells in culture, including cell lines and primary cells extracted from living organisms.
3. A wide variety of different analysis techniques can be used, adding additional value to metabolomics data
analyzed from a sample; this is of high value in experimental systems biology.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).
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This is a crucial step for experimental consistency; different amounts of cells in different samples
will lead to incorrect comparisons of metabolite levels (which can also occur with cell seeding).
Therefore, care should be taken to adequately scrape all wells and transfer asmuch cellularmaterial as
possible from the wells to the chloroform.
After these steps, the cells are shaken to completely lyse the membranes allowing for a more
efﬁcient extraction of all possible biomolecules. After shaking, there should be a clear separation
between the polar and non-polar phase for themetabolites, with awell-deﬁned interphase containing
proteins and nucleic acids.
Procedure – adherent cells
The following procedure is for adherent cells cultured on a 6-wellmultiplate. For cells cultured on a
12-well multiplate, divide the amount of extraction ﬂuids by two. Amounts for other cell culture
vessels should be adjusted accordingly.
1. Retain medium for quantiﬁcation of cellular consumption and secretion of metabolites.
2. Wash cells with 1mL 0.9% NaCl. Phosphate buffer solution is avoided because it would create a
large phosphate peak during mass spectrometric analysis, masking lower intensity metabolites.
3. Quench cells by adding 400mLmethanol at20 8C followed by 400mLMillipore H2O on ice. As soon
as the methanol has been added, place the multiwell plate on ice for the next steps.
4. Scrape wells with a cell scraper. Make sure that as few cells as possible remain attached to the plate
through careful and thorough scraping.
5. Transfer cell extract into an Eppendorf tube containing 400mL chloroform at 20 8C.
6. Agitate cells in a tube shaker (pre-cooled to 4 8C) for 20min at 1400rpm, followed by 5min of
centrifugation at a minimum of 16,100g at 4 8C.
Procedure – suspension cells
The following procedure is for suspension cells cultured on a 6-well multiplate. For cells cultured
on a 12-well multiplate, divide the amount of extraction ﬂuids by two. Amounts for other cell culture
vessels should be adjusted accordingly.
1. Centrifuge cells in medium at 250g for 5min to pellet the cells, collect medium and retain for
quantiﬁcation of cellular consumption and secretion of metabolites.
2. Wash cells with 1mL 0.9% NaCl, centrifuge at 250g for 5min to pellet the cells, then discard NaCl.
3. Quench cells by adding 400mL methanol at 20 8C and 400mL Millipore H2O on ice.
4. Add 400mL chloroform at 208C to the cells, transfer to Eppendorf tubes.
5. Agitate cells in a tube shaker (pre-cooled to 4 8C) for 20min at 1400rpm, followed by 5min of
centrifugation at a minimum of 16,100g at 4 8C.
Procedure – cell types with both adherent and suspension fractions
For cell types which are both suspended and adherent in culture, the procedure must be modiﬁed
somewhat to avoid over-dilution of the metabolites. The following procedure is for cells cultured on a
6-well multiplate. Amounts for other cell culture vessels should be adjusted accordingly.
1. Collect themedium from the plate, centrifuge cells inmedium at 250g for 5min to pellet the cells,
collect medium and retain for quantiﬁcation of cellular consumption and secretion of metabolites.
2. Wash the adherent fraction and suspension fraction of cells each with 1mL 0.9% NaCl, centrifuge at
250g for 5min to pellet the cells, then discard NaCl.
3. Quench cells by adding 200mL methanol at 20 8C and 200mL Millipore H2O on ice to both the
suspension cell pellet and the adherent cell pellet. As soon as the methanol has been added, place
the multiwell plate on ice for the next steps.
4. Scrape wells containing adherent cell fraction with a cell scraper. Make sure that, as few cells as
possible remain attached to the plate through careful and thorough scraping. Transfer the quenched
cells to the corresponding non-adherent cell fraction.
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5. Add 400mL chloroform at 208C to the cells, transfer to Eppendorf tubes.
6. Agitate cells in a tube shaker (pre-cooled to 48C) for 20min at 1400rpm, followed by 5min of
centrifugation at a minimum of 16,100g at 4 8C.
Separation of phases and polar metabolite extraction
Materials
 Glass vials for GC analysis
 Rotary vacuum evaporator
 High purity (MS grade) methanol at 208C
After centrifugation, the different phases are now separated, and each one can be sampled for
further analysis with multiple techniques. For gas chromatography coupled to mass spectrometry
(GC/MS) analysis, samples need to be transfered to a glass vial and dried at a low temperature under
vacuum to avoid metabolite degradation. No liquid should remain in the glass vials after drying, and
vials should be brought to room temperature under vacuum to avoid condensation. If liquid is still
present in the vial, simply dry further in the rotary evaporator. For liquid chromatography coupled to
mass spectrometry (LC/MS) analysis, the polar phase can be used directly for injection after
transferring to a glass vial.
Procedure
The following procedure is for adherent cells cultured on a 6-wellmultiplate. For cells cultured on a
12-well multiplate, divide the amount of polar phase extracted by half.
1. Carefully transfer 300mL of the polar (upper) phase to a glass vial without touching the interphase.
2. Evaporate polar phase in a rotary vacuum evaporator at 48C until dry (or overnight). When vials
are dry, raise temperature on the rotary vacuum evaporator to room temperature for 30min before
removing the vials to avoid condensation. After capping vials, store at 80 8C until analysis.
3. Remove unused polar phase while avoiding the removal of any interphase. After polar phase is
almost completely removed, tilt the Eppendorf tube at a 458, so that the interphasemoves out of the
way and the non-polar phase is more easily accessible. If analysis of non-polar phase is to be
performed, transfer 300mL into a glass vial and dry the same way as the polar phase. Otherwise,
discard the non-polar phase, being careful not to remove the interphase.
4. Wash the interphase with 300mL methanol at 20 8C, and centrifuge for 10min at a minimum of
16,100g at 48C.
5. Remove methanol, process interphase to extract proteins or mRNA for further analysis.
Alternatively, add 50mL methanol at 20 8C, and store interphase at 80 8C until further extraction
of nucleic acids or proteins.
6. Optional: For metabolomics analysis of amino acids in the protein fraction, hydrolyze the interphase as
follows: Remove methanol from interphase. Heat interphase overnight in 400mL of 6MHCl in a
tightly sealed tube at 1008C. Transfer 100mL to a glass vial and dry in a rotary vacuum evaporator at
48C until dry. Store at 80 8C until analysis.
Protein extraction from interphase and sample preparation for LC/MS proteomics analysis
Materials
 Denaturation buffer (6mol/L urea, 2mol/L thiourea, 20mmol/L HEPES, adjusted to pH 8.0)
 10mmol/L TCEP (tris(2-carboxyethyl)phosphine), dissolved in ABC-buffer (50 mmol/L ammonium
bicarbonate, adjusted to pH 8.5)
 55mmol/L chloroacetamide, dissolved in ABC-buffer (as above)
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 0.5 mg/mL Endopeptidase LysC dissolved in ABC-buffer (as above) – trypsin or other proteases can
also be used (at the same concentration)
 10% triﬂuoroacetic acid (TFA)
 Rotary vacuum evaporator
 Sonicator
 Stage tips, used for desalting
For proteomics analyses, it is necessary to further process the interphase so that the proteins
contained within can be analyzed on an LC-MS/MS instrument. For the proteomics analysis the
proteins have to be chemically modiﬁed and digested to peptides. The proteins are ﬁrst unfolded and
the disulﬁde bonds are reduced, removing their tertiary and secondary structure, leaving only a chain
of amino acids. The second step is the alkylation of the cysteines in order to prevent the spontaneous
formation of disulﬁde bonds. The last step is the digestwith a speciﬁc protease to generate peptides for
the LC-MS/MS analysis. In case the LC system is not equipped with a pre-column the peptides can be
concentrated and desalted using stage-tip puriﬁcation [5].
Procedure
1. Dry the washed interphases (containing the protein fraction) for 15min in a rotary vacuum
evaporator at 35 8C.
2. Resuspend the proteins in 60mL of denaturation buffer, and sonicate for 1min to break up protein
aggregates.
3. Quantify proteins using a Bradford assay, and isolate a total amount of 100mg of protein.
4. Mix 2mL of the TCEP solutionwith the 100mg of the sample protein (in solution) in a newEppendorf
tube, and incubate for 30min at room temperature to reduce the disulﬁde bonds in the proteins.
5. Add 1mL of chloroacetamide solution to 10mL of the sample protein, and incubate for 20min at
room temperature, alkylating the cysteine residues.
6. Add 4mL of LysC to the solution, and incubate for 3h at room temperature to digest the proteins. At
this point, the samples can be acidiﬁed to pH <2.5 by adding 10mL of 10% TFA solution to stop the
digestion, fractionated, desalted using stage tips, and analyzed using LC-MS/MS.
As an alternative to the LysC digestion in step 6, the proteins can be digested using trypsin using the
following steps:
 In this case, dilute the sample with 4 ABC (Make sure the end concentration of urea in the
sample does not exceed 2mol/L).
 Next, add 2mL trypsin and incubate overnight at room temperature. Stop the digestion by adding
10mL of 10% TFA solution, acidifying the sample to pH <2.5. At this point, the samples can be
fractionated, desalted using stage tips, and analyzed using LC-MS/MS.
Extraction of metabolites from cell culture medium
Materials
 An 8:1 mixture of methanol:H2O at 20 8C
 Glass vials for GC analysis
 Centrifuge at 48C
 Refrigerated rotary vacuum evaporator
An important part of characterizing the metabolic state of cells is understanding the uptake and
secretion of biomolecules. This can bemeasured throughmetabolomic analysis of cell culturemedium
used in an experiment. This information can be used to understand the energetic needs of a cell in
different conditions, and is complementary to the amounts of metabolites inside cellular
compartments. For analysis methods such as 13C-metabolic ﬂux analysis, quantiﬁcation of cellular
uptake and secretion rates are a vital part of the information needed to infer metabolic ﬂuxes [6].
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Procedure
The following procedure is for high glucose medium (25mmol/L). For media with less glucose, the
dilutions can be reduced.
1. Prepare Eppendorf tubes with 450mL 8:1 methanol:H2O at 20 8C.
2. Mix medium well; transfer 50mL to the extraction ﬂuid. Mix by shortly vortexing.
3. Centrifuge tubes for 5min at a minimum of 16,100g at 48C.
4. Transfer 100mL of supernatant to a glass vial and dry in a rotary vacuum evaporator at 48C. Cap
and store vials at 80 8C until analysis.
Optional: extension of this technique
If desired, alternate extraction techniques can be applied to the interphase after metabolic
extraction. As the interphase contains both nucleic acids and proteins, these biomolecules can be
isolated for alternate forms of analysis simultaneously with metabolomics. A hydrolysis of the
interphase would break down the biomolecules, allowing analysis of individual nucleobases or amino
acids using GC/MS and LC/MS. Nucleic acids, such as mRNA or DNA, can be extracted and used for
transcriptomics and genomics analyses (microarrays, qPCRs, and others).
Additional information
Integration of biological data across multiple levels of regulation increases the robustness of any
experimental result. In many cases, separate experiments are performed (either sequentially or in
parallel) using the same conditions, in order to target proteins, metabolites, RNA, or DNA through the
individual experiments. Even though care is taken to minimize variation, differences between
experiments can sometimes occur due to forces outside of the experimentalist’s control. Methods
which enable extraction of multiple types of biological material from single experiments allow direct
comparison of different cellular activities.
Sample preparation determines the overall sensitivity, accuracy, and robustness of a biological
analysis, and is therefore a very important step in experimental design. Thus, it is also the ideal place to
modify a protocol for the extraction of multiple type of biological materials. Since Bligh and Dyer
published their protocol on extraction of lipids [4], there has been a consistent effort to improve upon
extraction methods for metabolomics analyses. Particularly in recent times, as the methods and
techniques of metabolomics have increased in use, there has been a concurrent increase of
comparisons of different improvements on metabolite extraction protocols.
Complementary to metabolomics analysis, mass spectrometry-based proteomics can be used to
investigate the protein composition of a cell, to determine the members of protein complexes, their
structure, the protein composition of organelles, and the dynamics of these processes. Protocols for the
extraction of proteins have also been steadily improving over the last few decades [7,8], and it is
possible to take advantage of the similarities between these techniques and metabolomics extraction
techniques to extend current methods.
As it has been often stated that the chloroform/methanol/water extraction is optimal over a large
range of compound classes [2,3,9], we intend to broaden the scope of this protocol, including amethod
for quantiﬁcation of cellular metabolic uptake and secretion as well as adding the ability for
simultaneous proteomics analysis (or analyses of other ‘‘omics’’ levels) in the same sample. This will
allow for more robust systems biology approaches for the integration of different cellular regulatory
levels, where metabolomics can be used as a base for the understanding of different cellular
phenotypes.
It should be noted that this extraction technique could be applied for a wide variety of different
approaches. Modern techniques, such as 13C-ﬂux analysis, stable isotope labeling by amino acids in
cell culture (SILAC) proteomics, or the analysis of the posttranslational modiﬁcation state of proteins
and their dynamics [8] can be used along with this protocol.
Roume et al. [10] have previously described a comprehensivemethod for extraction frommicrobial
communities; while this method is comprehensive, it requires multiple kits and a large time
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commitment. The protocol described here is inexpensive and relatively quick to perform. In addition,
our protocol is designed for and tested onmammalian as opposed to microbial cells. Weckwerth et al.
[11] also have an existing protocol for extraction of multiple types of biomolecules from a single
sample, but their protocol is designed primarily for plant cells.More steps are necessary to break down
the plant cell walls, which increases the time and complexity compared to the technique described
here.
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Abstract
Background
Ship engine emissions are important with regard to lung and cardiovascular diseases espe-
cially in coastal regions worldwide. Known cellular responses to combustion particles in-
clude oxidative stress and inflammatory signalling.
Objectives
To provide a molecular link between the chemical and physical characteristics of ship emis-
sion particles and the cellular responses they elicit and to identify potentially harmful frac-
tions in shipping emission aerosols.
Methods
Through an air-liquid interface exposure system, we exposed human lung cells under realis-
tic in vitro conditions to exhaust fumes from a ship engine running on either common heavy
fuel oil (HFO) or cleaner-burning diesel fuel (DF). Advanced chemical analyses of the ex-
haust aerosols were combined with transcriptional, proteomic and metabolomic profiling in-
cluding isotope labelling methods to characterise the lung cell responses.
Results
The HFO emissions contained high concentrations of toxic compounds such as metals and
polycyclic aromatic hydrocarbon, and were higher in particle mass. These compounds were
lower in DF emissions, which in turn had higher concentrations of elemental carbon (“soot”).
Common cellular reactions included cellular stress responses and endocytosis. Reactions
to HFO emissions were dominated by oxidative stress and inflammatory responses, where-
as DF emissions induced generally a broader biological response than HFO emissions and
affected essential cellular pathways such as energy metabolism, protein synthesis, and
chromatin modification.
Conclusions
Despite a lower content of known toxic compounds, combustion particles from the clean
shipping fuel DF influenced several essential pathways of lung cell metabolism more
strongly than particles from the unrefined fuel HFO. This might be attributable to a higher
soot content in DF. Thus the role of diesel soot, which is a known carcinogen in acute air
pollution-induced health effects should be further investigated. For the use of HFO and DF
we recommend a reduction of carbonaceous soot in the ship emissions by implementation
of filtration devices.
Introduction
Epidemiological studies provide compelling evidence that pollution by airborne particulate
matter (PM) derived from fossil fuel combustion is an important cause of morbidity and
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premature death [1, 2]. Chronic PM exposure can induce short-term (e.g., cardiovascular dis-
eases or asthma) and long-term health effects, most notably cancer. Diesel automobile emis-
sions were recently classified as human carcinogens by the International Agency for Research
on Cancer [3].
Diesel ship emissions substantially contribute to worldwide anthropogenic PM levels, which
account for up to 50% of the PM-related air pollution in certain coastal areas, rivers and ports
[4–7]. Epidemiological studies attribute up to 60,000 annual deaths from lung and cardiovascu-
lar disease [8] to ship engine PM. A variety of new regulations will soon be implemented to en-
sure cleaner ship emissions [9–11]. Low-grade heavy fuel oils (HFOs) contain high levels of
sulphur, toxic polycyclic aromatic hydrocarbons (PAHs) and transition metals. Current regula-
tions target HFO use by limiting their sulphur content. In this context, the maximum sulphur
content in shipping fuel is internationally regulated by the International Maritime Organisa-
tion (IMO) at 3.5%; in most European and US coastal areas, the maximum allowed sulphur
content is 1% (Sulphur Emission Control Areas, SECA) [12, 13]. Furthermore, in 2015, a 0.1%
sulphur fuel limit will be implemented in the Baltic and North Sea SECAs [14]. To comply
with these new sulphur limits, highly refined distillate fuels are necessary (diesel fuel, DF, or
marine gas oil, MGO). Currently, MGO is the most used distillate fuel for marine shipping and
contains up to 1% sulphur. In 2011, 170 million tons of HFO and 43 million tons of MGO and
DF were consumed by ship diesel engines worldwide [15, 16]. This volume corresponds to ap-
proximately 21% of global fuel consumption [17].
The biological and health effects of land-based diesel engine emissions have been extensively
studied using submersed cell cultures subjected to collected diesel exhaust particles [18, 19].
This submersed cell culture approach neglects the effect of airborne particle exposure, which
can result in low sensitivity in measuring biological effects [20]. An alternative is the air-liquid
interface (ALI) cell exposure technology. Current systems are technically mature enough to en-
able reproducible, direct, on-site exposure of lung cell culture to emission aerosols under realis-
tic dilution, flow and humidity conditions [21]. Multiple ALI-exposure studies using car diesel
engines [22–25] highlight the improved sensitivity of ALI systems compared with submerged
toxicological test systems that use collected diesel exhaust particles (DEP) [20].
Up to now three main causes for PM-induced health effects have been identified: genotoxi-
city, inflammation and oxidative stress; other mechanisms have also been described [19]. Thus
far, all information on diesel PM has been inferred from research on car emissions. However,
diesel emissions from ships differ greatly from car or truck diesel emissions due to the fuel
composition (HFO) and combustion characteristics of ship engines [26]. Thus, the practice
currently used to estimate the health impacts of ship diesel emissions based on analogous car
or truck emissions [8, 12, 27] is problematic. The high levels of toxic compounds [6, 28] suggest
that HFO emissions produce more detrimental acute and chronic toxic effects than car or
truck diesel emissions.
This study targets the biological effects of airborne PM from both diesel and HFO ship
emissions based on their chemical compositions. The joint analysis of the biological multi-
omics data with the comprehensive aerosol analysis results provides an extensive overview of
affected biological mechanisms and pathways and further identifies potentially harmful frac-
tions of the shipping aerosols.
Results and Discussion
Experimental setup
The experimental setup is illustrated in Fig 1 (details in S1 and S2 Figs and in S1 Text). Briefly,
we operated a four-stroke, one-cylinder common rail research ship diesel engine (80 kW)
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using either HFO (HFO 180) containing 1.6% sulphur or DF containing less than 0.001% sul-
phur and 3.2% plant oil methyl ester in compliance with the 2014 IMO-SECA-legislation (DIN
EN590, see S1 Fig for the engine and fuel properties), which represents the common dual-fuel
use in commercial shipping [10, 29]. The engine was operated according to the test cycle ISO
8178–4 E2 for ship diesel engines with a balance between harbour-manoeuvring and cruising
engine-loads (Fig 2). The combustion aerosol was cooled and diluted with sterile air. Chemical
and physical properties of the HFO and DF aerosol were comprehensively characterised using
state-of-the-art, on-line and real-time techniques as well as off-line filter sample analyses. Re-
sults are summarised in Fig 2 (for details, see SI). In parallel with aerosol characterisation, con-
fluent layers of two human epithelial lung cell lines (the human lung alveolar cancer cell line
A549, purchased from the American Type Culture Collection, ATCC CCL-185; http://www.
lgcstandards-atcc.org/Products/All/CCL-185.aspx, and human SV40-immortalised bronchial
epithelial cells BEAS-2B, purchased from ATCC, CRL-9609; http://www.lgcstandards-atcc.org/
Fig 1. Experimental set-up and global omics analyses. (A) An 80 KW common-rail-ship diesel engine was operated with heavy fuel oil (HFO) or refined
diesel fuel (DF). The exhaust aerosols were diluted and cooled with clean air. On-line real-time mass spectrometry, particle-sizing, sensor IR-spectrometry
and other techniques were used to characterise the chemical composition and physical properties of the particles and gas phase. Filter sampling of the
particulate matter (PM) was performed to further characterise the PM composition. Lung cells were synchronously exposed at the air-liquid-interface (ALI) to
aerosol or particle-filtered aerosol as a reference. The cellular responses were characterised in triplicate at the transcriptome (BEAS-2B), proteome and
metabolome (A549) levels with stable isotope labelling (SILAC and 13C6-glucose). (B) Heatmap showing the global regulation of the transcriptome, proteome
and metabolome.
doi:10.1371/journal.pone.0126536.g001
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Products/All/CRL-9609.aspx)) [30] were exposed to the diluted engine exhaust for 4 h at the
ALI (Fig 1). Epithelial lung cells have direct contact to inhaled aerosol particles and gases and
were therefore used as a model of aerosol inhalation. The cell lines A549 and BEAS-2B have
been widely used for testing particles and gases at the air-liquid-interface [31–36]. The BEAS-
2B cells are considered to better resemble the situation in human lung tissue while require-
ments for the cultivation of the cancer derived cell line A549 are better suited for labeling with
the L-D4-Lysine isotope maker for the quantitative proteomics. The transcriptomics methodol-
ogy is not based on metabolic labelling and thus well suited for the analysis of BEAS-2B cells.
The quantitative comparative proteomics approach requires the labelling of the cells with
D4-Lysine. However the BEAS-2B cells require specialized media and coating of the plates,
which is currently incompatible with the metabolic labelling. Therefore simultaneuos SILAC-
based proteomic and metabolic analysis was performed with the established A549 cell model.
In summary the cells were analysed using transcriptome (BEAS-B), SILAC-proteome (A549),
metabolome and metabolic flux measurements (A549) as well as cytotoxicity tests (A549). The
omics data are stored in Gene Expression Omnibus (GSE63962) and Proteomics DB
Fig 2. Chemical and physical aerosol characterisation. (A) The ship diesel engine was operated for 4 h in
accordance with the IMO-test cycle. (B) Approximately 28 ng/cm2 and 56 ng/cm2 were delivered to the cells
from DF and HFO, respectively, with different size distributions. The HFO predominantly contained particles
<50 nm, and the DF predominantly contained particles >200 nm, both in mass and number. (C) Number of
chemical species in the EA particles. (D) Transmission electron microscope (TEM) images and energy-
dispersive X-ray (EDX) spectra of DF-EA and HFO-EA; heavy elements (black speckles, arrow); and
contributions of the elements V, P, Fe and Ni in the HFO particles using EDX (* = grid-material). (E)
Exemplary EA concentrations (right) and concentration ratios (left) for particulate matter-bound species. For
all experiments, n = 3.
doi:10.1371/journal.pone.0126536.g002
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(PRDB004215), respectively. All experiments were performed in triplicate (3 independent ex-
posures) and referenced to filtered aerosol (for normalising the effects induced by the gas
phase) because particles and particle-related chemicals play an important role in the health rel-
evance of diesel exhaust [37] and are therefor in the focus of this study.
The first phase of the experiment was used to find the optimal dose for the large-scale analy-
sis. Cells in the setup were exposed to different concentrations of aerosols. The reaction of the
cells was monitored using the Alamar Blue viability test. Due to the higher particle concentra-
tion in HFO-exhaust (see below) a dilution of 1:100 was required to achieve a non-impaired
cell status while for DF-exhaust a lower dilution of 1:40 was possible without any viability im-
pairment (i.e., a no acute toxicity exhaust dilution; S3A Fig). By applying the different dilution
ratios of 1:40 (DF) and 1:100 (HFO) for the exhaust gases for no acute toxicity at 4 h exposure,
a similar deposition dose (deposited particle mass per confluent cell culture surface area, see
below) was achieved. Based on a gravimetric filter analysis of PM 2.5 and assuming a size-inde-
pendent, constant deposition probability of 1,5% after Comouth et al. [38], the accumulated
particle mass deposited on the lung cell monolayer surface area was roughly estimated as
28 ± 1.5 (DF) and 56 ± 0.7 ng/cm2 (HFO) per 4 h exposure duration (see S3C Fig) with the var-
iance of the mass measurement expressed by the standard deviation of the filter samples. A
more elaborated model taking into account the particle size distribution from an electric low
pressure impactor (ELPI) and a size dependent deposition probability after Comouth et al.
[38], which was determined using previous measurements from ALI exposure systems, predicts
15.7 (DF) and 41.5 ng/cm2 (HFO) per 4 h exposure. Even for improved deposition approxima-
tion model, the estimated uncertainties, however, are rather high (about a factor of 2). There-
fore the deposition dose in both cases can be considered being approximately equal for DF and
HFO. We decided to perform the exposure for omics measurements at these dilutions, in order
to compare the specific molecular biological effect strength at an about equal deposition dose.
Note that in the following all aerosol parameters are reported considering the specific emis-
sion-aerosol dilution factors (i.e. the exposure aerosol, EA, as delivered to the cells).
Chemical and physical analysis
Consistent with previous studies [29], only small concentration differences of gaseous com-
pounds were found in the emissions of the ship engine using the two fuels. An exception was
SO2 (4 mg/m
3), which was below toxicity threshold after dilution in the HFO-EA. In addition,
the EA concentrations of the further potentially toxic gases NO, NO2 and CO were below 16.3,
0.4 and 7 ppm, respectively. These values are below the reported toxicity thresholds for the air-
liquid interface [39, 40] and even below the general NIOHS lifetime workplace 8-hr exposure
limit values of 25, 1 and 35 ppm, respectively [41].
The concentration of particles with an aerodynamic diameter larger than 200 nm was higher
for the DF-EA (particle number and mass concentration), whereas nanoparticles smaller than
50 nm were approximately 100-fold more abundant for the HFO-EA (see the size distributions
in Fig 2). However, note that the mass contribution of these nanoparticles is very small. TEM
images of the particles show that the smaller HFO particles (Fig 2) contained high levels of
amorphous organic material around carbonaceous fractal cores with metal inclusions. The
DF-EA particle analysis reveals a different picture (Fig 2), in which the particles appear larger
and are mostly composed of pure carbonaceous aggregates with spherical soot cores (Ø ~ 20–
30 nm). A layered graphite-like carbon structure became visible at a higher TEMmagnification
(S3 Fig). Based on the size-dependent deposition function described by Comouth et al. [38] (S3
Fig) and the low specific density of the observed fractal soot aggregates in DF-EA (Fig 2), the
deposited mass for the DF-EA cell exposure experiments is slightly lower than the above
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estimates. The particles deposited from the HFO-EA were of a higher dose in mass and number
compared to the DF-EA exposure.
Energy-dispersive X-ray spectroscopy (EDX, Fig 2) on TEM showed large differences be-
tween HFO-EA and DF-EA particles with regard to the abundance of heavy elements. High in-
tensities of elements such as vanadium, nickel, sulphur and iron were detected in the HFO
particles, whereas the DF particles primarily contained carbon and oxygen in the EDX spec-
trum. Fig 2 shows an overview of the differences in the inorganic and organic chemical compo-
sition (Fig 2) as well as the absolute concentrations of the respective substances in the DF- and
HFO-exposure aerosol particles (Fig 2 and S4 Fig). Almost all of the measured components, ex-
cept elemental carbon and black carbon, were more abundant in HFO-EA compared with
DF-EA, despite a 2.5-fold higher dilution for HFO-EA.
On-line aerosol mass spectrometry and off-line analyses showed considerably higher mass
concentrations of particle-bound organic material and much more complex organic material
in the HFO-EA (S1 Table). High-resolution mass spectrometry (ESI-FTICR-MS) revealed
3631 different polar organic compounds in the HFO particles compared with only 321 in the
DF particles (Fig 2); 244 compounds were common to both fuel types. The quantification of ar-
omatic and aliphatic compounds (S4 Fig) revealed that higher molecular weight components
were more abundant in the HFO particles (green text in Fig 2), such as the higher molecular
weight carcinogenic PAH benzo[a]pyrene (Fig 2 and S4 Fig). The sum of PAH toxicity equiva-
lency factors (Fig 2), which ranks different toxic PAHs weighted by their concentration and rel-
ative toxicity, was more than 10-fold higher in HFO-PM compared with DF-PM (Fig 2). The
only component over-represented in the DF-PM was the elemental carbon fraction (EC) and
the corresponding optically measured “black carbon” factor (BC; Fig 2).
Summarising the chemical and physical characterisations, particles emitted from ship en-
gines differ in concentration, size distribution, morphological appearance and chemical com-
position depending on whether DF or HFO is used. The DF particles in the inhalable size
region were dominated by elemental carbon-rich soot-aggregate particles [29], whereas the
HFO particles were smaller (nanoparticles) and rich in organic material, including known or-
ganic air toxicants (PAHs and their derivatives) and reactive transition metals such as V, Ni, Fe
and Zn (S4 Fig). However, it shall be noted that also DF-PM contains organic compounds in
relatively high concentrations. The HFO-PM just contains much higher concentrations (Fig 2).
Exposure and deposition dose
We exposed human lung cells for 4 h to concentrations which are corresponding to occupation-
al exposure scenarios or 10 times the concentration of an ambient high concentration scenario
(EA ~ 390 μg DF PM2.5/m2 and ~760 μg HFO PM2.5/m2). This concentration corresponds to
an ALI mass deposition dose of about 28 and 56 ng PM/cm2 for DF and HFO respectively.
These doses can be related to the human respiratory tract using the specific deposition effi-
ciency for different lung regions. From the measured size distribution and an estimated effective
particle density based on the mass-mobility-relation for aggregated diesel particles (between 1.1
and about 0.1 g cm-3, derived from [42, 43]), a deposition simulation was performed using a re-
cently updated model [44, 45] for the tracheobronchial lung region. A 4 h exposure of a human
being to the EA concentrations used in our experiments would result to a tracheobronchial de-
position of about 1.5 and 5 ng PM/cm2 for DF and HFO, respectively. Thus the deposited mass
in an ALI experiment corresponds to about 3 days (DF) or 2 days (HFO) exposure time for an
exposed person (note that for an equal dilution of 1:100 in both EAs the actual deposited tra-
cheobronchial dose for DF would correspond to a 7.5 days exposure of a person). However, one
should keep in mind that the size distribution may change quickly in the ambient atmosphere
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and in the airways, e.g. by coagulation or water condensation, causing additional uncertainty
thereby. The similarity between the size dependent deposition curve [38] for the ALI-system
and for the lung deposition curve [44] suggests a good transferability of the results, in particular
for the tracheobronchial region. In conclusion, the deposited mass concentration of at an equal
dilution of DF PMmass would be about ¼ of the deposited HFO PM. This however, only holds
true for directly emitted aerosols. In the atmosphere the more polar, sulphate containing HFO
emission particle will quickly grow considerably by water condensation, while the hydrophobic
DF particles size distribution will remain stable for longer time [46, 47]. Therefore, emission
size distributions might, to some extent, equalise soon.
Biological analysis
To relate the extensive chemical and physical characterisation of the exhaust aerosols to biolog-
ical effects, the HFO and DF emission particles were directly deposited on human lung cells
using ALI exposure technology. Transcriptome, proteome, metabolome and metabolic flux
analyses were performed, which yielded parallel and relative quantification of 42205 different
transcripts, 6192 proteins and 400 metabolic molecules. To reduce variability, the proteins and
metabolites were extracted from the same cell material (A549) that was previously metabolical-
ly labelled using D4-lysine (SILAC proteomics) and
13C6-glucose (metabolic flux analysis). Ri-
bonucleic acid (RNA) was isolated from BEAS-2B cells exposed through the same ALI
exposure system and was used for the transcriptome analyses [20].
The transcriptome, proteome and metabolome analyses revealed widespread changes in the
cellular system upon exposure to both HFO and DF aerosol particles. Surprisingly, more gene
expression levels were regulated in the DF-particle-exposed cells (i.e., the response was more
widespread compared with the HFO-particle-treated cells on all “omic”-levels; p<0.001, Figs 1
and 3 and S5 Fig). The most significantly regulated genes, proteins and metabolites also dif-
fered between the DF and HFO (S6 Fig), which shows that the response to emissions of each
type of fuel differed quantitatively and qualitatively in both human lung cell lines. A higher reg-
ulation alone only proofs a stronger biological reaction onto the deposited PM at the given ex-
posure conditions (i.e. 4 h exposure at a deposition dose below measurable cytotoxicity) and
does not necessarily indicate a higher toxicity or risk of disease.
Further conclusions can be drawn from a specific biological pathway analysis. Pro-inflamma-
tory signaling, chemical response (such as xenobiotic metabolism) and oxidative stress pathways
were indicated by the regulated genes (Fig 3 and S6 Fig)[19]. The HFO particles specifically in-
duced the transcription of primary and secondary inflammation markers (IL-8, IL-6 and IL-1),
and both fuel types affected the cytokines CSF3, CXCL1, and CXCL2. Considering xenobiotic
metabolism, CYP1A1 (PAHmetabolism) was induced by exposure to HFO particles (which cor-
responds to the higher PAH concentrations in HFO PM), whereas the DF particles affected
other cytochromes (CYP3A4 and CYP17A1) and the carbosulphotransferase CHST6 (Fig 3).
In addition to these, in the context of aerosol exposure well-known pathways [19, 48], we
searched for other cellular responses undergoing modulation. A meta-analysis combining the
proteome and transcriptome data was performed to examine the significant enrichment of
gene ontology (GO) terms. The results indicate that the HFO and DF particle effects were dis-
tinct (Fig 3 and, in more detail, S7 Fig). Particles from both fuels induced effects on cell motili-
ty, the cellular stress response, the response to organic chemicals, proliferation and cell death
(Fig 3 and S7 Fig). Genes and proteins associated with vesicle transport pathways were en-
riched, which might be connected to the endocytosis of diesel particulate matter.
The pathways specifically regulated by DF particle exposure included the general translation
pathway (Fig 3, S7 Fig and S2 Table). The translational elongation, RNA-processing and
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ribosome translation pathways were down-regulated, whereas the pathways that affect chroma-
tin organisation and modification were up-regulated. The down-regulated pathways included
histone acetylation, which may result in DF particle-induced epigenetic changes. Other path-
ways modulated by DF particles were involved in processes such as cell junction organisation
and cell adhesion. Pathways such as the energy metabolism, cell junction and cell adhesion
were clearly affected in both cell lines when assessed using transcriptomics and proteomics but
differed in the direction of regulation (Table 1, S2 Table and Fig 3), which indicates a time-de-
layed reaction in the cell. Exposure to DF particles induced mitochondria-associated genes and
proteins, which indicates that mitochondrial stress was induced, whereas the HFO particles did
not yield this response.
Pathways specifically regulated by the HFO particles include the homeostasis, oxidative
stress and inflammatory response pathways, whereas the metabolic and biosynthetic processes
were slightly down-regulated (Fig 3 and S2 Table).
Fig 3. Effects of shipping particles on lung cells. The net effects from the particles were referenced against the gaseous phase of the emissions. (A)
Number of the regulated components in the transcriptome shows more genes regulated by the DF than the HFO particles (in BEAS-2B cells). Similar results
were observed for the proteome (B) and metabolome (C) (in A549 cells). (D) Meta-analyses for the transcriptome and proteome using the combined Gene
Ontology (GO) term analysis of the 10%most regulated transcripts and proteins. Individual GO terms are listed in S2 Table; the hierarchical pathways are
indicated on the right. (E) Gene regulation of Wiki-pathway bioactivation; (F) gene regulation of Wiki-pathway inflammation; g, secreted metabolites; and h,
metabolic flux measurements using 13C-labelled glucose. For all experiments, n = 3.
doi:10.1371/journal.pone.0126536.g003
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Interestingly, the proteomics data reveal a direct induction of cell-cell interaction remodel-
ling, whereas the transcriptomics data show a down-regulation of similar GO terms. This find-
ing can be explained by assuming an immediate response of the proteome e.g. by stabilizing
the already synthesized proteins, while the transcriptome shows the shut-down of the system
in a time-delayed response. Although 40% of the observed protein regulation can be explained
by the changes in mRNA abundance, most of the changes indicate other modes of regulation.
Protein can be degraded in direct response to PM exposure, and translation or transcription
may be too slow to change the protein concentrations after 4 h of exposure [49].
The metabolome analyses supported the finding that biosynthetic and protein synthesis
processes were down-regulated in the DF particle-treated cells. ATP-binding cassette trans-
porters, which are involved in actively transporting biomolecules across membranes, were also
affected (S2 Table). Further information supporting the inhibition of biosynthetic activities in-
cludes the negatively affected metabolites secreted by the cells (Fig 3). The pathways affected
by HFO particle exposure include glycolysis and pyrimidine metabolism. Glycolysis is a path-
way that is typically altered during inflammation and is generally increased in cells under in-
flammatory conditions [50].
Glucose flux into lactic acid through glycolysis was significantly reduced (p<0.05) in cells
treated with DF particles (Fig 3 and S9 Fig). Mammalian cells oxidise glucose and glutamine in
the TCA cycle to produce NADH/H+, which is re-oxidised in the respiratory chain to produce
ATP. DF exposure strongly decreases the levels of relative glucose oxidation in the TCA cycle
compared with HFO, as reflected by the significantly lower levels of labelled citric acid
(p<0.001; ratio data: Fig 3). Simultaneously, we observed an increase in glucose-derived carbon
flux into glycine (Fig 3); enhanced glycine metabolism has previously been associated with
tumourigenesis in lung cancer [51]. These observations suggest a lower ATP production and,
hence, lower available energy compared with HFO. Increased carbon flux into glycine is
Table 1. Summary of the main HFO- and DF-particle exposure effects.
Effect HFO DF
Pro-inﬂammatory signaling " -
Oxidative stress " -
Cell homeostasis " -
Response to chemicals " #"
Cellular stress response " "
Motility " "
Endocytosis " "
Cellular signalling MAPK, TGF beta, PDGF, EGF, GPCR ID, kinase cascade
Energy metabolism - #"x
Protein synthesis - #
Protein degradation - "
RNA metabolism - #
Chromatin modiﬁcations - "
Cell junction and adhesion - #"*
The arrows indicate the direction of regulation for cellular functions derived from the most statistically
signiﬁcant enriched Gene Ontology terms from the transcriptome, proteome, and metabolome (details in S2
Table).
x BEAS-2B up, A549 down
* BEAS-2B down, A549 up
doi:10.1371/journal.pone.0126536.t001
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directly linked to the increased transformation of hydroxymethyl groups through one-carbon
metabolism. The latter is essential for DNA synthesis and repair.
Conclusions
We assessed human lung cell responses to ship exhaust particles. A unique combination of ex-
tensive chemical and physical aerosol characterization and multiple omics analysis was used to
generate a broad overview on cellular mechanisms affected by shipping particles and to identify
possibly harmful constituents of two types of ship exhaust aerosols. While not providing a clas-
sical toxicological risk assessment, which would require the testing of multiple doses and time-
points, this study rather gives a comprehensive picture on the cellular responses to ship exhaust
particles after short-term exposure, which should be used as starting point for more mechanis-
tic studies. Although the HFO particles deposited in the ALI system were about equal in mass,
higher in number and contained a large excess of toxic compounds, DF particle exposure in-
duced a broader biological reaction in the human lung cells (BEAS-2B and A549) on all investi-
gated "omic" levels. As discussed, a stronger affected cell metabolism is not an adverse effect
per se, but it holds a higher risk of disturbance of normal cell functions. Within known path-
ways, such as pro-inflammatory signaling, oxidative stress and xenobiotic metabolism, the lev-
els of certain well-known indicators (e.g., IL-1/6/8 and CYP1A1) surged following HFO
particle exposure. In contrast, DF particles strongly affected basic cellular functions (energy
and protein metabolism) and mechanisms little yet known to be affected by aerosol treatment,
such as mRNA processing and chromatin modification.
The obtained results also suggest formulating specific hypotheses and are motivating further
experiments to proof or disproof those. In this context the role of freshly formed “elemental
carbon, EC” fractions and the influence of organic compounds on the biological activity should
be investigated. The relatively large EC fraction in DF exhaust is one of the prominent differ-
ences between the two particle types. The chemical and physical surface properties of freshly
formed EC fractions might be of relevance here. Laboratory experiments using e.g. combustion
aerosol standard generator (CAST,[52]), which allows to generate fresh combustion particles
with adjustable EC/OC ratios, are currently under preparation.
There is no doubt that the carcinogenic emissions from HFO-operated vessels need to be
minimized and HFOs should be replaced by refined modern DF (at least if no flue gas cleaning
systems are installed). HFO emissions contain among other constituents high concentrations
of toxic metals (V, Ni etc.) and polycyclic aromatic hydrocarbons. However, also emission of
diesel engines operated with refined DF, are known to be toxic and carcinogenic, although the
toxicant concentrations are much lower [8] than in HFO emissions. Consequently the imple-
mentation of emission reduction measures for land-based diesel engines started decades ago
(e.g. with sulfur-reduced fuels) [18] and current efforts are directed towards the reduction of
particle emissions from diesel automobiles. Due to the substantial contribution of ship emis-
sions to global pollution, ship emissions are the next logical target for improving air quality
worldwide, particularly in coastal regions and harbour cities. In this context our findings on
the biological effects of HFO and DF ship diesel emissions can contribute to the current debate
about the reduction measures to be implemented for shipping. The results from this study pro-
vide the information that at comparable lung deposition doses the acute biological activity of
particles of ship emissions from DF fuelled ships is not less relevant than the activity of HFO
emission particles. This supports the suggestion that a general reduction of the PM emissions
(not the SO2 emission) from shipping in harbours and the vicinity of the coast should be imple-
mented for both, HFO- and DF-operated ships. Efficient particle filter technology (e.g., electro-
static precipitation or bag-filtration) is available. From a regulatory perspective, the next step
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should be the introduction of legal emissions limits for respirable PM (e.g. PM 2.5, in [mg/m3])
from ship emissions [29].
Supporting Information
S1 Fig. Sampling setup. (A) Simplified scheme of the sampling and measurement setup.
DR = dilution ratio, TC = temperature control, T = temperature measurement, P = pressure
meter. (B) Detailed setup of the used sampling train with porous tube and ejector diluter units.
(C) Properties of the used diesel fuel (DF) and heavy fuel oil (HFO). Most noticeable are the
high viscosity and high sulfur content of HFO compared with distillate fuels like EN 590 diesel.
(D) Experimental engine parameters. The engine is a single cylinder engine with common rail
injection system representing state of the art medium speed marine diesel engines. The dual
fuel system allows operation with both distillate and residual fuels.
(EPS)
S2 Fig. Air-Liquid-Interface (ALI) exposure.HICE exposure system: the left part shows the
data acquisition and control unit for the mass flow controllers, humidity and temperature. The
exposure unit in the right part contains three Vitrocell modules and is thermostated to 37°C.
Each module has six positions for cell exposure to either complete or filtered aerosol for gas
phase referencing. The flow through each of the exposure positions is individually controlled
by a mass flow controller (lower left) Cell exposure: the aerosol passes through the aerosol inlet
and is streaming directly over the cell cultures.
(EPS)
S3 Fig. Particle dosing and morphology. (A) Cell viability at DF and HFO aerosol particle
dose. A549 cells were exposed for 4h to 1:40 diluted DF or 1:100 diluted HFO. Directly after ex-
posure, cell viability was measured by reduction of Alamar Blue and compared to cells exposed
to the filtered aerosols. Reported are the means relative to filtered aerosol ± SD from 3 (HFO)
or 2 (DF) independent experiments. As requested for the further ‘omics study, the viability is
not impaired by the DF or HFO particle exposure. (B) Size dependent deposited dose of DF
and HFO particles (left ordinate) as well as deposition probability (W, right ordinate) calculat-
ed according to Comouth et al. (1) for a size dependent density profile. (C) Mass dose of DF
and HFO particles deposited per cell area. Data are estimated from gravimetric filter samples
(case 1, 2) and from electrical low pressure impactor (ELPI) size distributions (case 3, 4). Cal-
culations are performed assuming a constant deposition probability of W = 1.5% for all particle
diameters (case 1, 2). For comparison, calculations are performed additionally using the size
dependent probability Wρ(D) based on Comouth et al. (31) and a particle density based on a
mass-mobility relationship for DF and HFO (case 3, 4). In all cases the deposited PM dose is
about a factor 2 higher for the HFO case. d-g, TEM images of diesel fuel exposure aerosol parti-
cles. The typical soot agglomerate structure (D,E) and the layered graphitic structure (F,G) is
typical for rather pure, elemental carbon containing soot. (H-L), TEM images of heavy fuel oil
exposure aerosol particles. The often much smaller particles consist of heavier elements (black
speckles) and tarry substance (crusted appearance). The HFO-EA soot particles have a more
amorphous structure than the diesel fuel soot (J).
(EPS)
S4 Fig. Compounds in particulate matter. (A) Exemplary sum-parameters and compound-
class data for exposure aerosol (EA) particulate matter for HFO-EA and DF-EA. Particular
abundance and statistic parameters’ ratios (a), absolute concentrations (b) and statistic param-
eters on the sample complexity (c) reveal a substantial complexity of the organic-chemical
composition of the particulate matter. 1EC/OC coupled to SPI, 2EC/OC coupled to REMPI,
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3EC/OC-analysis (thermal-optical method), 4AMS, 5Filter weighing. 6Aethalometer, 7Compre-
hensive two-dimensional gas chromatography/Time-of-flight mass spectrometry, 8Fourier-
Transform Ion Cyclotron Resonance Mass Spectrometry with atmospheric chemical ioniza-
tion, 9Fourier-Transform Ion Cyclotron Resonance Mass Spectrometry with electrospray ioni-
zation, 10Thermal desorption/direct derivatization gas chromatography/Mass spectrometry,
11GC/MS. (B) Elemental analysis of the particulate matter. Exemplary concentrations-ratios
(HFO-EA- over DF-EA-particles) of elements (left). Absolute concentrations of the species in
the HFO-EA- (red bars) and DF-EA-particles (blue bars) are also shown (right). Method:
ICP-AES. (C) Exemplary concentration-ratios (HFO-EA- over DF-EA-particles) of polycyclic
aromatic hydrocarbons (PAH) (left). Absolute concentrations of the species in the HFO-EA-
(red bars) and DF-EA-particles (blue bars) are also shown (right). The larger the PAH-struc-
ture, the stronger is the prevalence of the compound in the HFO-EA-particles. Methods:
1Thermal desorption/derivatization gas chromatography/Mass spectrometry, 2Gas chromatog-
raphy/mass spectrometry, 3Liquid chromatography/Tandem mass spectrometry. (D) Exempla-
ry concentration-ratios (HFO-EA- over DF-EA-particles) of aliphatic hydrocarbons (left).
Absolute concentrations of the species in the HFO-EA- (red bars) and DF-EA-particles (blue
bars) are also shown (right). The same behaviour as in the PAH compound class is observed:
The larger the aliphatic-structure, the stronger is the prevalence of the compound in the
HFO-EA-particles.
(EPS)
S5 Fig. DF regulates more transcripts, proteins and metabolites than HFO. (A-C) Compari-
son of regulation magnitude and regulation significance (obtained with a two-tailed t-Student’s
t-test on the replicate measurements). Mean of log2 fold change aerosol/filtered is plotted vs.
-log10 p-value of complete datasets of transcriptome in BEAS-2B cells (A), proteome (B) and
metabolome (C) in A549 cells for DF and HFO. (D-F), Comparison of regulation magnitude
and abundance of regulated transcripts, proteins or metabolites. Mean of log2 fold change aero-
sol/filtered is plotted vs. mean of log10 fold intensity of complete datasets of transcriptome (D),
proteome (E) and metabolome (F) for DF and HFO.
(EPS)
S6 Fig. Cellular responses to DF and HFO differ qualitatively. (A-C) Distinct patterns of reg-
ulation of DF and HFO. Hierarchical clustering of highest regulated entities of each omic ap-
proach: transcriptomics (A) (BEAS-2B), proteomics (B) and metabolomics (C) (A549). (D,E)
Pathways known to be affected by diesel particle exposure. Transcriptome pathway analysis
was performed using 1.5-fold regulated genes. Typical PM-influenced pathways were selected
and according gene regulation were clustered hierarchically. Apoptosis (D, pro- and anti-apo-
ptotic genes), Oxidative stress (E).
(EPS)
S7 Fig. Meta-analysis of gene ontology-terms in the proteomic and transcriptomic mea-
surement of DF and HFO particle-treated samples. Significantly regulated proteins in A549
cells were determined using 10% of lowest and 10% of highest log2 fold change in the ratio
Aerosol/Gas and a cut-off of—log10(p-value)>1 for 3 replicates. According to the high identi-
fication number, significantly regulated transcripts in BEAS-2B cells were determined using
5% of lowest and 5% of highest log2 fold change of Aerosol/Gas and a cut-off of—log10(p-
value)>1 for 3 replicates. GO term analysis was performed using David Tool. The p-values of
GO-terms were z-transformed, hierarchically clustered, and plotted as a heat map.
(EPS)
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S8 Fig. DF- and HFO-particles disrupt lung epithelial integrity. (A) Histopathology of
HFO-/DF-particle treated NHBE cells. Light microscopy histological analysis of sections of the
NHBE cultures treated with PBS (control), and (B) HFO, (C) DF and (D) CB120 at a dose
150 μg/cm2 for 24 h. Hematoxylin and eosin staining, scale bar = 50 μm. (E) TEMmicrographs
of HFO- and (F) DF-particle treated NHBE cells. Ribosome agglomeration in cells of the
NHBE cultures after 24 h incubation at a dose 150 μg/cm2; n = 5. Scale bar = 2 μm.
(EPS)
S9 Fig. Secreted metabolites and metabolomic flux analysis.Metabolism of U-13C-Glucose
through central carbon metabolism in A549 cells. Reduced model of central carbon metabo-
lism, with labeled atom transition marked for selected metabolites. Red circles = 13C labeled
carbon; Blue circles = 13C labeled carbon fromMalic Enzyme activity; White circles = 12C unla-
beled carbon. Selected Secreted Metabolite Ratios. Selected metabolites were measured through
GC/MS analysis of cellular medium post exposure. Values shown are the ratios of unfiltered
treatments to filtered treatments for each fuel type during three replicates. Metabolic flux mea-
surements based on 13C-labeled glucose. Filtered and unfiltered aerosol samples were
analyzed separately.
(EPS)
S10 Fig. Exemplary light microscopic image of a confluent A459 cell layer. 4x105 A549 cells
were seeded into a 24mm trans-well insert. After 24h and just before ALI-exposure, confluence
was checked by light microscopy.
(TIF)
S1 Table. Chemical Analytics of Ship Exhaust Particles.
(XLSX)
S2 Table. Biological Responses to Ship Exhaust Particles.
(XLSX)
S1 Text. Materials and Methods.
(DOCX)
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Abstract
Exposure to air pollution resulting from fossil fuel combustion has been linked to multiple
short-term and long term health effects. In a previous study, exposure of lung epithelial cells
to engine exhaust from heavy fuel oil (HFO) and diesel fuel (DF), two of the main fuels used
in marine engines, led to an increased regulation of several pathways associated with
adverse cellular effects, including pro-inflammatory pathways. In addition, DF exhaust
exposure was shown to have a wider response on multiple cellular regulatory levels com-
pared to HFO emissions, suggesting a potentially higher toxicity of DF emissions over HFO.
In order to further understand these effects, as well as to validate these findings in another
cell line, we investigated macrophages under the same conditions as a more inflammation-
relevant model. An air-liquid interface aerosol exposure system was used to provide a more
biologically relevant exposure system compared to submerged experiments, with cells
exposed to either the complete aerosol (particle and gas phase), or the gas phase only
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(with particles filtered out). Data from cytotoxicity assays were integrated with metabolomics
and proteomics analyses, including stable isotope-assisted metabolomics, in order to
uncover pathways affected by combustion aerosol exposure in macrophages. Through this
approach, we determined differing phenotypic effects associated with the different compo-
nents of aerosol. The particle phase of diluted combustion aerosols was found to induce
increased cell death in macrophages, while the gas phase was found more to affect the met-
abolic profile. In particular, a higher cytotoxicity of DF aerosol emission was observed in
relation to the HFO aerosol. Furthermore, macrophage exposure to the gas phase of HFO
leads to an induction of a pro-inflammatory metabolic and proteomic phenotype. These
results validate the effects found in lung epithelial cells, confirming the role of inflammation
and cellular stress in the response to combustion aerosols.
Introduction
Air pollution from anthropogenic sources are consistently associated with adverse health
effects, such as asthma, cardiovascular problems, and cancer [1, 2]. Near harbors and other
water-based industrial areas, there is a large amount of exhaust from ship engines, which run
on different fuel types with very different chemical compositions. Marine gas oil, or diesel fuel
(DF), is similar to the standard fuel used in diesel automobiles, while heavy fuel oil (HFO) has
very different chemical properties, including much higher levels of toxic chemicals, such as
polycyclic aromatic hydrocarbons, carbonylic compounds, and also different transition metals.
Epidemiological studies have associated the combustion of these fuels with an increased inci-
dence of lung and cardiovascular diseases [3], and it is important to study the mechanisms of
these effects so that through technology, measures can be taken which focus on minimizing the
health problems caused by ship emissions.
A prominent effect of combustion aerosols on human health is an increase of inflammatory
responses in affected tissues. As inhalation is the main route of aerosol exposure, the lungs are
primarily affected. Many studies have investigated the effects of particulate matter (PM) emis-
sions on lung cells (both in vitro and in vivo [4–7]), but most of these studies have focused on
the use of submerged experiments. While useful for studying the effects of particles present in
aerosols, these exposures are less representative of real-world inhalation of combustion emis-
sions. For this reason, exposure at an air-liquid interface (ALI) can be used to represent a more
biologically accurate exposure to lung epithelial cells, as well as other cells present in lung tis-
sue. In addition to being a more realistic in vitromodel system, these experiments are able to
elucidate differences between the gas and particle components of aerosols through the use of
in-line filters [8]. Validation studies for the ALI system have been performed previously [9,
10], and there have also been multiple studies that have used ALI technology to uncover novel
chemical and biological insights, including more accurate modeling of particle deposition effi-
ciencies [11], as well as the investigation of epithelial cell-macrophage co-culture responses to
waste incineration emission aerosol [12]. In addition, and not only for the reasons outlined
above, ALI systems are preferred compared to submerged experiments for cell exposure, as has
been discussed previously [13].
In the framework of the international project HICE (Helmholtz Virtual Institute of Com-
plex Molecular Systems in Environmental Health, www.hice-vi.eu) a novel ALI exposure tech-
nology for cell exposure in the field has been established in conjunction with multi-omics
cellular response studies. This concept has been applied to study emissions from a ship engine
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and their effects on a lung epithelial cell line [14]. To summarize the previous study, biological
effects triggered by PM from ship diesel engines in a lung epithelial cell line pointed out that
particles originated from the use of refined, sulfur-free DF induce a similar or even stronger
acute activation of many adverse pathways than the use of HFO [14]. This was a surprising
result, as PM from HFO contains much higher concentrations of known toxic compounds,
including polycyclic aromatic hydrocarbons (PAH), oxygenated compounds and transition
metals, such as vanadium and nickel [14, 15]. In addition, one of the main pathways affected
was the inflammatory response, promoting increased transcription of pro-inflammatory mark-
ers, including IL-8, IL-1, and CXCL2, particularly for HFO exposure. It was also hypothesized
that endocytosis of particulate matter was regulated in response to both fuel types. Transcrip-
tomic and proteomic effects highlighted that energy metabolism was affected as well, suggest-
ing a focus on metabolism would be interesting for this study. In order to extend the results of
the previous study to a more inflammatory-focused and phagocytotic model, as well as to com-
pare the effects of DF and HFO exposure in another cell type to validate the previous findings,
we used the same experimental setup to simultaneously investigate a macrophage cell line
using a primarily metabolism-focused approach, supported by quantitative proteomics
(SILAC) and cytotoxicological measurements.
Macrophages are a type of differentiated phagocytotic monocyte that have important roles
in both innate and adaptive immunity, and particularly in the inflammatory response [16].
There is a large heterogeneity in macrophage phenotypes (largely related to their activation
states) [17], and these cells play an important role in maintaining tissue homeostasis, mediating
pro- and anti-inflammatory reactions, as well as a variety of other well-characterized functions
[18]. In lung tissue, macrophages are present in much higher amounts than other immune cells
[19], and populations can increase under inflammatory conditions (along with the associated
pro-inflammatory phenotypic changes) [20].
The effect of combustion aerosols on the induction of inflammation in macrophage popula-
tions has been studied both in ALI experiments and in animal studies [12, 21–23]. While much
of the research has focused on cytokine production, transcriptional expression, and physiologi-
cal effects (such as changes in immune cell populations) involved in aerosol-induced acute
lung inflammation, metabolic changes due to these conditions have been largely unexplored.
Where metabolism has been mentioned, it has been tied to enzymatic activity or transcrip-
tional regulation of metabolic genes and proteins. Metabolomics studies focus on the metabolic
profile in the cell, looking at changes in the effector molecules in the various biochemical path-
ways that control cell function [24]. Non-targeted metabolomics analyses provide a compre-
hensive view of metabolites present in a biological system, while stable isotope-assisted
metabolomics makes use of labeled tracer molecules to elucidate the flux of biomolecules
through central carbon metabolism [25]. In addition, metabolomics data can be integrated
with other data to uncover a more complete picture of biological function [26].
In this study, we expose a murine macrophage cell line to diluted emission aerosols from a
ship diesel engine operated with two types of marine fuel: DF and HFO, and study the cytotoxic,
metabolic, and proteomic effects. DF is commonly used in inland waterway transportation, while
HFO and DF are both used in sea-based transportation. The study mimics a real-life engine load
scenario, with both a full aerosol exposure and a particle-filtered aerosol exposure (with only the
gas phase exposed to the cells), in order to look at the net effect of the particles. The gas phase of
these aerosols is characterized, and cellular effects are presented from a metabolomics point of
view, with integration of complementary data from toxicological and proteomic studies. Using
this approach, we were able to highlight the metabolic changes and some proteomic effects asso-
ciated with the inflammatory response of macrophages to aerosol exposure. Furthermore, the
current work aims to verify the findings of the previous study on lung epithelial cells, in order to
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add support to their conclusion that DF PM exposure may have similar or possibly stronger bio-
logical effects than HFO exposure at comparable deposition doses.
Materials and Methods
Engine and exposure
A four-stroke single-cylinder direct-injected diesel engine test bed situated at the University of
Rostock in the Chair of Piston Machines and Internal Combustion Engines was used to gener-
ate aerosol for the exposure study. Heavy fuel oil HFO 180 was used as a representative fuel for
ship operation outside of sulfur emission control areas (SECAs). Distillate diesel fuel (DF)
according to DIN EN 590 was used as a reference. The DF fuel represents a modern, sulfur-free
distilled fuel as used in inland waterway transportation and SECAs. The engine ran at four dif-
ferent operating points: 100%, 75%, 50%, and 25% load at a nominal speed of 1,500 rev/min. A
detailed characterization of the aerosol composition at the ALI exposure system was per-
formed, [27]. The duration of each operation point was set in accordance to their weighting
factors as described in ISO 8178-4 E2. The total cycle duration was 2 hours, and this cycle was
run twice for a single exposure. To obtain comparable particle deposition doses for the experi-
ments with the two fuel types, clean air dilution ratios of 1:40 and 1:100 were used for the
exhaust aerosols of DF and HFO emissions, respectively. The diluted concentrations of PM 2.5
in the aerosols were 340 μg/cm3 and 760 μg/cm3 for DF and HFO, respectively. Based on these
values, and a post-experiment gravimetric filter analysis of PM 2.5 and assuming a constant
deposition probability of 1.5%, which was determined using previous measurements from ALI
exposure systems [11], the particle mass deposited on the lung cell monolayer surface was cal-
culated at 28 ± 1.5 ng/cm2 (DF) and 56 ± 0.7 ng/cm2 (HFO) for the 4 hour exposure [14].
Physical and chemical profiling of aerosols
Profiling of the particulate matter from the exposure aersosols from both fuel types was per-
formed as in the previous study [14, 15]. To summarize, on-line and off-line analysis tech-
niques, including gas chromatography mass spectrometry, high resolution mass spectrometry
(ESI-FTICR-MS), energy-dispersive X-ray spectroscopy (EDX), on-line aerosol mass spec-
trometry, well as others have been used. Detailed information on the particulate matter analysis
has been reported previously [14], and a summary is shown in S1 Fig. On-line analyses were
performed in parallel with cellular exposures, and off-line techniques were performed using
particulate matter collected on filters during cellular exposures.
Data on gas phase aerosol compounds were derived from on-line photo-ionization mass
spectrometry [28]. Aromatic species were measured by resonance enhanced multi-photon ion-
ization (REMPI) mass spcectrometry, which utilizes intense short laser pulses of 266 nm gener-
ated by a Nd:YAG laser. Ionization occurs by subsequent ionization of two photons, providing
selectivity and enhanced sensitivity for aromatic species. Benzene and butadiene were analyzed
by on-line single photon ionization (SPI) mass spectrometry using 126 nm Vacuum-UV radia-
tion generated by an electron beam pumped rare gas excimer lamp [29]. Ionization occurs by
absorption of a single photon. Carbonyl compounds were sampled by derivatisation with
2,4-dinitrophenylhydrazine (DNPH) using commercially available cartridges ‘ORBO/555’
(Sigma Aldrich, USA) and subsequently analyzed by GC-MS [27]
Cell culture conditions
The mouse macrophage RAW 264.7 cell line was obtained from ATCC (ATCC© TIB-71™).
Cells were cultured in RPMI-1640 medium supplemented with 10% (v/v) Fetal Bovine Serum
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and 100 U/ml penicillin, 100 mg/ml streptomycin (Life Technologies, Darmstadt), and culti-
vated in an incubator at 37°C with 5% CO2. For stable isotope labeling experiments, cells were
seeded 24 hours before the experiment in RPMI-1640 medium as above, with 12.5 mmol/L
U-13C6-Glucose (Cambridge Isotope Laboratories, USA) substituted for unlabeled glucose.
Air-liquid interface exposure
An automated ALI exposure system station (VITROCELL Systems, GmbH, Waldkirch, Ger-
many) with 18 exposure positions was used as the interface for cellular exposures of the diesel
engine exhaust [30]. ALI exposures were performed in a custom built mobile HICE S2 bio
safety laboratory, placed next to the engine hall. Diluted DF or HFO aerosol was led through
heated stainless steel lines from the engine test bed into the ALI system. The combustion aero-
sols coming from the engine’s exhaust pipe were cooled and diluted with sterile air, and then
transferred directly to the ALI for cellular exposure. A PM 2.5 impactor removed large particles
before the exhaust entered the ALI system. Cells exposed to complete aerosols used the humidi-
fied exhaust from the engine, while cells exposed to only the gas phase had particles removed
directly above the cell chamber using a Whatman HEPA polydisc filter (GE Healthcare). Expo-
sures were performed as described for ALI exposures of BEAS2B and A549 epithelium cells
[14].
Cells were seeded in FCS supplemented RPMI-1640 on transferrable 24 mm Transwell1
inserts with a 0.4 μm pore polyester membrane (Type #3450, Corning, NY, USA) 24h before
exposure at a density of 1 x 106 cells/mL/insert (2.1 x 105 cells/cm2 growth area) with 1.5 mL
cell culture medium provided beneath the insert membrane. For cell exposure, the culture
medium on the apical side was completely removed and cells were placed in the ALI exposure
system with RPMI-1640 medium without FBS, supplemented with 10 mMHEPES, provided at
the basolateral side. Cells were then exposed for 4h to the diluted and conditioned (85% r.h.,
37°C, maintained by a software controlled humidifier in the ALI exposure system) aerosols
with a controlled flow of 100 mL/min for each insert [13, 30]. Cells were exposed to both the
complete aerosol (with both particle phase and gas phase), and the gas phase only (with parti-
cles filtered out of the complete aerosol by a high efficiency particle membrane filter). All fuel-
specific results represent both the filtered and unfiltered treatments, unless otherwise stated.
LDH release assay
After exposure, medium from the compartment under the membrane was collected and frozen
at -80°C for later analysis. An aliquot was used for quantification of released lactate dehydroge-
nase (LDH), an indicator of plasma membrane integrity. An LDH detection kit was used in
accordance with the manufacturers’ instructions (Roche, Mannheim, Germany) with slight
modifications: the dye solution was diluted 1:1 (v/v) with PBS to slow down the reaction time
caused by elevated LDH values due to the high cell densities used for ALI exposure experi-
ments. After 20 minutes, before saturation was reached, the reaction was stopped and the
absorbance of the reaction mix was measured at 490 nm with a microplate reader. Absorbance
read from the samples was normalized to the absorbance of blank medium. Statistical analysis
was performed using an analysis of variance (ANOVA) test, followed by a post-hoc Tukey test
for pairwise statistical analysis. Cells exposed with HEPA-filtered ambient air humidified to
85% r.h. at 37°C used as a control treatment. Cells used for a positive control for cellular toxic-
ity were kept under control conditions and lysed with Triton X-100 (Sigma Aldrich) for 30
minutes prior to the end of the exposure period.
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Metabolite extraction and GC-MS processing
For metabolomics experiments, cells kept in an incubator at 37°C with 5% CO2 were used as a
control treatment. Metabolite extraction was performed as previously described [31]. Briefly,
after washing cells with 0.9% NaCl, a 1:1:1 extraction using methanol, water, and chloroform
was used to quench metabolism and create a three-phase separation. Cells were agitated for 20
minutes and then centrifuged to enforce phase separation. 200 μL of the polar phase was used
for gas chromatography coupled to mass spectometry (GC-MS) analysis. The interphase was
then used for proteomics analysis.
Compound derivatization was performed with a Gerstel autosampler directly before mea-
surement on the GC-MS. Dried metabolites were dissolved in 15 μL of 2% methoxyamine
hydrochloride in pyridine at a temperature of 40°C for 30 minutes. Then, 15 μL of 2,2,2-tri-
fluoro-N-methyl-N-trimethylsilyl-acetamide + 1% chloro-trimethyl-silane was added and
incubated at 40°C for 30 minutes. Methoxyamine hydrochloride derivatization breaks apart
cyclic forms of some metabolites, reducing confusing of metabolites with different forms (such
as glucose) eluting at different times based upon their structure. 2,2,2-trifluoro-N-methyl-N-
trimethylsilyl-acetamide + 1% chloro-trimethyl-silane is used to block polar groups and allow
for efficient transition of the metabolites into the gas phase.
The metabolite extracts were measured on an Agilent 7890 GC with a 30 m DB-35MS capil-
lary column (Agilent Technologies) with an internal diameter of 0.25 mm and a film of
0.25 μm. The GC was connected to an Agilent 5975C MS operating in electron ionization (EI)
at 70 eV. The MS source was kept at a constant temperature of 230°C and the quadrupole at
150°C. The detector was operated in scan mode with an m/z range of 70 to 800.
1 μL of derivatized sample was injected at 270°C in splitless mode. Helium was used as the
carrier gas at a flow rate of 1 mL/min. The GC temperature program started at 80°C with a
hold for 6 minutes, followed by a gradient of 6°C/min to 300°C, a hold for 10 minutes, and an
additional gradient of 10°C/min to 325°C. The total splitless GC-MS run time of one sample
was 59 minutes. An alkane mix was run with the experimental sequence in order to provide
retention index calibration for the experimental samples. The above program was used for the
measurement of polar intracellular metabolic extracts from samples. In order to determine
secretion of lactic acid, both control and experimental cellular medium was analyzed with the
above parameters in a 25 minute method.
All chromatograms were normalized to a standard alkane mix (Sigma 68281) to standardize
retention times (RT) to retention indicies (RI) across sample runs. To identify metabolites
found in experimental chromatograms, an in-house developed metabolite library was used,
and mass spectra as well as normalized RI values were compared. This library was created by
running analytical standards run on the same instruments using the same parameters as our
experimental samples. All identified metabolites were verified using the NIST 11 spectral data-
base [32]. Metabolic analysis and mass isotopomer distribution (MID) calculation, including
correction for naturally occuring stable isotopes, was performed with the MetaboliteDetector
software [33, 34].
Metabolic data were factor-normalized based on standardized pool samples run with each
GC-MS sequence. The pool samples were a standardized extract of intracellular metabolites
from control conditions, to provide a baseline and control for GC-MS drift and buildup on the
GC column. Changes in the pool samples were calculated, and this factor was applied to nor-
malize the experimental samples. In order to reduce noise and to focus on metabolites chang-
ing between conditions, a further filtering was applied, removing all compounds present in less
than 80% of all treatments. All metabolic statistical significance measurements were performed
using an unpaired, two-tailed student’s t-test unless otherwise noted.
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Stable isotope labeling by amino acids in cell culture (SILAC)
RAW 264.7 mouse macrophages were cultured for six passages as above, with either 48.67 μg/
mL H4-lysine (lysine 0, Sigma-Aldrich) or D4-lysine (lysine 4, Sigma-Aldrich) to achieve com-
plete labeling of the proteome [35]. In order to detect unlabeled contaminants for each sample
the reverse experiment was performed by exchanging lysine 0 and lysine 4.
Proteome extraction and LC-MS/MS analysis of peptides
Proteome extraction was performed as previously described [31]. In brief, after metabolite
extraction as above, the proteins were present in the interphase of the sample. The tertiary and
secondary structure of the proteins were broken down with TCEP and chloroacetamide, and
LysC protease was added to digest the proteins. After this, the samples were used for liquid
chromatography coupled to two-dimensional mass spectrometry (LC-MS/MS).
The protein extracts were digested using an automated sample-preparation workflow [36].
The purified peptides were lyophilized and resuspended in 0.06% FA/3% ACN buffer and sepa-
rated on an in-house packed reversed-phase chromatography column (20 cm length, 75 μm ID,
3 μm—Dr. Maisch C18). A 155 min gradient (solvent A: 5% acetonitrile, 0.1% formic acid; sol-
vent B: 80% acetonitrile, 0.1% formic acid) was applied for the samples. A volume of 5 μL sample
was injected and the peptides eluted with gradients of 4 to 76% ACN and 0.1% formic acid in
water at flow rates of 0.25 μL/m. The samples were injected into a Q-Exactive Orbital-trap mass
spectrometer (Thermo-Fisher GmbH, Germany) using electrospray ionization at spray voltage of
2.2 kV and measured twice in a data-dependent acquisition mode, selecting the top 10 peaks for
HCD fragmentation. MS acquisition was performed at a resolution of 70,000 in the scan range
from 300 to 1700 m/z. Dynamic exclusion was set to 30 s and the normalized collision energy to
26eV. The mass window for precursor ion selection was set to 2.0 m/z.
Proteomics Data Analysis and Bioinformatics
The recorded MS-files were analyzed using the MaxQuant software package (version 1.2.2.5)
with the IPI-mouse database (version 3.84) complemented with frequently observed contami-
nants using oxidation and acetylation as variable modifications and carbamidomethylation of
cysteins as fixed modification with a maximum of 2 missed cleavages.
Data obtained from the mass spectrometric data was log-transformed for the Aerosol/Gas
replicates. Means for the four replicates were calculated and used for the determination of sig-
nificantly regulated proteins. The cut-off for the experiments was set to 10% for the up- and
downregulated proteins. The regulated proteins were used for the Gene Ontology analysis
using the DAVID online tool [37].
Results
Chemical and physical properties of the ship engine exposure aerosol
In order to understand the composition of the aerosols that the cells were exposed to, analysis
of the chemicals in both the particulate matter (PM) (see ref. [14] and S1 Fig for a summary)
and the gas phase (new data presented in this work in Fig 1) of ship engine emission from both
fuels was performed. Note that the data presented in S1 Fig and Fig 1 are representing the
exposure concentrations as subjected to the cells in the ALI systems (thus including the differ-
ent dilution ratios that were applied to generally equalize the PM concentrations). The physical
characterization (PM size distribution and mass) has been reported in detail previously [14].
This information, along with the new data on the gas phase composition (Fig 1), has been used
to obtain as well as estimate and validate the estimated exposure dose for HFO and DF PM (see
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above). In the following, the previously reported chemical composition of the particulate mat-
ter is summarized and the here newly reported gas phase composition results of the exposure
aerosol are discussed.
The PM of the HFO exposure aerosols exhibits much higher concentrations of organic com-
pounds compared to the DF PM. This includes the carcinogenic polycyclic aromatic hydrocar-
bons as well as aliphatic compounds, such as alkanes (S1 Fig). Investigations with modern
high-resolution analytical methods, such as comprehensive two-dimensional gas chromatogra-
phy with ultra-high resolution mass spectrometry, depict that HFO PM also exhibits a largely
increased chemical complexity, as well as considerably higher amounts of toxic transition met-
als, such as vanadium, nickel and iron [14]. Conversely, the PM of DF aerosols contains more
“carbonaceous soot,”measured either thermo-optically as elemental carbon (EC) or optically
Fig 1. Characterization of gas phase from HFO and DF aerosol (cell exposure concentrations including dilution). The concentrations of each
component measured in the aerosol are shown on the right, while the concentration ratios are shown on the left. Exponents refer to method used: (1) Gas
monitor, (2) On-line photo ionisation mass spectrometry (REMPI-MS), (3) Gas chromatography mass spectromery, (4) On-line photo ionisation mass
spectrometry (SPI-MS).
doi:10.1371/journal.pone.0157964.g001
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as black carbon (BC) [15]. The reduced EC and BC values (“soot”) in HFO exhaust is likely due
to the high sulfur content of the HFO fuels, which quenches the formation of the larger aro-
matics and therefore also of soot in the combustion process [38]. In the previous study, the rel-
atively higher content of rather pure carbonaceous soot in the DF PM was associated with the
surprisingly high biological activity of DF PM. The results of the comprehensive gas characteri-
zation of the exposure aerosol are depicted in Fig 1. With the applied dilution differences,
many gas phase compounds (including the bulk pollutants CO and NO) are 2 to 3 times more
abundant in the DF exposure aerosol compared to HFO. One of the main differences is that
the sum of the alkylated benzenes are found at higher concentrations in DF aerosol while the
alkylated phenanthrenes (three-ring PAHs) are considerably more abundant in the HFO aero-
sol (Fig 1). These compounds are partially unburnt fuel residues and the differences are due to
the different boiling point cuts in DF and HFO generation [15]. Smaller alkylated PAHs are
currently suspected to be biologically active and potentially health relevant [39–41]. Carboxylic
compounds in sum are about equally abundant in HFO and DF aerosol, with acetaldehyde and
acetone being more concentrated in the HFO aerosol, while formaldehyde and other low abun-
dant aldehydes are more abundant in the DF aerosol. Furthermore, the content of SO2 is very
high in the HFO aerosol compared to DF. The SO2 concentration, however, is below the con-
centration where adverse effects are expected, which was determined in the previous study to
be 2 ppm for transcriptomics, and 3.3 ppm for LDH release [14].
Toxicity of aerosol exposure to macrophage cells
DF and HFO aerosol (1:40 and 1:100 diluted, respectively) exposure both led to a detectable
loss of membrane integrity due to cell death after 4 hours, with a slightly higher toxicity for the
DF aerosol (Fig 2). When the particulate phase was removed from the aerosol through filtering,
Fig 2. Toxicity of aerosol exposure onmacrophages occurs with exposure to both fuel types. (a) Lactate dehydrogenase (LDH) assays were
performed on cellular medium after exposure to complete aerosol and filtered aerosols (without particles). DF dilution was 1:40, while HFO dilution was
1:100 in order to obtain comparable particle levels. Blank represents cell free medium, used as a negative control. Triton represents cells lysed with Triton,
used as a positive control. Levels represent the mean of three biological replicates (*** = p < 0.001. Error bars represent s.e.m.) (b) Density plot of Log2
fold change distribution of regulated proteins of RAW 264.7 cells in response to DF and HFO particles. RAW 264.7 cells show broadening of the protein
regulation in response to DF particles (blue) in comparison to HFO particles (red), which indicates higher amount of regulated proteins in DF treated
samples.
doi:10.1371/journal.pone.0157964.g002
Metabolism of RAW 264.7 Macrophages under Ship Engine Aerosol Exposure
PLOS ONE | DOI:10.1371/journal.pone.0157964 June 27, 2016 9 / 22
resulting in an exposure of the cells to the combustion gases only, the toxicity clearly decreased
and no significant difference to either the controls or the cell-free “blank”medium could be
observed.
The clear reduction of released LDH after particle removal indicates a predominantly parti-
cle mediated toxicity for DF aerosol exposure. For HFO aerosol exposure, the gas phase (fil-
tered aerosol) shows some toxicity, although a 2.5 times larger dilution was set for the HFO
emissions in order to establish comparable particle deposition doses. This suggests that the
HFO gas phase shows more acute cytotoxicity than the DF gas phase, which might be attrib-
uted to the higher concentration of gaseous toxic compounds, such as gaseous aldehydes and
ketones [27] or alkylated polyaromatic species in the HFO exhaust [39–41]. Thus, with the
tested dilution ratios, the gases formed by the DF are not, or in the case of HFO combustion to
a part, responsible for the observed aerosol toxicity. The main toxicity, however, is governed by
the particle exposure, and it is likely that DF particles show even a stronger cytotoxic impact
compared to the HFO particles. These results are in line with our previous study on lung epi-
thelial cells, in which DF particle exposure was shown to produce larger biological effects than
HFO particle exposure at comparable deposition doses [14]. These findings are surprising, as
the concentration of known toxic compounds (such as PAH, oxygenated species, or heavy met-
als) is much higher in HFO particles than DF particles. Note that LDH release is a rather strong
cytotoxicity endpoint, reflecting irreversible cell death by membrane damage. A lower LDH-
based toxicity, therefore, does not exclude the presence of strong adverse cellular effects.
Results from the proteomics analysis show that particles from DF ship diesel combustion
aerosols cause broader proteomic response in RAW 264.7 cells than particles from HFO ship
diesel combustion. Fig 2 shows a larger distribution of proteins that are differentially regulated
in response to DF in comparison to HFO, which indicates higher amount of up and down reg-
ulated proteins in DF combustion treated samples. This result is very similar to the previous
observations in lung epithelial cells [14], and reinforces this finding in a further lung-relevant
cell type. The broadening of protein regulation does not itself prove increased toxicity, but
instead shows a wide biological reaction to the given aerosol exposure conditions. In conjunc-
tion with the cytotoxicity data, the proteomics results support for the conclusion that DF parti-
cle exposure leads to a higher cytotoxic effect in macrophages compared to the HFO particle
exposure, likely due to the relatively high soot content of the DF aerosol.
Differential metabolic profiles of aerosol-treated macrophages
Non-targeted metabolomics analysis uncovered 230 compounds present in the four different
conditions. After normalization and filtering out compounds present in less than 80% of each
treatment, 203 compounds were subjected to principal component analysis (PCA) and
ANOVA analysis. PCA analysis shows groupings based upon fuel type (70.8% of explained var-
iance), with minimal separation due to particle phase (7% of explained variance) (Fig 3). This
result is the opposite of the toxicity profile, suggesting that metabolic effects are due to the gas
phase of the aerosol more than the PM.
After ANOVA analysis, 167 compounds were found to be significantly differing between
HFO and DF exposure at a cutoff of p< 0.01. Of the compounds discovered, 34 were able to
be identified with our in-house metabolite library, and are listed in S1 Table. Clustering of sig-
nificantly changed metabolite groupings show almost no separation between complete aerosol
and gas phase exposure (Fig 3). This suggests that the effect of the particulate matter on the
metabolic profile of macrophages is negligible, compared to the gas phase. Most compounds
were found at increased levels with HFO exposure, while relatively fewer compounds (includ-
ing Tyrosine and glycerol) are increased under DF treatment.
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Certain metabolites found increased in HFO-exposed macrophages suggest a pro-inflam-
matory metabolic phenotype, specifically succinic acid and lactic acid (Fig 4). Succinic acid lev-
els have been found to be increased in pro-inflammatory macrophages to aid increased
inflammatory cytokine production [26]; this has been shown to lead to an increased glycolytic
flux with reduced pyruvate intake into the TCA cycle [42]. Increased glycolysis with decreased
pyruvate flux into the TCA cycle would shunt the flux towards lactic acid. This cellular metabo-
lism profile is common in certain cellular conditions, and is often called the Warburg effect
[43]. The Warburg effect is mostly associated with tumor cells, however has been recently
found to be present in pro-inflammatory macrophages. [44]
Another metabolite, itaconic acid, has been associated with antimicrobial activity of pro-
inflammatory macrophages [45]. Itaconic acid has only been found in certain immune cells
(including macrophages), and only when these cells were in a pro-inflammatory state. There-
fore, it is a good marker for inflammatory macrophages. To identify this metabolite, experi-
mental spectra were compared to an itaconic acid standard measured previously and
integrated into our metabolite identification library (S2 Fig). Itaconic acid was found in all
macrophages exposed to HFO aerosols, but was not present in DF-treated macrophages (Fig
4), a result independent of the presence of PM therefore an effect of gas phase exposure. Some
itaconic acid was also found in the control cells, at higher levels than DF treatment. The DF
treated cells have a much more complicated chromatogram, and this would increase the noise
baseline for the analysis. The itaconic acid signal might fall below the baseline, and would
Fig 3. Metabolic profile of macrophages exposed to combustion aerosols. (a) Principal Component Analysis shows separation of fuel types, but no
separation by presence of particles. (b) Heatmap represents metabolites with significantly differing abundances between treatments (ANOVA test, p < 0.01).
Data was batch normalized, and metabolites found in less than 80% of all treatments were removed. DF: Diesel Fuel, HFO: Heavy Fuel Oil, f: filtered aerosol
exposure (n = 4), uf: unfiltered (complete) aerosol exposure (n = 5).
doi:10.1371/journal.pone.0157964.g003
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therefore be not measured even if it is present in low amounts. However, its presence in macro-
phages stimulated with aerosols could point to a novel role for this metabolite in inflamma-
tion-governed environmental health effects.
The metabolic profile of HFO-exposed macrophages also shows increased levels of other
compounds compared to DF-exposure. The increase of adenine and uracil, two bases involved
in nucleic acid synthesis, suggests increased cellular DNA and RNA production, a process
known to be increased in activated macrophages [46]. Adenine is also an important molecule
for energy metabolism, present in both ATP and NAD+; its increase could be tied to an
increased cellular energy production from increased glycolytic flux to lactic acid (which pro-
duces ATP, and aids in NAD+/NADH balancing), necessary for macrophages dealing with
inflammatory stimuli.
Effects of aerosol treatment on metabolic dynamics: Carbon flux from
glucose to intracellular metabolites
Stable-isotope labeling provides a complementary source of information on how glycolytic flux
is impacted by combustion aerosol exposure. By looking at the labeling pattern of certain
metabolites in cells cultured with uniformly 13C-labeled glucose, we were able to gain insight
into how the glucose is metabolized in the cell through central carbon metabolism, and the
rates of glycolysis and glucose oxidation can be compared between different conditions. We
measured the labeling in lactic acid, giving more information into glycolytic flux, as well as two
metabolites from the TCA cycle (fumaric acid and glutamic acid), which allows the tracing of
how glucose is differentially oxidized through the TCA cycle with exposure to the different
combustion aerosols.
While both aerosol types lead to a similar amount of lactic acid labeling derived from glu-
cose (Fig 5), labeling of TCA cycle intermediates derived from glucose were significantly
reduced in DF exposure compared to HFO exposure (Fig 5). These results suggest that DF-
exposed macrophages have a decreased amount of relative glucose oxidation into the TCA
cycle compared to macrophages with HFO-exposure. As HFO stimulates a pro-inflammatory
phenotype in the macrophages, this decrease in glucose oxidation is presumably tied to an
Fig 4. Levels of intracellular metabolite pools in aerosol-exposedmacrophages. Pools of (a) lactic acid, (b) succinic acid, and itaconic acid were
measured. Levels represent the mean of 9 biological replicates. *** = p < 0.001. Error bars represent s.e.m.
doi:10.1371/journal.pone.0157964.g004
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alternative metabolic phenotype. As it is known that macrophages exhibit a wide variety of
phenotypic states depending on the stimulant [47], the metabolic changes seen here suggest a
macrophage state slightly different from canonical activation states.
Effects of combustion aerosol treatment on the proteome in RAW 264.7
macrophages
Analysis of the changes to the proteome of exposed RAW 264.7 cells support the findings of
the metabolomics analysis, with differing regulation of proteins by HFO particles compared to
DF particles (Fig 2 and S3 Fig). An analysis for gene set enrichment of the regulated proteins
using the DAVID online pathway analysis tool [37] showed that different pathways and
Fig 5. Relative oxidation of glucose in the TCA cycle for aerosol-exposedmacrophages.Metabolism of U-13C6-Glucose was measured in
macrophages after exposure. (a) M2 fumaric acid isotopologue levels, (b) M2 glutamic acid isotopologue levels, and (c) M3 lactic acid isotopologue levels.
Levels represent the mean of 4–6 biological replicates. *** = p < 0.001. Error bars represent s.e.m.
doi:10.1371/journal.pone.0157964.g005
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biological processes are induced in response to DF and HFO particles. Two of the main path-
ways seen to be affected by PM exposure are endocytosis and the activation of the immune
response.
Proteins relating to the GO term endocytosis (GO:0006897) were found to be upregulated
in both HFO and DF treated samples, while the different fuel types induced activation of differ-
ent groups of proteins involved in endocytosis (S8 Fig). Proteins involved in the immune
response pathway (GO:0006955) were found to be upregulated only in HFO treated macro-
phages (p = 0.059), while DF stimulation shows no significant upregulation of the pathway
(Fig 6). This data supports the metabolic analysis in so far that enrichment of the immune
response pathway GO term indicates an activation of inflammatory pathways on a larger scale,
mainly through the NF-kappa-B (NF-kB) signaling pathway (Fig 6).
Stimulation of the toll-like receptor (TLR2) leads to activation of NF-kB, which plays a key
role in regulating the immune response. Tumor necrosis factor alpha-induced protein 8-like
protein 2 (TNFAIP8L2) acts as a negative regulator of innate and adaptive immunity by main-
taining immune homeostasis. TNFAIP8L2 prevents hyperresponsiveness of the immune sys-
tem by negative regulation of TLR2, and inhibition of NF-kappa-B activation [48].
Peroxiredoxin 2 (Pdrx2) reduces hydrogen peroxide and is involved in redox regulation of the
cell. Prdx2 inhibits NF-kB activation, which is induced by H2O2, and regulates immune
response [49].
These findings in macrophages are in line with the previous study on lung epithelial cells
[14]: the endocytosis pathway was found to be upregulated after aerosol exposure from both
fuel types, while the immune response was only upregulated after HFO exposure.
Discussion
Results from this study point to a differential effect between the gas and particle phases of com-
bustion aerosols from ship engines on RAW 264.7 macrophages. For both of the fuel types
studied, the emitted particle phase has a strong impact on cytotoxicity, while the gas phase of
the aerosol alone has a stronger effect on the internal metabolism of the cells. The stronger gas
phase effects seen with HFO aerosol suggest that the source of these effects could be from the
compound class of smaller alkylated polycyclic aromatic hydrocarbons, such as alkylated phen-
anthrenes. These compounds are the only more abundant compound class detected in the
HFO aerosol gas phase, if the (at the applied dilution) toxicologically noncritical sulfur dioxide
is neglected. While this cannot be directly proven by this study, the results here motivate fur-
ther experiments with semi-volatile compounds, such as smaller alkylated aromatics, to deter-
mine what, if any, gas phase effects are caused by their presence.
As different cellular effects can be seen due to gas exposure compared to combined gas and
particle exposure, currently used submerged cell culture particle exposure experiments only
partially highlight aerosol-induced changes in cellular metabolism; there should be more of a
focus on research done with complete aerosol exposure in order to elucidate biological effects
which are closer to those found in vivo.
The findings from this study validate and confirm the rather surprising results of the previ-
ously reported lung epithelial cell based multi-omics experiments on the effect of shipping
engines emissions on lung epithelial cells [14], and extend the findings to a completely different
cell type. This includes the observation that, according to the chemical analysis, the supposedly
much less toxic particles from high quality, refined diesel fuel (DF) induce a broader biological
reaction in lung cells than heavy fuel oil (HFO) particles at comparable exposure doses,
although the toxicant concentration in particles from the latter is extremely high. As the overall
particle mass deposited on the cells from DF exposure was lower than that from HFO, and the
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toxicity was around the same for both fuel types, it follows that DF exhaust is more toxic than
was previously thought, and possibly on par with HFO. It was concluded that the high concen-
tration of soot-like, elemental carbon in DF likely is responsible for this surprising effect [14].
As in the previous study with epithelial cells, a broader proteomic response after DF aerosol
exposure was also seen in the macrophages, whereas HFO aerosol exposure was found to be an
important inflammatory instigator, both on a metabolite and protein level. Endocytosis, which
was identified as a regulated pathway in the epithelial cells, is also upregulated with exposure
from both fuel types in macrophages, which is likely associated with particle uptake (S8 Fig).
Furthermore, it was observed in the previous study [14] that DF and HFO particles induce
different biological pathways, assuming a different mode of action for the fairly different parti-
cle types (i.e. DF particles consist of carbon rich soot-like particle agglomerates while HFO par-
ticles are smaller, with mixed carbon/metal oxide cores and a surface covered with organic
compounds and sulfates). The applied exposure concentrations (which are the same as in this
study) were too low to induce direct cytotoxic effects in the epithelial cells. The macrophages,
however, represent the first line of defense against particles and other pathogens in the lung.
They can readily engulf the deposited particles through phagocytosis and thus are more vulner-
able to PM exposure than lung epithelial cells. The cytotoxicity results summarized in Fig 2
suggest that the DF particles exhibit a stronger cytotoxicity than the particles from the HFO
aerosol. This lends further evidence to the unexpected result from the previous study, that
cleaner fuels (i.e. fuels that reduce the emission of toxic chemicals) do not automatically impli-
cate a lower acute cytotoxicity of the formed particles.
Previous studies using submerged culture exposure of collected particles show induction of
cytotoxicity and inflammatory signals in epithelial cells as well as macrophages [4, 6]. Our
results, determined using the more realistic air-liquid interface cell exposure, support these
findings by adding metabolic inflammatory signals found under aerosol exposure. However, it
becomes clear from our data that the strength of inflammatory signals depend on the specific
properties and source of the aerosol, and that this effect is not only dependent on particle expo-
sure alone. HFO aerosols stimulate a pro-inflammatory response in the macrophages, leading
to an increase in metabolites and protein regulatory pathways known to be associated with
antimicrobial activity and a pro-inflammatory phenotype. This is especially highlighted by the
induction of a metabolite indicating inflammation, itaconic acid, by HFO exposure. Proteomics
data supports this finding by showing an upregulation of inflammatory-associated proteins in
the NF-kB signaling pathway. This phenotypic effect is solely induced by the gas phase of the
combustion aerosol. The increase of succinic acid levels in macrophages suggest a role for HIF-
1a in this process, and these signaling pathways would be promising for continued research
into aerosol-based inflammation in macrophages.
While air-liquid interface exposures already represent a step towards a more realistic model
of airway exposure, an important further improvement would be taking into account the pul-
monary surfactant system, integrating it into an improved air-liquid interface exposure system.
It has been shown that proteins from this system have an impact on how pathogen-associated
Fig 6. HFO particles induce activation of immune response in RAW 264.7 macrophages. (a) The Gene
Ontology term GO:0006955, corresponding to activation of immune response, was found to be significantly up-
regulated in HFO-treated samples (p = 0.059) and not regulated in the DF-treated samples. (b) Model of how the
regulated proteins found in this study affect the NF-kB immune response pathway in the cell. Stimulation of the toll-
like receptor (TLR2) leads to activation of NF-kB. Tumor necrosis factor alpha-induced protein 8-like protein 2
(TNFAIP8L2) acts as a negative regulator of TLR2, preventing hyperresponsiveness of the immune system, and
inhibiting NF-kappa-B activation. Peroxiredoxin 2 (Pdrx2) reduces hydrogen peroxide, inhibiting NF-kappa-B
activation.
doi:10.1371/journal.pone.0157964.g006
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molecular pattern recognizing proteins and cytokines are expressed in stimulated macrophgaes
[50], and addition of this system into the experimental setup used in this study would thus
increase it’s applicability even further.
As metabolism is becoming more and more implicated in the inflammatory response of
many cells (including macrophages), as well as the progression of many diseases (including
cardiovascular diseases and cancer), studies integrating metabolomics with other techniques
(such as proteomics), probing the effect of anthropogenic aerosols on metabolism, are vital to
increase our understanding of cellular mechanisms underlying the negative health effects. Fur-
thermore, a focus should be put on studies that characterize the complete aerosols found in the
environment, with in-depth research as well on the possible effects of gaseous components on
human health. In this way, the complex composition of aerosols can be broken down, and sim-
pler models of aerosol can be studied to understand the most important components of aerosol
relative to human health effects. Finally, it can be seen that fuel changes alone are not sufficient
for the mitigation of health effects from aerosol combustion, and means of reducing particles
should be integrated into the reduction of shipping-related health effects.
Finally, this work support the conclusion of the previous work [14], that legislation enforc-
ing fuel changes (i.e. establishment of sulphur emissions control areas, SECA [51] alone are not
sufficient for a safe mitigation of health effects from shipping aerosol emissions. Moreover,
measures reducing particles and toxic gases from shipping emissions (exhaust gas scrubbers,
particle filters, precipitators, or others) need to be further developed and legally prescribed for
the reduction of shipping-related health effects.
Supporting Information
S1 File. Previous Supporting Work. The manuscript Oeder et al 2015, which is referenced by
this work.
(PDF)
S1 Table. Metabolite List. List of final 34 metabolites identified in experimental intracellular
samples. All compounds were identified with an in-house library.
(EPS)
S2 Table. Metabolomcs Dataset. Non-targeted metabolomics dataset containing the 230 com-
pounds found in each of the four different experimental conditions.
(CSV)
S3 Table. LDH Dataset. Raw data from the lactate dehydrogenase (LDH) assay.
(CSV)
S1 Fig. Chemical Characterization of Particulate Matter In Aerosol. Concentrations (right)
and concentration ratios (left) of particulate matter-bound species in HFO and DF aerosols.
Modified from Oeder et al, 2015. Exponents refer to methods used to obtain data: (5) ICP-AES,
(6) Thermal desorption/direct derivatization gas chromatography/Mass spectrometry, (7)
AMS, (8) Filter weighing, (9) EC/OC-analysis (thermal-optical method), (10) Aethalometer.
(EPS)
S2 Fig. Itaconic Acid Identification.Mass spectrum of experimentally discovered itaconic
acid (top) compared with the in-house library spectrum (bottom). Retention index of experi-
mental compound was 1417.21, while retention index of library compound is 1409.20. Using
the ICBM algorithm for matching, experimental itaconic acid was identified with a score of
0.97.
(EPS)
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S3 Fig. Proteome Christmas Tree Plot. Comparison of regulation magnitude and abundance
of regulated proteins. Mean of log2 fold change Aerosol vs. Gas is plotted vs. mean of log10
fold sum of intensities of complete dataset of proteins in response to DF (blue) and HFO (red)
particles. RAW 264.7 cells show broadening of the protein regulation in response to DF parti-
cles (blue) in comparison to HFO particles (red), corresponding to higher amount of up and
down regulated proteins in DF particles treated samples.
(EPS)
S4 Fig. Proteome Volcano Plot. Comparison of regulation magnitude and regulation signifi-
cance. Mean of log2 fold change Aerosol vs. Gas is plotted vs. -log10 p-value of complete data-
set of proteome in response to DF (blue) and HFO (red) particles. RAW 264.7 cells show
broadening of the significant protein regulation in response to DF particles (blue) in compari-
son to HFO particles (red), corresponding to higher amount of significantly up and down regu-
lated proteins in DF particles treated samples.
(EPS)
S5 Fig. Proteome Correlation Plot. Correlation of log2 fold changes Aerosol vs. Gas between
HFO and DF. Log2 fold changes Aerosol vs. Gas of protein regulation in response to HFO and
DF show no correlation (Cor2 = 00357), which indicates that HFO and DF particles cause dif-
ferent regulation of different proteins in RAW 264.7 cells.
(EPS)
S6 Fig. Proteome QQ Plot—DF. The Q–Q plot for proteomic response of RAW 264.7 cells to
DF Aerosol vs. DF Gas. The line is a parametric curve with the parameter, which is the interval
for the quantile. The points with linearly related distributions lie on the line, which suggests
that they are normally distributed. On the left and right sides of the plot the points are not line-
arly related and show no normal distribution, which corresponds to populations of up and
down regulated proteins in response to DF particles.
(EPS)
S7 Fig. Proteome QQ Plot—HFO. The Q–Q plot for proteomic response of RAW 264.7 cells
to HFO Aerosol vs. HFO Gas. The line is a parametric curve with the parameter, which is the
interval for the quantile. The points with linearly related distributions lie on the line, which
suggests that they are normally distributed. On the left and right sides of the plot the points are
not linearly related and show no normal distribution, which corresponds to populations of up
and down regulated proteins in response to HFO particles.
(EPS)
S8 Fig. Regulation of Endocytosis Related Proteins.DF and HFO particles induce activation
of different proteins involved in endocytosis in RAW 264.7 macrophages. The Gene Ontology
term Endocytosis was found up regulated in HFO and DF Aerosol vs. Gas treated samples.
This data suggests that particles play a role in the regulation of endocytosis in macrophages.
Necap1, Necap2 and Lrp1 (red) are up regulated in HFO treated samples, while Lrp1, Vamp7,
Tfrc and Ube3a (blue) are up regulated in DF treated samples.
(EPS)
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UponstimulationwithTh1cytokinesorbacterial lipopolysac-
charides, resting macrophages shift their phenotype toward a
pro-inflammatory state as part of the innate immune response.
LPS-activated macrophages undergo profound metabolic
changes to adapt to these new physiological requirements. One
key step tomediate thismetabolic adaptation is the stabilization
ofHIF1, which leads to increased glycolysis and lactate release,
as well as decreased oxygen consumption. HIF1 abundance can
result in the induction of the gene encoding pyruvate dehydro-
genase kinase 1 (PDK1), which inhibits pyruvate dehydrogenase
(PDH) via phosphorylation. Therefore, it has been speculated
that pyruvate oxidation through PDH is decreased in pro-in-
flammatory macrophages. However, to answer this open ques-
tion, an in-depth analysis of this metabolic branching point was
so far lacking. In this work, we applied stable isotope-assisted
metabolomics techniques anddemonstrate that pyruvate oxida-
tion is maintained in mature pro-inflammatory macrophages.
Glucose-derived pyruvate is oxidized via PDH to generate cit-
rate in the mitochondria. Citrate is used for the synthesis of the
antimicrobial metabolite itaconate and for lipogenesis. An
increased demand for thesemetabolites decreases citrate oxida-
tion through the tricarboxylic acid cycle, whereas increased
glutamine uptake serves to replenish the TCA cycle. Further-
more, we found that the PDH flux is maintained by unchanged
PDK1 abundance, despite the presence of HIF1. By pharmaco-
logical intervention, we demonstrate that the PDH flux is an
important node for M(LPS) macrophage activation. Therefore,
PDH represents a metabolic intervention point that might
become a research target for translational medicine to treat
chronic inflammatory diseases.
Macrophages are innate immune cells that differentiate from
monocytes, which circulate in the bloodstream. Upon differen-
tiation, they invade the surrounding tissue and become resident
macrophages (1).Macrophages can be activated by cytokines or
toll-like receptor agonists, e.g. lipopolysaccharide (LPS). In very
general terms, macrophage activation can result in rather pro-
inflammatory responses, serving as host defense mechanisms
or in wound healing responses and aiding in tissue repair and
remodeling. However, depending on the type of activation, very
different subtypes of activation occur (2). Upon activation with
LPS (M(LPS)) or the cytokine interferon- (M(INF)), macro-
phages undergo profound metabolic reprogramming, neces-
sary to activate cellular defense mechanisms as well as to cope
with differentmicro-environments in the inflamed tissue (3). A
marker for pro-inflammatory activation is high expression of
Irg1 (4, 5). We recently showed that Irg1 codes for the enzyme
cis-aconitate decarboxylase (IRG1/CAD) that catalyzes the syn-
thesis of the antimicrobial metabolite itaconate from cis-aconi-
tate (6). Therefore, metabolic reprogramming due to these
adaptations could affect the availability of substrate needed for
the synthesis of itaconate during host defense.
The reprogramming during macrophage activation shows
overlapping features with cancer cells; both have increased gly-
colytic rates and increased lactate release, known as aerobic
glycolysis or theWarburg effect (7, 8). Increased glycolytic rates
are observed in any cell type that exceeds the energy demand
derived from oxidative phosphorylation (9). In macrophages, it
has been revealed that this metabolic rewiring is mediated by
stabilization of HIF1 (10). A well described HIF1 target is the
gene encoding pyruvate dehydrogenase kinase 1 (PDK1), an
inhibitor of Pyruvate dehydrogenase (PDH)3 (11). When HIF1
is stabilized, the PDH flux can be inhibited by PDK1-mediated
phosphorylation, resulting in decreased pyruvate-derived
acetyl-CoA levels. In this case, reductive carboxylation of -ke-
toglutarate (KG) increases to provide sufficient acetyl-CoA
for lipogenesis, needed for cell proliferation (12–15). Increased
glycolytic rates, decreased PDH flux, and increased reductive
carboxylation can also be induced in any cell type when oxygen
tension is decreased or when oxidative phosphorylation is
impaired. In this case, NADH oxidation is compromised, and
citrate levels decrease. This decrease in citrate is linked to an
increase in NADH, which thermodynamically promotes the
metabolic adaptation to hypoxia by increasing reductive car-
boxylation of KG (13, 16, 17). However, it is currently unclear
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whether this full panel of metabolic consequences upon HIF1
stabilization is also true for pro-inflammatory macrophages.
Although it has been demonstrated that HIF1 can be stabi-
lized and activated by cytokines, e.g. TNF and IL1 (18, 19),
the detailed metabolic consequences are still uncertain.
HIF1 can bind to the promoter of the Tlr4 gene, thereby
acting through a positive feedback loop on the TLR4 defense
axis (20). Reactive oxygen species were shown to inhibit protea-
somal degradation of HIF1 (21), and recently, increased suc-
cinate levels in pro-inflammatory macrophages have also been
described to stabilize HIF1, by inhibiting prolyl hydroxylase-
mediated hydroxylation of HIF1 (10).
In this study, we asked whether the stabilization of HIF1 in
M(LPS) macrophages alters TCA cycle fluxes similarly to
hypoxic cells. We show that LPS-activated macrophages
exhibit a metabolic adaptation with overlapping features to
hypoxic cells, but also distinct differences, resulting in a unique
LPS-specific metabolic signature. The most striking difference
to hypoxic cells with stabilized HIF1 is that there is no
decrease in relative glucose flux through PDH and no increase
in reductive carboxylation of KG. The sustained PDH flux
provides sufficient acetyl-CoA for citrate production, which
keeps the rate of reductive carboxylation of KG at a low level,
as well as providing citrate that is needed for the synthesis of
fatty acids and itaconate. Upon LPS stimulation, high PDH
activity is maintained by a repression of Pdk1. As a result PDH
phosphorylation on Ser-232 and Ser-293 remains at a low level.
Finally, we demonstrate that the PDH flux is indeed important
to sustain M(LPS) activation in macrophages.
Experimental Procedures
Chemicals—UK5099 (Sigma, PZ0160) was first diluted in
DMSO and further diluted in medium to a working stock con-
centration of 10 mM and then added to the wells of the culture
dish to a final concentration of 100M. The final concentration
of DMSO did not exceed 1%; LPS (Escherichia coli, Sigma
L6529) was prepared as a working stock of 1 g/ml in glucose-
and glutamine-free DMEM and added 1:100 into the wells of
the culture dish for a final concentration of 10 ng/ml. Cells were
stimulated for 6 h; interferon  (mouse) (E. coli, Sigma I4777)
was prepared as a working stock of 5 mg/ml in glucose- and
glutamine-free DMEM and added 1:100 into the wells of the
culture dish for a final concentration of 50 ng/ml. Cells were
stimulated for 6 h.
Stable Isotope Tracing—13C stable isotope tracers were
obtained from Eurisotop as follows: glucose, CLM-1396; gluta-
mine, CLM-1822-H. The tracer medium was prepared in
DMEM without glucose and glutamine. [13C]Glucose (final 25
mM) and [12C]glutamine (final 4 mM) (or vice versa) was added
to the medium; pH was set to 7.3; 10% FBS and 1% penicillin/
streptomycin were added, and finally, the medium was sterile-
filtered. Tracer medium was prepared in advance and incu-
bated in the hypoxia chamber overnight to remove excessive
oxygen from the medium (only for hypoxia conditions). The
next morning, medium was replaced by tracer medium, and
cells were incubated for 24 h with the tracer medium to reach
isotopic steady state. LPS was added after 24 h and left on the
cells for an additional 6 h prior to extraction. For further infor-
mation regarding stable isotope-assisted metabolomics, see
also Refs. 22, 23.
Cell Culture—RAW 264.7 cells (ATCC TIB-71TM) were
obtained from ATCC and were cultivated according to the
manufacturer’s instructions. Briefly, cells were kept in
DMEM5796 with 10% FBS and 1% penicillin/streptomycin at
37 °C and 5% CO2 under atmospheric oxygen concentrations.
In the case of hypoxia, cells were cultivated in an incubator at
37 °C and 5% CO2 located in a closed hypoxia chamber with an
oxygen concentration of 2%. Cells were simultaneously seeded
in the afternoon at a density of 150,000 cells per well in 12-well
plates (Thermo Scientific, Nunc Multidish 12 Nunclon Delta
Si) and then either incubated either at 21 or 2% O2 overnight.
The next day, medium was replaced. In the case of hypoxia,
medium was already incubated in the hypoxia chamber over-
night to remove excessive oxygen from the medium. For com-
parison reasons,medium for normoxic conditionswas also pre-
pared the day before and incubated in a similar way under
atmospheric oxygen conditions. For LPS activation, LPS was
added 18 h after medium replacement. 24 h after medium
replacement cells were harvested.
Viability Assay—To assess cell viability, cells were trans-
ferred into tubes and analyzed using a Vi-CellTM XR (Beckman
Coulter) automated cell counter. To determine viability, cells
were incubated with trypan blue and number of stained cells
was determined.
cDNA Synthesis and Gene Expression Analysis—cDNA syn-
thesis and quantitative PCR was performed as described previ-
ously (6). Briefly, RNA was isolated from the interphase after
extraction of metabolites, using the Qiagen RNeasy mini kit.
0.5–1 g of RNA was used for cDNA synthesis using Super-
Script III (Invitrogen), following the manufacturer’s instruc-
tions. Quantitative PCR was performed using iQ SYBR Green
Supermix (Bio-Rad) as per the manufacturer’s instructions.
PCR was carried out on a Light Cycler 480 (Roche Applied
Science). Data analysis was performed using the analysis soft-
ware according to manufacturer’s instructions (Roche Applied
Science). Gene expression was normalized to the housekeeping
gene L27. For primer sequences, see Table 1.
Extraction of Intracellular Metabolites—Extraction was
according to Ref. 24. Briefly, cells were cultivated in 12-well
plates and washed with 1 ml of 0.9% NaCl and quenched with
TABLE 1
Primer sequences used for quantitative PCR
Gene 5 to 3 sequence
L27_F ACATTGACGATGGCACCTC
L27_R GCTTGGCGATCTTCTTCTTG
Irg1_F GCAACATGATGCTCAAGTCTG
Irg1_R TGCTCCTCCGAATGATACCA
Tnfa_F GGTTCTGTCCCTTTCACTCAC
Tnfa_R TGCCTCTTCTGCCAGTTCC
iNos_F AGCCCTCACCTACTTCCTG
iNos_R CAATCTCTGCCTATCCGTCTC
Pdk1_F TGCAAAGTTGGTATATCCAAAGCC
Pdk1_R ACCCCGAAGCTCTCCTTGTA
Il1b_F TGCCACCTTTTGACAGTGATG
Il1b_R TGATGTGCTGCTGCGAGATT
Cpt1_F TGGCAGTCGACTCACCTTTC
Cpt1_R CAAACAGTTCCACCTGCTGC
Hif1a_F TGACGGCGACATGGTTTACA
Hif1a_R AATATGGCCCGTGCAGTGAA
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0.2 ml of 20 °C methanol. After adding an equal volume of
4 °C cold water, cells were collected with a cell scraper and
transferred to tubes containing 0.2 ml 20 °C chloroform.
The extracts were shaken at 1400 rpm for 20 min at 4 °C
(Thermomixer Eppendorf) and centrifuged at 16,000 g for
5 min at 4 °C. 0.2 ml of the upper aqueous phase was col-
lected in specific glass vials with micro inserts and evapo-
rated under vacuum at4 °C using a refrigerated CentriVap
Concentrator (Labconco).
Gas Chromatography-Mass Spectrometry—Metabolite deriv-
atization was performed using a Gerstel MPS. Dried polar
metabolites were dissolved in 15 l of 2% methoxyamine
hydrochloride in pyridine at 40 °C under shaking. After 60min,
an equal volume of MTBSTFA was added and held for 60 min at
40 °C. 1l of sample was injected into an SSL injector at 270 °C
in splitlessmode. GC/MS analysis was performed using an Agi-
lent 7890A GC equipped with a 30-m DB-35MS  5-m Dura-
guard capillary column.Heliumwas used as carrier gas at a flow
rate of 1.0 ml/min. The GC oven temperature was held at
100 °C for 2 min and increased to 300 °C at 10 °C/min. After 3
min, the temperature was increased to 325 °C. The GC was
connected to an Agilent 5975C inert XLMSD, operating under
electron ionization at 70 eV. TheMS source was held at 230 °C
and the quadrupole at 150 °C. TheMSwas operated in selected
ion monitoring. The total run time of one sample was 25.00
min. All GC/MS chromatograms were processed by using
Metabolite Detector software (25). MIDs were determined and
corrected for natural isotope abundance using Metabolite
Detector software.
Measurement of glucose and lactate intensities was per-
formed by derivatization with an equal volume of MSTFA
(instead ofMTBSTFA) and held for 30min at 40 °C under con-
tinuous shaking. A 1-l sample was injected into an SSL injec-
tor at 270 °C in split 10mode. GC oven temperature was held at
90 °C for 1 min and increased to 300 °C at 15 °C/min for 8 min
to 320 °C. The total run time of one sample was 24.3 min. For
absolute quantification of glucose and lactate, a dilution series
of a standardmixwas included in the sequence andmeasured in
triplicate. For normalization, we used [U-13C]glucose and
[U-13C]lactate as internal standards (in this case, medium sam-
ples contained only [12C]carbon sources).
Quantification of Amino Acids—Quantification of amino
acids was performed on an Agilent 1100 HPLC system
equipped with a Diode Array Detector. Separation was carried
out on a ZORBAX amino acid analysis column (150 4.6 mm,
5 m) with a preceding ZORBAX amino acid analysis guard
cartridge (Agilent Technologies, Santa Clara, CA) at 40 °C in
gradient mode (see Table 1). The eluents used were 40 mM
Na2HPO4 (pH 7.8, eluent A) and a mixture of acetonitrile,
methanol, and water (45:45:10, eluent B). 0.02% sodium azide
was added to eluent A to prevent microbial growth. Primary
amines were automatically derivatized with ortho-phthalalde-
hyde in borate buffer (0.4 N in water, pH 10.2) and diluted in
eluent A prior to injection. The resulting ortho-phthalaldehyde
derivatives were subsequently detected at 338 nm (10-nm
bandwidth; reference wavelength, 390 nm; 20-nm bandwidth).
Allmedium samples were diluted 1:1with the internal standard
L-2-aminobutyric acid (final concentration, 300 M) to correct
for deviations resulting from the derivatization process. Exter-
nal calibration standards as well as referencemediawith known
concentrations were measured with every run to determine
sample concentrations and ensure stability of the analysis. Gra-
dient profile: 1.9 min, 0% eluent B; 18.1 min, 57% eluent B; 18.6
min, 100% eluent B; 22.3 min, 100% eluent B; 23.2 min,0% elu-
ent B; 26 min, 0% eluent B.
Western Blot—For preparation of whole cell extract, 1 106
cells were harvested, washed with ice-cold 1 phosphate-buff-
ered saline (PBS) (Invitrogen/Life Technologies, Inc., Europe
BV Belgium), lysed in 1M-PER, mammalian protein extrac-
tion Reagent (Thermo Scientific, Belgium) completed with 1
protease inhibitor mixture (Complete, Roche Applied Sci-
ence, Luxembourg), and further processed according to the
manufacturer’s instructions. A nanodrop analyzer was used to
measure the protein concentration. Proteins were separated by
size using SDS-PAGE (12%) and transferred to an Immo-
bilon-FL PVDF membrane (Merck Millipore) using the Mini-
PROTEAN Tetra Cell and PowerPac Basic Power Supply (Bio-
Rad, Belgium). The membrane was blocked in 5% nonfat milk
powder in PBS/Tween for 1 h at room temperature or overnight
at 4 °C. The antibodies used were as follows: anti-IRG1 (Sigma,
hpa040143) 1:750 in PBS-T 5% nonfat milk powder for 1 h at
room temperature; anti-PDK1 (rabbit) (Enzo catalog no. ADI-
KAP-PK112) 1:3000 in TBST 5% BSA, overnight at 4 °C; anti-
PDH-E1 (rabbit) (Ser(P)-232) (Millipore catalog no. AP1063)
1:1000 in TBST 5% BSA, overnight at 4 °C; anti-PDH-E1 (rab-
bit) (Ser(P)-300) (Millipore catalog no. ABS194) 1:1000 in
TBST 5% BSA, overnight at 4 °C; anti-PDH-E1 (rabbit)
(Ser(P)-293) (Millipore catalog no. ABS204) 1:10,000 in TBST
5% BSA, overnight at 4 °C; anti--tubulin (mouse) 1:5000 in
TBST 5% BSA, overnight at 4 °C; anti-rabbit HRP 1:5000 in
TBST 5% skim milk (Cell Signaling); anti-mouse HRP 1:5000
in TBST 5% skim milk (Cell Signaling). Visualization was done
using the ECL Plus Western blotting detection system Kit (GE
Healthcare, Netherlands). Signals were detected using the LI-
COR system. Quantification of band intensities was done using
the ImageStudioLight Software package.
Cell Imaging andDataAnalysis—Phase contrast imageswere
acquired using a10 objective on a Nikon Ti Eclipse inverted
microscope with motorized stage (Nikon Corp., Tokyo, Japan)
enclosed in a bench top incubator. Automatic microscope con-
trol, stage programming, and acquisition were done using the
OptoMorph version of MetaMorph 7.8.10 (Cairn Research,
Kent, UK). LPS-treated anduntreatedRAW264.7 cells growing
in 12-well Nunc plates (50,000 cells per well) were imaged in
positive phase contrast. Nine adjacent but non-overlapping
images were automatically acquired in a 3 3 grid around the
center of each well. The entire imaging experiment was per-
formed twice, resulting in 36 images acquired per condition.
One out-of-focus image and five containing cell aggregates
were excluded from further analysis. Surfaces of strongly
attached cells were estimated by thresholding in ImageJ 2.0.0-
rc-31/1.49v using the IJ_IsoData algorithm. Congruence of
thresholding results with cell contours was verified by visual
inspection. Cell sizes were calculated using the particle analysis
tool, allowing for areas from 50 to 5000 pixels and excluding
particles on the image edges. Average sizes were reported for
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each image. Halo and contrast effects resulting from the phase-
contrast imaging were analyzed to discriminate between
strongly and weakly attached cells. Strongly attached cells
appeared darker than background with a weak halo, although
weakly attached cells appeared brighter than backgroundwith a
strong halo. Histograms of pixel intensities of the entire field of
viewwere analyzed using custom software written inMATLAB
R2014b. First, the intensity peak corresponding to the back-
ground signal (cell-free surface) was identified and approxi-
mated by aGaussian function. The approximated peakwas sub-
tracted from the original histogram, and the weighted sum of
intensities below (dark) and above (bright) the background
peak was calculated, respectively. The ratio of dark-to-bright
values informs on the ratio of strongly-to-weakly attached cells.
Renormalization of this ratio by values obtained for individual
strongly and weakly attached cells yielded an adhesion index
with values from 0 (no cells attached) to 1 (all cells attached).
Statistical Analyses—To analyze a significant difference
between two groups, unpaired Welch’s t test was applied. p
values are indicated in each panel (*, p 0.01; or as indicated)
and was considered as significantly different with a p value
0.05. The number of independent replicates is indicated in
the figure legends. Each experiment was at least performed
three times with cells of a different passage. Each individual
experiment consisted of three wells per condition.
Results
M(LPS) Macrophages Show a Distinct Metabolite Sig-
nature—The macrophage environment is likely to be hypoxic,
as these cells infiltrate hypoxic tissues such as tumors, wounded
regions, or sites of inflammation. At the site of inflammation,
different oxygen tensions result from increased oxygen demand
as well as swelling or vascular damage (26, 27). To physiologi-
cally meet these challenging conditions, macrophages are well
adapted to hypoxia by their ability to adjust their gene expres-
sion profile and increase glycolytic activity (28). To study
whether the activation of macrophages reprograms metabo-
lism to a hypoxia-like phenotype, we cultivated the murine
macrophage cell line RAW264.7 under normoxia (21%oxygen)
and hypoxia (2%) and activated it with LPS for 6 h.We selected
this timepoint, because it reflects the highest expression level of
irg1/Cad, the enzyme that catalyzes the synthesis of the antimi-
crobial metabolite itaconate (6).
We analyzed intracellularmetabolite levels and revealed that
LPS stimulation resulted in increased levels of itaconate, succi-
nate, and lactate under normoxia (Fig. 1, A–C). These three
metabolites are marker metabolites for M(LPS) activation,
demonstrating a clear pro-inflammatory activation (6, 10, 29,
30). Moreover, we observed increased levels of the TCA cycle
associated metabolites malate and glutamate, whereas aspar-
tate and citrate levels remained unchanged (Fig. 1, D–G). The
amino acids glycine, serine, and alaninewere also elevated upon
LPS stimulation (Fig. 1, H–J). Compared with normoxia, LPS
treatment of hypoxic cells was unable to induce similar itacon-
ate and succinate levels (Fig. 1, A and B). As expected, lactate
levels further increased upon hypoxia as a result of reduced
respiration and concomitant increased glycolysis, known as the
Pasteur Effect. Non-activated hypoxic cells exhibited decreased
levels of the TCA cycle associated metabolites malate, aspar-
tate, glutamate, and citrate. However, LPS stimulation under
hypoxia resulted in increased levels of malate, aspartate, and
glutamate but not citrate (Fig. 1,D–G). The amino acids glycine
and serine were unchanged between hypoxia and normoxia.
Upon LPS activation of hypoxic cells, serine and alanine were
increased (Fig. 1,H–J). Interestingly, we also observed a trend of
increased levels of the branched chain amino acids isoleucine,
leucine, and valine under hypoxia for both non-stimulated and
LPS stimulated conditions (Fig. 1K; p value0.05).
We concluded from these results that LPS affects the metab-
olite profile of macrophages independent of the oxygen supply
and that this profile is clearly different from a pure hypoxic
profile. Intriguingly, we observed decreased abundance of the
antimicrobial metabolite itaconate under oxygen-limiting
conditions, which could have direct effects on the immune
response in tissues with low oxygen tension.
Decreased Itaconate Levels under Hypoxia Are Not the Result
of Decreased Irg1 Expression or Lower IRG1/CAD Protein
Abundance—To investigate whether the reduced levels of itac-
onate are caused by transcriptional repression, post-transcrip-
tional regulation, or post-translational regulation, we analyzed
gene expression and protein levels of the catalyzing enzyme
IRG1/CAD. We found that hypoxia does not significantly
reduce the gene expression level or the protein abundance of
IRG1/CAD, indicating a regulation at the post-translational
level or a result of decreased substrate concentrations (Fig. 2,A
andB). To confirmLPS activation ofmacrophages, we analyzed
gene expression of the pro-inflammatory marker genes Tnf,
iNos, and Il1 (Fig. 2, C–E). We found clear up-regulation
under both oxygen conditions when the cells were treated with
LPS. However, hypoxia resulted in a 20% reduction of Tnf
expression and3-fold higher expression of Il1 and iNos.
It has been reported in several recent publications that
HIF1 gets stabilized in M(LPS) macrophages compared with
resting macrophages (10, 21, 29, 31). Therefore, we also ana-
lyzed gene expression of Hif1, and we observed increased
expression of Hif1 in response to LPS treatment under
hypoxia (Fig. 2F), indicating thatHIF1 stabilization in hypoxic
M(LPS) macrophages can be a combined effect of increased
transcriptional expression and post-translational stabilization.
Under normoxia, no difference in Hif1 expression was
detected.
Based on these results, we conclude that the reduction of
itaconate under hypoxia is mostly a result of post-translational
effects such as alteredmetabolic fluxes, either due to an enzyme
modification that regulates its activity or by changing substrate
concentrations. To that end, we were interested to compare
cellular flux changes with LPS activation between hypoxia and
normoxia.
LPSActivation Promotes PyruvateOxidation via PDHbyPre-
venting Pdk1 Expression—Tomonitor intracellular glucose-de-
rived fluxes in M(LPS) macrophages, we incubated RAW 264
cells for 24 h in the presence of uniformly labeled [U-13C]glu-
cose to reach isotopic steady state conditions. During these
24 h, labeled glucose is metabolized within the cells and is
incorporated in cellularmetabolites downstreamof glucose. To
obtain the specific labeling patterns, intracellular metabolites
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were extracted and analyzed with gas chromatography/mass
spectrometry to determineMIDs (corrected for natural isotope
abundance), which reflect relative metabolic fluxes (Fig. 3A for
atom transitions) (22, 23).
As expected, stable isotope labeling revealed that hypoxia
resulted in decreased pyruvate flux through PDH, illustrated by
decreased M2 citrate isotopologues (Fig. 3B). Concomitant
with decreasing citrate M2 isotopologues under hypoxia, we
observed increased abundance of citrate M0 isotopologues,
representing citrate molecules derived from carbon sources
other than glucose (Fig. 3B). This decrease is a result of HIF1
stabilization and Pdk1 induction, where the PDK1 protein
FIGURE 1.Metabolome analysis of RAW 264macrophages in the context of LPS activation and hypoxia. Analysis of intracellular metabolite abundance
in RAW 264 cells, cultivated under normoxia (21%O2) and hypoxia (2%O2), unstimulated or stimulated with LPS. Metabolites were extracted and analyzed by
GC/MS. Signal intensities (peak area) are normalized to unstimulated cells under normoxia. Cells were treatedwith 10 ng/ml LPS for 6 h. Error bars indicate S.E.
(Welsh’s t test; *, p 0.01, n 3 wells). n.s., not statistically significant. One representative experiment with three individual wells per condition is presented.
The experiment was performed three times.
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inhibits PDH by phosphorylation (32, 33). Decreased pyruvate
oxidation under hypoxia promotes decreasing downstream
substrate levels, most probably resulting in the observed
decreased itaconate levels (Fig. 1A). However, HIF1 has also
been shown to be stabilized inM(LPS)macrophages under nor-
moxic conditions (10, 29). Therefore, it is speculated that pyru-
vate oxidation through PDH is decreased in M(LPS) macro-
phages, a similar phenotype to cancer cells with stabilized
HIF1 (3, 34). However, we did not observe decreased citrate
M2 isotopologues in normoxic M(LPS) macrophages, raising
the question whether PDH is inhibited under these conditions.
To analyze regulation of Pdk1 inmore detail, we investigated
geneexpressionandprotein abundanceofPDK1andphosphor-
ylation status of PDH (Fig. 3, C–H). In line with current knowl-
edge, hypoxia-mediated stabilization of HIF1 resulted in
increased Pdk1 expression (Fig. 3C), which complements our
observation of hypoxia-dependent, decreased glucose flux to
citrate (Fig. 3B). Intriguingly, we observed that LPS stimulation
resulted in a drastic reduction of Pdk1 expression at both nor-
moxia and hypoxia, indicating that PDK1-mediated inhibition
of PDH is reduced inM(LPS)macrophages (Fig. 3C).Moreover,
analysis of PDK1 protein abundance revealed similar PDK1 lev-
els in non-activated orM(LPS)-activatedmacrophages. Only in
hypoxia did we observe a significant increase of PDK1 abun-
dance (Fig. 3,D and E). To investigate whether the low levels of
PDK1 have an effect on PDH, we analyzed phosphorylation of
PDH on serine 232, 293, and 300 (Fig. 3,D and F–H). Phospho-
rylation of these residues has been reported to result in an inhi-
bition of PDH activity (33). As expected, hypoxia resulted in
increased phosphorylation of the three analyzed serine resi-
dues (not significant in case of Ser-300). However, and in line
with low PDK1 levels in normoxic M(LPS) macrophages,
LPS activation did not increase phosphorylation levels of
Ser-232 and -293. Regarding Ser-300, we observed signifi-
cantly increased phosphorylation upon LPS activation,
although there was no further significantly increased phos-
phorylation due to hypoxia. Whether Ser-300 specifically
has a unique function in the context of LPS activation in
macrophages remains to be determined in future work. Our
results from this part of the study reveal that HIF1-mediated
induction of Pdk1 can be attenuated by LPS stimulation,
which is in line with increased citrate M2 isotopologues
upon LPS activation (Fig. 3B).
In line with the results of PDK1 abundance and PDH phos-
phorylation status, our stable isotope analysis revealed that LPS
stimulation did not result in a decreased relative pyruvate oxi-
dation, both under hypoxia and normoxia (Fig. 3, B and I), indi-
cating that HIF1 did not mediate PDH inhibition upon LPS
stimulation. We observed increased citrate M2 isotopologue
levels, reflecting even higher relative pyruvate flux through
PDH (Fig. 3B). To normalize for upstreamchanges in glycolysis,
we determined the ratio of M2 citrate/M3 pyruvate and
observed an increase upon LPS stimulation, indicating
increased pyruvate flux through PDH in M(LPS) macrophages
(Fig. 3I). As a reduction of citrate M2 isotopologues was only
observed under hypoxic conditions, HIF1-mediated inhibition
of PDH depended only on the oxygen tension and not on the
macrophage activation status. Indeed, LPS activation can even
partially recover the HIF1- mediated PDH inhibition under
hypoxia (Fig. 3, B and I).
The M2 abundance of KG and malate was significantly
lower than in citrate (Fig. 3, J and K), suggesting that large
amounts of citrate, cis-aconitate, or isocitrate are either used
for pathways other than the oxidative TCA cycle or that other
carbon sources (e.g. glutamine) increase their contribution to
KG and malate. Stimulation with LPS as well as hypoxia fur-
ther decreased glucose contribution to KG andmalate, as can
be seen by a decreasing abundance of KG and malate M2
isotopologues (Fig. 3, J and K).
Next, we analyzed glucose uptake from the medium and cel-
lular lactate release, to evaluate whether M(LPS) macrophages
increase their glycolytic rate. Under normoxia, LPS-stimulated
macrophages increased glucose uptake and lactate release, and
under hypoxia, glucose uptake and lactate release were exceed-
ing the rate of M(LPS) macrophages under normoxia (Fig. 3L).
This effect was further enhancedwhen hypoxic cells were addi-
tionally stimulated with LPS (Fig. 3L). Under normoxia, the
lactate to glucose ratio was increased from 1.2 to 1.6 upon LPS
stimulation, indicating increased activity of lactate dehydroge-
nase, which is in line with the Warburg-like phenotype of
M(LPS) macrophages (3). However, 20% of the overall glucose
carbon pool is still available for othermetabolic pathways, indi-
cating that M(LPS) macrophages still contain sufficient pyru-
vate to maintain oxidation through PDH.
It has been shown before that STAT3-specific signaling can
inhibit PDHand thus block pyruvate oxidation through PDH in
primary fibroblasts and cancer cell lines (35). Therefore, we
investigated whether, and in contrast to LPS treatment, a
STAT3-dependent activation with the cytokine INF might
inhibit PDH. To this end, we treated the cells with INF or LPS
and analyzed the isotope enrichment in citrate. We did not
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FIGURE 2. Expression analysis of pro-inflammatory associated genes. A,
relative gene expression of Irg1. B, Western blot against IRG1/CAD, the pro-
tein that catalyzes the conversion of cis-aconitate to itaconate (no significant
difference (data not shown)). C–F, relative gene expression of Tnf, iNos, Il1,
and Hif1, normalized to normoxia control (LPS). Error bars indicate S.E.
(Welsh’s t test, *, p 0.01, n 3). Gene expression data represents the mean
over three independent experiments.
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observe a difference between LPS and INF treatment (Fig.
3M). In both cases, M2 citrate was significantly increased com-
pared with untreated controls. In line with LPS activation, we
also observed decreased expression of Pdk1 inM(INF)macro-
phages (Fig. 3N), indicating no inhibition of pyruvate oxidation
in M(INF) macrophages. In conclusion, sustained pyruvate
flux through PDH and its regulation by PDK1 seems to be inde-
pendent of TLR4 signaling.
LPS Activation Increases Glutamine Uptake but Does Not
Induce Reductive Carboxylation of KG —It has been demon-
strated that hypoxic cells metabolize increased amounts of glu-
tamine via reverse IDH activity to generate citrate by reductive
FIGURE 3. PDH flux analysis inM(LPS)macrophages. A, schematic of atom transitions in central metabolism using [U-13C]glucose as a tracer for determina-
tion ofMIDs to infer relative intracellular fluxes. 13C-carbons are in gray and 12C in black. The dotted line indicates endof one route.Aco, aconitase; Idh, isocitrate
dehydrogenase; Akgdh, KG dehydrogenase; OA, oxaloacetate. B, MID of citrate. M0 to M6 indicates the different mass isotopologues. C, gene expression
analysis of Pdk1. D–H, Western blot analysis of PDK1 and PDH phosphorylation on Ser-232, -293, and -300. -Tubulin serves as loading control. D shows one
representative Western blot of three independent experiments. -Tub, -tubulin. E–H shows quantification of three independent experiments. I, ratio of M2
citrate/M3 pyruvate indicating relative pyruvate oxidation through PDH. J and K, MID of KG and malate. L, absolute quantification of glucose uptake and
lactate release, and ratio of lactate release/glucose uptake to infer fractional lactate formation per glucose.M, activation of RAW264 cells with 10 ng/ml LPS or
50 ng/ml interferon- (INF) in medium with [U-13C]glucose. Presented are citrate M2 isotopologues as a readout for relative glucose flux through PDH. N,
relative gene expression of Pdk1 normalized to normoxia control (Ctrl) (LPS). Error bars indicate S.E. (Welsh’s t test, *, p 0.01, n 3). One representative
experiment with three individual wells per condition is presented. Each experiment was performed at least three times, except for C. Presented is themean	
S.E. over three independent experiments. (Welsh’s t test, *, p 0.01, n 3).
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carboxylation of KG (12–15). This pathway fuels the citrate
pool to provide sufficient acetyl-CoA for lipogenesis. Because
M(LPS) activation also results in a stabilization of HIF1 (10,
19, 21, 29) and increased glycolytic flux (see Fig. 3, I and L), we
investigated whether these cells exhibit increased reductive
carboxylation of KG. To that end, we applied a uniformly
labeled [U-13C]glutamine tracer and determinedMIDs of TCA
cycle metabolites (Fig. 4A for atom transitions).
As expected, under hypoxic conditions we observed a drop
in oxidative TCA cycle activity and a strong induction of
reductive carboxylation, inferred from decreased citrate M4
and increased citrate M5 isotopologues (Fig. 4, B–D). This
pattern was also reflected by decreasing malate M4 (oxidative
route) and increasing malate M3 (reductive route) isotopo-
logues (Fig. 4E). However, when cells were stimulated with LPS
at normoxic conditions, reductive carboxylation of KG was
not increased (Fig. 4D).
Using the glutamine tracer, we observed that the major
carbon source of KG was glutamine and that upon LPS
stimulation and under hypoxia the abundance of M5 isoto-
pologues increased, suggesting an increase in glutamine
influx and a decreasing glucose contribution (Fig. 4F).
Although hypoxia results in increased usage of KG for
reductive carboxylation and decreased KG oxidation (14,
15), we did not find evidence that LPS stimulation under
normoxia compromises the relative glutamine carbon flux
through KG dehydrogenase, indicated by a similar enrich-
ment pattern of KG and malate.
To analyze glutamine metabolism in more detail, we quanti-
fied glutamine uptake from the medium and glutamate release
from the cells. Although hypoxia did not result in increased
glutamine uptake, we observed a strong increase of glutamine
uptake upon LPS stimulation under both oxygen levels (Fig.
4G). Because glutamate is produced from glutamine and can be
FIGURE 4. Contribution of glutamine to central metabolism in M(LPS) macrophages. A, schematic of atom transitions in central metabolism using
[U-13C]glutamineas a tracer. 13C-carbonsare ingray, 12C inblack. Citratemoleculesderived fromreductive carboxylationofKGareM5 isotopologues,whereas
citrate molecules from the oxidative route of the TCA cycle are M4 isotopologues. The dotted line indicates end of one route. Aco, aconitase; Idh, isocitrate
dehydrogenase; Akgdh, KG dehydrogenase; Acly, ATP-dependent citrate lyase; FA, fatty acid. B,MID of citrate.M0 toM6 indicates the different mass isotopo-
logues. C and D, determination of oxidative TCA cycle activity: ratio of M4 citrate/M5 glutamate and ratio of M5 citrate/M5 glutamate indicating relative
reductive Idh flux. E and F, MID of malate and KG. G–I, absolute quantification of glutamine uptake, glutamate release, and uptake of the branched chain
amino acids (valine, isoleucine, and leucine). J, carbon contribution (%) of glucose, glutamine, and other carbon sources to citrate,KG,malate, and itaconate.
Carbon contributions are based onMIDs from [U-13C]glucose labeling (Fig. 3) and [U-13C]glutamine labeling. Carbon contribution to itaconate under non-LPS
conditions should not be considered because itaconate levels are negligibly low under these non-stimulated conditions (Fig. 1A). Error bars indicate S.E.
(Welsh’s t test, *,p0.01,n3).One representative experimentwith three individualwells per condition is presented. Eachexperimentwasperformedat least
three times.
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released from the cell, we quantified glutamate release to infer
glutamine anaplerosis to the TCA cycle. Although we observed
increased glutamate release upon LPS stimulation, the net
uptake of glutamine in LPS-stimulated cells was still higher
compared with untreated controls (control 12.84 versus LPS
20.5 fmol/cell/h) (Fig. 4,G andH). As indicated by the intracel-
lular metabolite levels (Fig. 1K), we also observed a trend of
increased consumption of branched chain amino acids from
the medium upon LPS stimulation (Fig. 4I). However, these
differences were only significant in the case of leucine. Never-
theless, we believe that the influence of branched chain amino
acids on central metabolism is higher upon LPS activation.
To better understand the impact of the different carbon
sources to the TCA cycle metabolites, we calculated the carbon
contributions of glucose and glutamine to citrate, KG,malate,
and itaconate (Fig. 4J).We observed a small decrease in glucose
contribution to citrate upon LPS activation. However, based on
the [U-13C]glucose-derived MIDs, this decrease mostly origi-
nated from decreased citrate cycling through the oxidative
TCA cycle (compareM3,M4, andM5 isotopologues in Fig. 3B)
or increased glutamine influx, rather than decreased pyruvate
flux through PDH (M2 isotopologue). Hypoxia resulted in a
stronger reduction of glucose contribution to citrate, whichwas
a result of PDH inhibition. Along with the decrease in glucose
contribution, the glutamine contribution to citrate was
increased uponLPS, especially under hypoxia, where glutamine
is the major carbon source of citrate. For KG and malate, the
glucose contributionwas significantly lower comparedwith cit-
rate, indicating that major parts of the citrate pool are not used
for further oxidation through the oxidative TCA cycle, but for
anabolic processes such as lipid synthesis or itaconate synthe-
sis. In line with this observation, we observed higher glucose
contribution to itaconate, compared with KG and malate.
Moreover, upon LPS stimulation, and especially with hypoxia,
we observed an increase of other carbon sources than glucose
or glutamine, which is in line with potentially increased uptake
of branched chain amino acids (Figs. 1K and 4I).
In summary, we observed that glutamine is themajor carbon
source of the TCA cycle in M(LPS) macrophages and is the
main substrate for TCA oxidation. Glucose carbon still enters
the cycle at citrate; however, significant amounts of the citrate
pool are not further oxidized through IDH but are distributed
to othermetabolic pathways.Glutamine serves to replenish this
lack of carbon by increased uptake upon LPS stimulation.
LPS Causes an Increase in Lipogenesis in RAW 264 Cells—
Besides transcriptional and metabolic adaptations to inflam-
mation, it has been described that pro-inflammatory macro-
phages also undergo morphological changes from small and
spherical to a larger andmore attached form (Fig. 5A). To dem-
onstrate the surface enlargement during LPS activation, we
monitored cell size by using two orthogonal microscopy
approaches (Fig. 5B), demonstrating an increase in cell surface
and thus pointing to an increased demand on lipids needed for
membrane formation. Furthermore, M(LPS) macrophages
increase intracellular and extracellular vesicle formation during
pathogen defense (36). Therefore, M(LPS) macrophages have
an increased demand for lipids, needed for morphological
changes and vesicle formation. To meet this demand, LPS-
activated macrophages need to prioritize their metabolism
toward lipogenesis and to repress lipid oxidation. In line with
this necessary metabolic shift, we observed decreased expres-
sion of carnitine palmitoyltransferase 1 (Cpt1), the gene of the
protein that imports palmitate into themitochondrion for lipid
oxidation and subsequent energy production (Fig. 5C). A
reduction of -oxidation is in line with reports of decreased
oxidative metabolism in M(LPS) macrophages (37) and sup-
ports the observed increased demand for lipids. High activity of
lipid degradation, simultaneously to their synthesis, would be a
waste of energy.
To generate lipids from central metabolism, cells export
mitochondrial citrate into the cytoplasmwhere it is hydrolyzed
via ATP-dependent citrate lyase to provide acetyl-coA for lipo-
genesis. In this preferred case, citrate utilization is for anabolic
processes rather than the TCA cycle. To analyze the contribu-
tion of glucose and glutamine to palmitate, an end point of fatty
acid synthesis, we determined theMIDs of and the carbon con-
tributions to palmitate after both the application of [U-13C]g-
lucose and [U-13C]glutamine as tracers in independent experi-
ments (Fig. 5, D and E). We observed that under normoxia,
nearly 50% of the carbon in palmitate originated from glucose.
Under hypoxic conditions, a shift in isotopologues indicated
that the glucose contribution was reduced while glutamine
contributionwas increased, suggesting increased reductive car-
boxylation under hypoxia, but not as a result of LPS stimula-
tion. Although dependent on the pool sizes of the metabolites,
increased production of itaconate and palmitate from glucose-
derived citrate in M(LPS) macrophages indicates reduced cit-
rate oxidation through the TCA cycle inM(LPS) macrophages.
Pyruvate Flux to Citrate Is Important for LPS Activation in
RAW264Cells—To investigate the importance of the PDH flux
in M(LPS) macrophages, we used a pharmacological approach
to impair pyruvate oxidation through PDH by inhibiting the
pyruvate transporter with the specific inhibitor UK5099 (38).
Using this inhibitor togetherwith the [U-13C]glucose tracer, we
observed a significant decrease of citrate M2 isotopologues,
indicating reduced relative pyruvate oxidation through PDH
(Fig. 6A). Addition of LPS to UK509-treated cells could not
restore the abundance ofM2 citrate, because pyruvate supply is
impaired by the inhibition of the transporter. Analysis of intra-
cellular metabolite levels revealed that inhibition of pyruvate
transport into the mitochondrion resulted in decreased
amounts of citrate, originating from reduced substrate levels
for citrate synthase (Fig. 6B). Intriguingly, we also observed
decreased amounts of the inflammatory marker metabolites
itaconate and succinate under pro-inflammatory conditions
(Fig. 6,C andD). Decreased amounts of itaconate and succinate
could either result from decreased glucose flux into the TCA
cycle, similar to hypoxia, or from a metabolic alteration in
M(LPS) macrophages. To analyze these hypotheses, we inves-
tigated the gene expression profiles of pro-inflammatory
marker genes (Fig. 6, E–H). Although Il1b gene expression was
not significantly decreased (Fig. 6E), we observed that UK5099
treatment of LPS-stimulated macrophages resulted in de-
creased expression levels of iNos, Irg1, and Tnf (Fig. 6, F–H),
indicating that in this case and in contrast to hypoxia, the
observed decreased itaconate level roots back to decreased Irg1
PDH Flux Is Important for Activation ofM(LPS) Macrophages
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levels. Moreover, application of UK5099 to LPS-stimulated
cells resulted in increased Cpt1 expression levels, similar to
untreated controls, although Pdk1 expression was still reduced,
due to the fact that pyruvate import into the mitochondrion
was inhibited and thus regulation of PDH not necessary (Fig. 6,
I and J). To exclude a potential toxic effect of UK5099 on RAW
264 cells, we performed a viability assay and did not observe
significant changes in viability (Fig. 6K). To further exclude the
possibility of timing effects due to simultaneous addition of LPS
and UK5099, we repeated the experiments with a modified
experimental setup, where we first activated the cells with LPS
for 3 h and then added UK5099 for an additional 6 h to investi-
gate whether this intervention can repress the pro-inflamma-
tory profile of M(LPS) macrophages (Fig. 6L). Following this
approach, we also observed significantly decreased citrate, itac-
onate, and succinate levels (Fig. 6, M–O) and significantly
decreased expression of Tnf, iNos, Irg1, and Il1b (Fig. 6, P–S).
These results indicate that inhibition of pyruvate import into
the mitochondrion can indeed suppress pro-inflammatory
responses in M(LPS) macrophages. Finally, we investigated
the effect of carbon contribution to palmitate for these con-
ditions, using [U-13C]glucose as a tracer, in combination
with UK5099. In line with decreased citrate, itaconate, and
succinate levels upon UK5099 treatment, we also observed
lower carbon contribution from glucose to palmitate (Fig. 6,
T and U).
In summary, these data demonstrate that the pyruvate flux
through PDH is important for LPS activation in macrophages.
Apparently, altered metabolic fluxes or changes in metabolite
concentrations enable a feedback mechanism to regulate cellu-
lar gene expression profiles. Hence, metabolic intervention can
be used to attenuate activation of M(LPS) macrophages.
Discussion
M(LPS) macrophages require extensive reprogramming to
enable host defense mechanisms. Although M(IL4) macro-
phages increase oxidative metabolism optimized for tissue
repair (39), M(LPS) macrophages develop aWarburg-like phe-
notype by increasing glycolysis and lactate release (3). It has
been demonstrated that pro-inflammatory activation results
in the stabilization of HIF1, HIF1 complex formation with
monomeric or dimeric PKM2, along with an increased
expression of M(LPS)-associated cytokines and bacterial
defense mechanisms (29). While under hypoxia HIF1 not
only increases the glycolytic activity but also represses PDH
activity through PDK1, it was speculated that glucose flux
FIGURE 5. Morphological changes upon LPS activation require sustained lipogenesis in macrophages. A, microscopy (bright field image) of RAW
macrophages unstimulated or stimulated with 10 ng/ml LPS for 6 h. White bar indicates 100 m. B, mean average of cell size (pixels) (left) and analysis of
adhesion index (right) of LPS-stimulated and -non-stimulated cells obtained from bright field microscopy. Analysis demonstrates morphological adaption of
macrophages during LPS activation. For further details regarding the analysis approach, see under “Experimental Procedures.” C, relative gene expression
of carnitine palmitoyl transferase1 (Cpt1) normalized to normoxia control (Ctrl) (LPS), indicating inhibition of-oxidation upon LPS stimulation.D and E,MID
of palmitate using [U-13C]glucose (D) and [U-13C]glutamine (E) as a tracer. Contribution of each carbon source is depicted in the top right corner of each panel.
Error bars indicate S.E. (Welsh’s t test, *, p 0.01,n 3). One representative experimentwith three individualwells per condition is presented. Each experiment
was performed at least three times, except for C. Presented is the mean	 S.E. over three independent experiments. (Welsh’s t test, *, p 0.01, n 3).
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through PDH is also repressed in M(LPS) macrophages (3,
40). However, this would diminish the carbon supply neces-
sary for lipogenesis and synthesis of the antimicrobial
metabolite itaconate.
In this work, we demonstrate that the PDH flux plays an
important role in maintaining full LPS-specific activation and
that pharmacological intervention to prevent pyruvate oxida-
tion represses pro-inflammatory activation. Although an active
PDH flux has been speculated for early macrophage differenti-
ation and for dendritic cells before (3, 41), our results demon-
strate that pyruvate oxidation through PDH is fully active in
mature M(LPS) macrophages and that this is even essential to
sustain LPS activation. Moreover, we discovered that this pro-
cess is facilitated by repressed Pdk1 expression and no increase
in PDK1 protein abundance, as well as significantly lower phos-
phorylation of PDH compared with hypoxic conditions, illus-
trating that M(LPS) macrophages sustain an active pyruvate
flux through PDH.
Under hypoxia, HIF1 decreases pyruvate oxidation through
PDH by inducing Pdk1 (32). In contrast to hypoxia, we demon-
strated that although glycolysis is increased and oxygen con-
sumption is decreased (29) in M(LPS) macrophages, pyruvate
oxidation through PDH is not inhibited, because PDK1 abun-
dance is not increased. Active PDH facilitates a stable citrate
pool, which in turn prevents increased reductive carboxylation
of KG by thermodynamic means (16). M(LPS) macrophages
have been shown to increase their expression of the mitochon-
drial citrate carrier to transport citrate from themitochondrion
into the cytosol (42), and we have shown that M(LPS) macro-
phages have an increased lipid demand. Because we demon-
strated that reductive carboxylation of KG is not increased,
the high demand of citrate has to bemostly supplied by glucose
through PDH.
WhenPDH flux is repressed, citrate is increasingly generated
by reductive carboxylation of KG, which is mostly derived
from glutamine (43). An increased demand on glutamine in
M(LPS) macrophages has been reported before (44). Here, we
describe in detail how this glutamine is utilized. In M(LPS)
macrophagesmost glutamine is preferentially used for glutami-
nolysis rather than for reductive carboxylation of KG. Besides
ATP-dependent citrate lyase-derived oxaloacetate, increased
glutaminolysis additionally provides oxaloacetate, which is
needed as an acceptor for pyruvate-derived acetyl-CoA and the
synthesis of citrate. It also replenishes the TCA cycle to com-
pensate for increased lipogenesis and the loss of carbon that is
used for the synthesis of itaconate.
It is known that LPS activation results in decreased oxygen
consumption, which suggests that TCA cycle activity is
decreased and would provide less NADH to be oxidized via the
ETC (29, 45, 46). However, we found evidence that the oxida-
tive TCA cycle is still running and is fueled by increased
amounts of glutamine. TCA cycle-derived NADH can be used
for alternative routes and would consequently not be oxidized
via the ETC and thus would also result in reduced oxygen con-
sumption rates. Mitochondrially derived NADH can alterna-
tively be converted to NADPH by nicotinamide nucleotide
transhydrogenase (17, 47), which is utilized by M(LPS) macro-
phages for ROS production via NADPH oxidase, needed for
antibacterial activity (48), or transferred to the cytoplasm (49)
where it is needed for lipogenesis. Therefore, it is possible that
M(LPS) macrophages use increased amounts of TCA cycle-
derived NADH for the generation of NADPH rather than oxi-
dizing it via the ETC, which fits to the reported decreased oxy-
gen consumption rates (6, 45, 46). Additionally, the ETC can be
directly inhibited by nitrosylation (50, 51) promoted by increased
expressionof iNos,whichwehaveshowntobe increaseduponLPS
stimulation.Therefore,decreasedoxygenconsumption inM(LPS)
macrophages due to decreased ETC activity is reasonable, but a
decreased ETC activity does not necessarily have to result in
decreased oxidative TCA cycle activity.
Although we could demonstrate that PDH activity is impor-
tant in M(LPS) macrophages, the mechanism of how Pdk1
repression is facilitated despite the presence of HIF1 needs
additional research. One possibility would be a weaker stabili-
zation because HIF1 is not as abundant as in hypoxic cells.
However, in this case, we would still expect a similar mode of
action and therefore a moderate induction of Pdk1. LPS activa-
tion exhibits distinct regulatory modules (2), and we conclude
that these specific networks overlap with the classical HIF1 signa-
ture tomediate LPS-specific activation. Becausewe demonstrated
thatM(LPS)macrophagesdependonthePDHflux to inducecyto-
kineexpressionandsynthesisof itaconate, it appears that a specific
HIF1-induced upstream regulator exists which specifically pre-
vents Pdk1 expression. In this way, increased glucose uptake and
lactate release can still be facilitated byHIF1,whereas PDK1 activ-
ity is prevented by an additional regulator. Overall, this points
toward a context-dependent HIF1 response.
With the hypoxia model, we demonstrated that the
decreasedpyruvate flux throughPDHresults indecreased levelsof
the antimicrobial metabolite itaconate as well as decreased levels
of succinate.However, geneexpressionof Irg1wasunchanged.We
conclude that, under hypoxia, decreased metabolite levels are a
FIGURE 6. Inhibition of pyruvate transport into mitochondria suppresses pro-inflammatory responses in M(LPS) macrophages. A, application of
the specific pyruvate transport inhibitor UK5099 to inhibit flux through PDH. Cells were treatedwith 100MUK5099 for 6 hwith or without 10 ng/ml LPS
at normoxia. Prior to treatment start, cells were cultivated for 24 h in [U-13C]glucose. Presented are citrate M2 isotopologues as a readout for relative
glucose flux through PDH. B–D, intracellular metabolite levels of citrate, itaconate, and succinate upon LPS stimulation and after application of 100 M
UK5099. Metabolite levels were determined using GC/MS and normalized to cell number. E–J, relative gene expression of Il1, iNos, Irg1, Tnf, Cpt1, and
Pdk1 normalized to normoxia control (Ctrl) (LPS), upon LPS stimulation and after application of 100 M UK5099 for 6 h. K, viability assay to test a
potential effect of UK5099 on cell viability. Assay was performed using trypan blue, dead and live cells were counted. L, to validate the effect of UK5099
a modified experimental setup has additionally been performed. Cells were first activated with 10 ng/ml LPS for 3 h and then UK5099 was added to the
cells for additional 6 h. In total, LPS activation was 9 h in this case. Non-UK5099 treated and non-activated cells served as control. M–O, intracellular
metabolite levels for citrate, itaconate, and succinate (analysis as in B–D). P–S, relative gene expression analysis of Tnf, iNos, Irg1, and Il1. T and U,MID
of palmitate using [U-13C]glucose as a tracer. Experimental setup as in A. U, glucose contribution to palmitate, determined from T. Error bars indicate S.E.
(Welsh’s t test, *, p 0.01, n 3). One representative experiment with three individual wells per condition is presented. Each experiment was performed
at least three times.
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passive effect of decreased pyruvate oxidation and decreased oxi-
dative mitochondrial metabolism. This also illustrates that HIF1-
mediated inhibition of PDHwould be disadvantageous toM(LPS)
macrophagesandthatpartsof theTCAcycleare indeed important
for M(LPS) macrophages, e.g. for the synthesis of lipids and
itaconate.
By inhibiting the pyruvate import into the mitochondria
of M(LPS) macrophages, we observed decreased metabolite
levels of itaconate and succinate, similar to hypoxia. Intrigu-
ingly, in the case of transport inhibition, gene expressions of
Irg1, Tnf, and iNos were decreased as well. All of these
genes are hallmarks of LPS activation, indicating a general
impairment of activation in matured M(LPS) macrophages.
Based on our observations, we can now extend the existing
metabolic model of M(LPS) macrophages (Fig. 7). 1) We
confirmed the findings of increased glycolysis and increased
lactate release. 2) Furthermore, reductive carboxylation of
KG is not increased in M(LPS) macrophages, but instead
glutamine is still oxidized through KG dehydrogenase. 3)
Finally, pyruvate is still oxidized through PDH, which turned
out to be essential for full LPS activation. Our work revealed
an LPS-specific metabolic feature that is essential for activa-
tion and that might be approached by further studies in the
light of translational medicine to develop novel therapies
against inflammatory dysfunctions.
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immunoresponsive gene 1 and itaconate inhibit succinate
dehydrogenase to modulate intracellular succinate lev-
els
Cordes T, Wallace M, Michelucci A, Divakaruni AS, Sapcariu SC, Sousa
C, Koseki H, Cabrales P, Murphy AN, Hiller K, Metallo CM. Jounral of Bi-
ological Chemistry. 2016, 291(27), 14274-14284. doi:10.1074/jbc.M115.685792
My contributions to this article were the design, execution, and analy-
sis of experiments related to Irg1 knock out BMDMs. To support the find-
ings that itaconic acid inhibit succinate dehydrogenase activity in order
to increase intracellular succinate during the inflammatory response in
macrophages, I stimulated Irg1 KO BMDMs with LPS, and measured re-
duced intracellular levels of itaconic acid and succinic acid compared to
wild type BMDMs. This data is seen in figure 6 in the manuscript.
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Metabolic reprogramming is emerging as a hallmark of the
innate immune response, and the dynamic control of metabo-
lites such as succinate serves to facilitate the execution of
inflammatory responses in macrophages and other immune
cells. Immunoresponsive gene 1 (Irg1) expression is induced by
inflammatory stimuli, and its enzyme product cis-aconitate de-
carboxylase catalyzes the production of itaconate from the tri-
carboxylic acid cycle. Here we identify an immunometabolic
regulatory pathway that links Irg1 and itaconate production to
the succinate accumulation that occurs in the context of innate
immune responses. Itaconate levels and Irg1 expression corre-
late strongly with succinate during LPS exposure in macro-
phages and non-immune cells. We demonstrate that itaconate
acts as an endogenous succinate dehydrogenase inhibitor to
cause succinate accumulation. Loss of itaconate production in
activated macrophages from Irg1/ mice decreases the accu-
mulation of succinate in response to LPS exposure. This meta-
bolic network links the innate immune response and tricarbox-
ylic acidmetabolism to function of the electron transport chain.
Immune cells must sense cues from the extracellular
microenvironment and respond rapidly to protect against bac-
teria, viruses, or other pathogens (1). An emerging hallmark of
inflammation and the innate immune system of cells is meta-
bolic reprogramming (2). One of the most general metabolic
changes that occurs under proinflammatory conditions is a bio-
chemical switch from oxidative phosphorylation to aerobic gly-
colysis (3–5), which is mediated, in part, via stabilization of
hypoxia-inducible factor 1 (HIF-1)2 after pathogen infection
(6), LPS binding to toll-like receptors (7), or by cytokine expo-
sure (8). Although it is known that macrophages undergo dras-
tic metabolic reprogramming upon exposure to inflammatory
stimuli, the underlying mechanisms driving this response are
not completely understood.
Increased succinate levels in macrophages are important
mediators of the inflammatory response, linkingmetabolism to
innate immunity. In addition to its role in TCA metabolism,
succinate acts as a regulatory signal enhancing Il-1 expression
through stabilization of HIF-1, which, in turn, influences the
function of various other metabolic pathways (9). Succinate
inhibits the hydroxylation of HIF-1 by EGLN1, resulting in
pseudohypoxic HIF-1 stabilization under normoxic condi-
tions (10–12). Various mechanisms have been proposed as the
cause of succinate accumulation, including increased gluta-
mine anaplerosis and oxidation in the TCA cycle or increased
flux through the GABA shunt (9, 13), although glycolytic
metabolism is a prerequisite (14). However, the specific driv-
er(s) of this phenomenon has/have not yet been identified.
Given the central role of succinate as a metabolic signal in
inflammation, elucidation of themetabolic pathway(s) involved
in succinate accumulation and its/their regulationmay provide
new avenues for controlling this process.
Metabolites are important functional triggers that can regu-
late the activity of enzymes via substrate/product inhibition,
posttranslational modifications, or allosteric interactions (15).
Beyond their direct roles as substrates and products, metabo-
lites often serve as substrates for posttranslational modifica-
tions, as shown for succinate to succinylate proteins (9). On the
other hand, fructose 1,6-bisphosphate (16), serine, and other
amino acids can allosterically influence the activity of the
enzyme pyruvate kinase isoformM2 (PKM2) (17, 18). Recently,
synthesis of the antimicrobial metabolite itaconate was identi-
fied in mammalian immune cells as being selectively up-regu-
lated under proinflammatory conditions (19). Itaconate exhib-
its an antibiotic function (20) via inhibition of isocitrate lyase, a
key enzyme of the glyoxylate shunt needed by many bacteria to
survive during infection (21–23). Inmammals, itaconate is pro-
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duced through the decarboxylation of the TCA cycle interme-
diate cis-aconitate, which is catalyzed bymammalian cis-aconi-
tate decarboxylase (CAD, also known as immune-responsive
gene 1 (IRG1) protein) encoded by immunoresponsive gene 1
(IRG1) (20). Itaconate production represents one of two char-
acteristic TCA cycle “break points” discovered in classically
activated immune cells (24, 25). The first break occurs at isoci-
trate dehydrogenase, leading to the accumulation of citrate, the
precursor for itaconate, and the second break occurs at succi-
nate dehydrogenase (SDH), which may allow for succinate
accumulation. Although itaconate has been shown previously
to inhibit SDH ex vivo (26–28), and LPS-activated murine
macrophages produced up to 8 mM intracellular itaconate (20),
a potential role of endogenously produced itaconate in succi-
nate accumulation under inflammatory conditions has not yet
been addressed and is unknown.
To elucidate the role of itaconate in reprogramming immune
cell metabolism, we modulated intracellular itaconate levels in
primary bone marrow-derived macrophages (BMDMs), a
macrophage cell line, as well as a lung adenocarcinoma cell line.
In all cellmodelswe observedmetabolic changes reminiscent of
SDH inhibition, including succinate accumulation. By measur-
ing substrate-specific mitochondrial respiration, we demon-
strated the inhibition of SDH by itaconate in a dose-dependent
manner. Furthermore, stimulated BMDMs from Irg1 KOmice
failed to produce itaconate and exhibited decreased succinate
accumulation compared with BMDMs from WT mice. Based
on these studies, we have elucidated an Irg1-induced immuno-
modulatory pathway inmacrophages whereby its product, itac-
onate, acts as an endogenously producedmetabolic regulator of
mitochondrial metabolism.
Experimental Procedures
Cell Culture and Isotopic Labeling—RAW 264.7 macro-
phages (29) (ATCC, TIB-71) and A549 cells (30) (ATCC, CCL-
185) were maintained in high-glucose DMEM (Life Technolo-
gies) supplemented with 10% (v/v) FBS, 100 unitsml1
penicillin/streptomycin, 25mM glucose, and 4mM L-glutamine.
Cell lines tested negative for mycoplasma contamination
using the MycoAlert mycoplasma detection kit (Lonza)
according to the instructions of the manufacturer. Purified
Escherichia coli LPS was used for the activation of RAW
264.7 macrophages and BMDMs at a concentration of 10
ngml1. A549 and RAW 264.7 cells and BMDMs were
exposed to increasing itaconate concentrations (5, 10, and 25
mM) for 6 h. For isotopic labeling experiments, RAW 264.7
macrophages were cultured in DMEM (Sigma) supple-
mented with 25 mM glucose, 4 mM [1-13C]glutamine (Cam-
bridge Isotopes Inc.) and 10% (v/v) dialyzed FBS for 24 h
prior to addition of LPS for 6 h. For isotope tracing with
exposure to unlabeled itaconate, RAW 264.7 cells were
exposed to labeled [U-13C6]glucose and [U-13C5]glutamine
tracers over a period of three subcultures and then exposed
further for 6 and 24 h to 10 mM unlabeled itaconate.
BMDMs—BMDM collection was approved by the Institu-
tional Animal Care and Use Committee and was conducted
according to the Guide for the Care and Use of Laboratory
Animals (US National Research Council, 2010). BMDMs were
isolated from femora and tibiae of C57BL/6J mice (The Jackson
Laboratory, Bar Harbor, ME). Bones were collected in ice-cold
PBS, cleaned of muscle, and flushed with 5 ml BMDM growth
medium (DMEM, Life Technologies) supplemented with 10%
(v/v) FBS, 100 unitsml1 penicillin/streptomycin, 25 mM glu-
cose, 4 mM L-glutamine, 20 ngml1 recombinant-macrophage
colony-stimulating factor (eBioscience), and 3.4 ll1 -mer-
captoethanol). Cells were seeded at 5 106 cells on Petri dishes
in 10 ml of growth medium. 5 ml of fresh growth medium was
added on day 3. On day 6, BMDMs were collected and replated
into 6-well tissue culture plates at a density of 5 105 cells/well
in growth medium containing 2 ngml1 recombinant-macro-
phage colony-stimulating factor.Metaboliteswere extracted on
day 7.
For Irg1 KO versusWTBMDM experiments, all animal pro-
cedures, such as handling and euthanasia, were performed
according to the Federation of European Laboratory Animal
Science Associations guidelines for the use of animals in
research. The Irg1 KO mice were generated by Dr. Haruhiko
Koseki at the RIKEN Institute using stem cells purchased from
the Knockout Mouse Project Repository under strain ID
Irg1tm1a(KOMP)Wtsi. Mice were anesthetized by intraperitoneal
injection of 50 mgkg1 of ketamine hydrochloride and 5
mgkg1 xylazine hydrochloride, and bonemarrowwas isolated
and cultured as described previously (31). Briefly, bonemarrow
was flushed from femora and tibiae of Irg1KOand age-matched
C57BL/6 WT mice, and the resultant cell suspension was
passed through a 70-m filter (Greiner Bio-One). After 10 min
of centrifuging at 250  g, the supernatant was discarded, and
the pellet was resuspended in 2 ml of hypotonic solution (170
mM NH4Cl) for 5 min to allow lysis of any remaining extracel-
lular red blood cells. Bone marrow-derived cells were plated in
12-well plates (Greiner Bio-One) at 5  105 cells/well. Cells
were cultured for 6 days at 37 °C in RPMI 1640 VLE (Very Low
Endotoxin) (Biochrom FG 1415) supplemented with 10% FBS
and 20% conditioned medium from macrophage colony-stim-
ulating factor-secreting L929 fibroblasts. After 6 days in cul-
ture, the BMDMs were used for experiments.
Metabolite Quantification—Metabolite levels of itaconate
and TCA cycle intermediates were quantified using external
standardcurves(threebiologicalreplicates).Formetabolitestan-
dard curves, increasing standard solutions were extracted
under the conditions of sample preparation. Using the depicted
standard curve, the metabolite quantity in each cell extract was
calculated, taking into account cellular diameter (d, microme-
ters) of detached cells and cell number.We assumed a spherical
shape and calculated the intracellularmetabolite concentration
using the following equation: [metabolite]metabolite quan-
tity (moles)/(((4/3000) (d/2)3) cell number). Cell number and
cell diameter were determined using a Countess automated cell
counter (Invitrogen).
Cell Transfections—Irg1 gain-of function experiments in
A549 cells were performed as described previously (20). Briefly,
A549 cells were transfected with the pCMV6-Irg1 (OriGene)
overexpressing plasmid or empty plasmid using Lipofectamine
2000 (Invitrogen) and further incubated for 24 h.
RNA Isolation and RT-PCR—Total RNA was purified from
cultured cells using the Qiagen RNeasy mini kit (Qiagen)
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according to the instructions of the manufacturer. First-strand
cDNA was synthesized from total RNA using SuperScript III
(Invitrogen) with 1 l (50 M)/reaction oligo(dT)20 as primer
according to the instructions of the manufacturer. Individual
20-l SYBR Green real-time PCR reactions consisted of 2 l of
diluted cDNA, 10 l of fast SYBR Green Master Mix (Applied
Biosystems), and 0.5 l of each 10 M forward and reverse
primers. For standardization of quantification, L27 was ampli-
fied simultaneously. PCRwas carried out in 96-well plates on an
Applied Biosystems ViiaTM 7 real-time PCR system using the
following program: 95 °C for 20 s, 40 cycles of 95 °C for 1 s, and
60 °C for 20 s (Irg1, GCAACATGATGCTCAAGTCTG (for-
ward) and TGCTCCTCCGAATGATACCA (reverse); L27,
ACATTGACGATGGCACCTC (forward) and GCTTGGCG-
ATCTTCTTCTTG (reverse)).
Oxygen Consumption Measurements—Respiration was mea-
sured in adherent monolayers of RAW 264.7 macrophages or
BMDMs using a Seahorse XF96 analyzer. RAW 264.7 macro-
phages were plated at 3  104 cells/well (for assays with per-
meabilized cells) and 4  104 cells/well (for assays with intact
cells) and BMDMs at 5  104 cells/well 24 h before measure-
ment. Intact cells were assayed inDMEM(Sigma, 5030) supple-
mented with 8 mM glucose, 3 mM glutamine, 3 mM pyruvate,
and 2 mM HEPES. Cells were permeabilized with 3 nM perfrin-
golysin O (commercially, XF PMP (XF PlasmaMembrane Per-
meabilizer)) as described previously (32). Phosphorylating
(state 3), succinate-driven respiration in permeabilized cells
was measured in cells offered 4 mM ADP, 2 M rotenone, two
different succinate concentrations (2.5 and 10 mM), and
increasing itaconate concentrations (0, 5, 10, and 25 mM).
When measuring respiration on different respiratory sub-
strates, permeabilized cells were offered succinate (10 mM)/ro-
tenone (2 M), glutamate/malate (each 10 mM), pyruvate/
malate (each 10 mM), or ascorbate (10 mM) plus N,N,N,N-
tetramethyl-p-phenylenediamine (TMPD) (100 M) and
antimycin A (1 M). Maximal respiration was calculated as the
difference between protonophore-stimulated respiration (600
nM carbonyl cyanide p-trifluoromethoxyphenylhydrazone) and
nonmitochondrial respiration (measured after addition of 1M
antimycin A). All data are mean S.E. of two or three repeated
experiments (with a minimum of five biological replicates per
experiment) as indicated in the text. For assays with BMDMs,
cells were obtained from three different mice.
GC-MS Sample Preparation and Analysis—Polar metabo-
lites were extracted using methanol/water/chloroform as
described previously (20). For medium metabolites, medium
was centrifuged at 4 °C for 5 min at 300 g. 10 l of superna-
tant was added to 80 l of a 20 °C 8:1 methanol/water mix-
ture, mixed for 10min at 4 °C, and centrifuged at 16,000 g for
10 min at 4 °C. 80 l was collected and evaporated under a
vacuum at 4 °C. Metabolite derivatization was performed
using a Gerstel MPS. Dried polar metabolites were dissolved in
15 l of 2% (w/v) methoxyamine hydrochloride (Thermo Sci-
entific) in pyridine and incubated for 60 min at 45 °C. An equal
volume of 2,2,2-trifluoro-N-methyl-N-trimethylsilyl-acet-
amide (MSTFA) or N-tert-butyldimethylsilyl-N-methyltrifluo-
roacetamide (MTBSTFA) with 1% tert-butyl dimethylchlorosi-
lane (Regis Technologies) was added and incubated further for
30 min at 45 °C. After derivatization, MSTFA-derivatized sam-
ples were analyzed as described previously (20). Briefly,
derivatized samples were analyzed by GC-MS using a
DB-35MS column (30 0.25 mm inner diameter 0.25 m,
Agilent J&W Scientific) installed in an Agilent 7890A gas
chromatograph interfaced with an Agilent 5975Cmass spec-
trometer. For MTBSTFA-derivatized samples, the GC oven
was held at 100 °C for 1 min, increased to 255 °C at 3.5 °C
min1, increased to 320 °C at 15 °C min1, and held at
320 °C for 3 min. The total run time for one sample was 54.62
min. For Irg1 KO versus WT BMDM metabolite measure-
ments, the GC oven was held at 100 °C for 2min, increased to
300 °C at 10 °C min1, and held at 325 °C for 3 min. The total
run time for one sample was 26 min.
MSTFA-derivatized metabolites were determined using the
following quantification ions: itaconate (m/z 259) and succinate
(m/z 247). Metabolite levels and mass isotopomer distribu-
tions of MTBSTFA-derivatized samples were analyzed by
integrating metabolite fragment ions (itaconate, m/z 301–
310; succinate, m/z 289–294; citrate, m/z 459–469; -keto-
glutarate, m/z 346–355; malate, m/z 419–428; and fumar-
ate, m/z 287–292) and corrected for natural abundance
using in-house algorithms.
Statistical Analysis—All results shown as averages of one to
three repeated experiments with each at least two biological
replicates as indicated in the text. A repeated experiment is
defined as a separate experiment temporally. Biological repli-
cates are defined as separate spatial replicates (i.e. wells of a
tissue culture plate) within an experiment. In the case of
BMDMs, repeated experiments are defined as cells from differ-
ent mice. Error bars indicate mean S.E. The statistical tool R
(33) was used to calculate the Pearson correlation coefficient.
For comparison of means between two different treatments,
the statistical analysis was done by two-tailed Student’s t test. *,
p 0.05; **, p 0.01; ***, p 0.001.
Results
Succinate and Itaconate Accumulate in LPS-activated RAW
264.7 Macrophages—To better understand the relationship
between Irg1-mediated itaconate production and the repro-
gramming of TCA metabolism under LPS-stimulated condi-
tions, we quantified the dynamics of itaconate and TCA inter-
mediate abundances in RAW264.7macrophages over time. To
elicit an immune response, we exposed RAW 264.7 macro-
phages to 10 ngml1 LPS for 6 h, conditions that induce high
expression of Irg1 encoding CAD, the enzyme catalyzing itac-
onate production from cis-aconitate (20). Intriguingly, the lev-
els of itaconate and succinate exhibited similar trends upon
activation, in contrast to the dynamics of citrate, -ketogl-
utarate, fumarate, and malate (Fig. 1a), suggesting that itacon-
ate and succinate (or the enzymes metabolizing them) are reg-
ulated in a coordinated manner. Notably, basal oxygen
consumption rates (OCR) remained unchanged comparedwith
resting macrophages (Fig. 1b).
Exogenous Itaconate Drives Succinate Accumulation—To
determine whether itaconate directly contributes to succinate
accumulation, we next supplemented the growth medium of
resting and LPS-activated murine RAW 264.7 macrophages
ItaconateModulates Succinate Levels via SDH Inhibition
14276 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 27•JULY 1, 2016
 at U
niversité du Luxem
bourg on July 17, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
with increasing itaconate concentrations for 6 h and observed
how intracellular itaconate levels correlated with those of
various TCA cycle intermediates (Figs. 2, a–f). LPS-activated
murinemacrophages can produce up to 8mM intracellular itac-
onate (20), but higher levels may accumulate in specific com-
partments (e.g. mitochondria). Therefore, we considered four
different itaconate concentrations ranging from 0–25 mM.
Exposure to exogenous itaconate resulted in increasing intra-
cellular itaconate levels in a dose-dependent manner (Fig. 2c),
indicating that cells have the capacity to take up itaconate from
medium.However,medium itaconate levels were not apprecia-
bly affected (Fig. 2g). Interestingly, no mitochondrial or plasma
membrane itaconate transporters have been described inmam-
malian cells to date.
We next calculated the Pearson correlation coefficient (r)
between the intracellular abundance of itaconate and eachTCA
intermediate to gauge the relationship across each pair. Intrigu-
ingly, we observed that intracellular itaconate levels correlated
strongly with succinate levels in resting (r  0.99) as well as
LPS-activated macrophages (r 0.99) so that higher itaconate
levels were associated with elevated succinate levels (Fig. 2e).
Importantly, the levels of other TCA intermediates, including
citrate,-ketoglutarate, fumarate, andmalate correlated poorly
(or in some cases negatively) with intracellular itaconate levels
(Fig. 2, a, b, d, and f). Because succinate accumulates after expo-
sure to exogenous itaconate in RAW 264.7 macrophages (Fig.
2e) as well as BMDMs (Fig. 2h), these data suggest that LPS-
induced itaconate production bymammalian CAD contributes
to the elevated succinate levels observed in activated macro-
phages. Importantly, exposure to exogenous itaconate induces
succinate accumulation in resting RAW 264.7 macrophages
(Fig. 2e) as well as resting BMDMs (Fig. 2h), indicating that the
mechanism through which itaconate acts is independent of
other inflammatory signaling events.
Itaconate and Irg1-induced Succinate Accumulation Is Not
Specific to Immune Cells—To further investigate whether itac-
onate reprograms TCAmetabolism independent of inflamma-
tory signals, we supplemented increasing itaconate concentra-
tions (0, 5, 10, and 25 mM) to the growth medium of human
A549 lung adenocarcinoma cells and quantified intracellular
metabolite concentrations after 6 h. As before (Fig. 2c), uptake
of extracellular itaconate from the medium was evidenced by
increasing intracellular itaconate levels (Fig. 3a), whereas
medium itaconate abundances did not change (Fig. 3b). Succi-
nate levels increased linearly with itaconate levels and corre-
lated strongly (r  0.99), whereas other TCA cycle intermedi-
ates, including citrate, -ketoglutarate, fumarate, and malate,
did not accumulate (Fig. 3a). These results are consistent with
our observations using RAW 264.7 macrophages (Fig. 2), and
because A549 cells do not express IRG1 (20) they suggest that
itaconate-mediated succinate accumulation occurs even in the
absence of an active inflammatory signaling cascade.
To determine whether CAD-mediated itaconate production
can affect succinate levels in non-immune cells, we overex-
pressed Irg1 in human A549 cells using a pCMV6-plasmid
encoding murine Irg1. Itaconate was only produced at detecta-
ble levels in pCMV6 Irg1-overexpressing A549 cells (pmIrg1)
compared with vector (pCMV6) controls (Fig. 3c). Notably,
pmIrg1 cells accumulated significantly higher amounts of suc-
cinate compared with pCMV6 controls (Fig. 3d), indicating
that ectopic expression of CAD alone is sufficient to impact
succinate levels. Collectively, these observations provide strong
evidence that itaconate functions as metabolic trigger to mod-
ulate succinate levels.
Itaconate Is Not Metabolized to Succinate—One explanation
for the above results could be that accumulated itaconate is
metabolized to succinate directly or indirectly in macrophages.
Indeed, Pseudomonas sp. can metabolize itaconate as a carbon
FIGURE 1. Succinate and itaconate accumulate in LPS-activatedmurine RAW 264. 7macrophages. a, dynamics of itaconate, succinate, citrate, -ketogl-
utarate, fumarate, andmalate levels. Cellswere exposed to 10 ngml1 LPS, andmetaboliteswere extracted every hour over a 6-h period. Graphs represent the
mean S.E. of time-dependent, intracellular metabolite concentrations [mM] of two repeated experiments, each with three biological replicates. b, the basal
OCR is unchanged in LPS-activated (LPS) macrophages compared with resting macrophages (Ctr). Error bars represent mean  S.E. of two repeated
experiments.
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source through cleavage into pyruvate and acetyl-CoA (34), and
a similar itaconate degradation pathway has been observed in
isolated liver mitochondria (35). To exclude the possibility that
degradation of itaconate to succinate occurs, we applied a
[1-13C]glutamine tracer to LPS-activated RAW 264.7 macro-
phages. During oxidative glutamine metabolism, decarboxyla-
tion of M1 -ketoglutarate derived from this tracer results in
M0 succinate. In contrast to the oxidative pathway, M1 -ke-
toglutarate is converted to M1 isocitrate and citrate via reduc-
tive carboxylation (36), subsequently leading to M1 itaconate
labeling. Thus, if itaconate is appreciably metabolized to succi-
nate through the aforementioned degradation pathways, then
we would detect significant labeling on succinate from this
tracer (Fig. 4a). Although we observed high fractions of M1
itaconate isotopologues (65%) because of itaconate produc-
tion via reductive glutamine metabolism, no labeling was
detected on succinate (Fig. 4b).
To further demonstrate that itaconate is not metabolized
to succinate, we cultured 13C-labeled resting and LPS-
activated RAW 264.7 macrophages in the presence of
10mM unlabeled itaconate and quantified succinate labeling.
We exposed cells to labeled [U-13C6]glucose and [U-13C5]
glutamine tracers over a period of three subcultures to
obtain adequate isotope enrichment in succinate pools (Fig.
4c). Because labeling of succinate after exposure to exoge-
nous, unlabeled itaconate was unchanged (even in the physi-
ological concentration used here) (Fig. 4d), these data therefore
confirm that itaconate is not metabolized to succinate in these
mammalian cells.
Itaconate Inhibits SDH—Although enhanced flux through
succinate-producing pathways from glutamine or glucose is
likely contributing to its accumulation in inflammatory cells,
our results suggest that itaconate degradation does not occur.
An alternative mechanism through which endogenous itacon-
ate could influence succinate levels is through inhibition of
SDH/complex II. Indeed, in vitro enzyme activity assays using
isolated SDH and respiratory studies have indicated that itac-
onate can reduce the activity of SDH (27, 28, 37). Mammalian
CAD is localized to mitochondria in murine macrophages (38);
therefore, itaconate production within or near this compart-
ment could modulate SDH activity and, subsequently, succi-
nate levels. To investigate the potential for itaconate to act as an
SDH inhibitor, we measured mitochondrial respiration in per-
meabilized murine RAW 264.7 macrophages and BMDMs.
First, we exposed permeabilized macrophages to increasing
itaconate concentrations (0–25 mM) in the presence of two
different succinate concentrations (2.5 and 10 mM) with 2 M
rotenone. Succinate is the substrate for complex II (SDH) of the
mitochondrial respiratory chain, whereas rotenone was used to
inhibit complex I and to prevent accumulation of the SDH
inhibitor oxaloacetate (39), enabling us to directly measure
maximal SDH-driven respiration. We observed a dose depen-
FIGURE 2. Exogenous itaconate drives succinate accumulation. Intracellular TCA cycle intermediate and itaconate quantification in resting (Ctr, continuous
line) and LPS-activated (LPS, dashed line) RAW 264.7macrophages after 6-h exposure to increasing extracellular itaconate concentrations (0, 5, 10, and 25mM)
(a, malate; b, citrate; c, itaconate; d, -ketoglutarate; e, succinate; f, fumarate). Cells were exposed to 10 ngml1 LPS for 6 h. Graphs represent themean S.E.
of intracellular metabolite concentrations [mM] of two repeated experiments, each with three biological replicates. Pearson correlation coefficient (r) repre-
sents correlation between intracellular itaconate and TCA cycle intermediate concentrations. g, medium itaconate levels of resting and LPS-activated RAW
264.7 macrophages (10 ngml1 LPS) at 0 h (black) and after 6 h (gray). Data represent themean S.E. of metabolite levels [mM] of three biological replicates.
h, intracellular succinatequantification in restingandLPS-activatedBMDMsafter 6-hexposure to0mM (black) or 25mM (gray) extracellular itaconate. Cellswere
exposed to 10 ngml1 LPS for 6 h. Graphs represent the mean  S.E. of succinate concentration [mM] obtained from two different mice, each with three
biological replicates. *, p 0.05; **, p 0.01.
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dent inhibition of OCRs by itaconate in RAW 264.7 macro-
phages (Fig. 5a) and BMDMs (Fig. 5b), suggesting a regulatory
role of itaconate for SDH activity. When the succinate concen-
tration was lowered to 2.5 mM, itaconate had a greater propor-
tional inhibitory effect. Considering the structural similarity of
succinate to itaconate (also known asmethylene succinate), our
data suggest that itaconate acts as a competitive SDH inhibitor
in immune cells, similar to the mechanisms described previ-
ously for the inhibition of purified SDH (27) and purified isoci-
trate lyase (22).
Next, to confirm that itaconate specifically inhibits SDH
rather than other mitochondrial pathways, we offered permea-
bilized RAW 264.7 macrophages various oxidizable substrates
and compared the maximal uncoupler-stimulated OCR in the
presence of 0 and 10 mM itaconate (Fig. 5c). As expected,
itaconate supplementation significantly reduced respiration
(	75%) in the presence of succinate (SDH substrate) and rote-
none (complex I inhibitor). On the other hand, oxygen con-
sumption rates in permeabilized cells in the presence of either
pyruvate with malate or glutamate with malate, substrates that
drive respiration via complex I activity, were not affected by
itaconate supplementation. Additionally, ascorbate and TMPD
were used to supply electrons for complex IV activity in the
presence of antimycin A, an inhibitor of complex III. Itaconate
also failed to impact this complex IV-mediated respiration.
Together, these data provide evidence that itaconate contrib-
utes to succinate accumulation in macrophages by acting as an
endogenous SDH inhibitor.
Loss of Irg1 Influences Succinate Levels in BMDMs—To
determine how succinate levels are affected in the absence of
endogenously produced itaconate, we analyzed BMDMs
derived from Irg1KOmice.We confirmed that Irg1mRNAwas
not expressed in LPS-stimulatedKO-derived BMDMs (Fig. 6a).
Consistent with this result, LPS-stimulated BMDMs from Irg1
KO mice failed to produce significant levels of itaconate (Fig.
6b). Notably, succinate concentrations in stimulated BMDMs
from Irg1 KOmice were significantly lower than those quanti-
fied in BMDMs from WT mice, suggesting that CAD-derived
itaconate influences succinate accumulation in LPS-induced
macrophages (Fig. 6c).
These results provide evidence that Irg1-mediated itaconate
production plays a role in succinate accumulation within
immune cells. Taken together, our data highlight amechanistic
function of itaconate whereby this metabolite acts as a SDH
FIGURE 3. Itaconate- and Irg1-induced succinate accumulation is not specific to immune cells. a, intracellular itaconate and succinate levels increase in
A549 lung adenocarcinoma cells after exposure to increasing exogenous itaconate concentrations (0, 5, 10, and 25 mM). Data represent the mean S.E. of
metabolite levels [mM] of two repeated experiments with each three biological replicates. b, itaconate levels in medium after 6 h (gray) are not significantly
affected compared with 0 h (black). Data represent the mean S.E. of metabolite levels of two repeated experiments with three biological replicates each. c
and d, intracellular levels of itaconate (c, black) and succinate (d, gray) increased in Irg1 overexpression A549 cells after transient transfection with murine
pCMV6-Irg1 overexpression (pmIrg1) plasmid compared with empty pCMV6-Entry (pCMV6) control plasmid. Error bars represent the intracellular metabolite
levels (ion counts) 24 h after transfection of three biological replicates (mean S.E.). *, p 0.05; **, p 0.01.
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inhibitor to influence TCA cycle metabolism by driving succi-
nate accumulation (Fig. 7).
Discussion
Here we have demonstrated an important function of itac-
onate; it acts as a key regulatory metabolite to modulate TCA
metabolismand succinate levels. In the cells studied, exogenous
and endogenous, CAD-produced itaconate strongly correlated
with succinate accumulation. Substrate-specific respirometry
studies in permeabilized cells confirmed that itaconate acts as
an SDH inhibitor. Finally, modulation of endogenous itaconate
production in LPS-activated primary macrophages from Irg1
KO mice reduces succinate levels. Thus, itaconate alters mito-
chondrial metabolism to influence succinate accumulation in
macrophages (Fig. 7).
Numerous metabolic pathways have been implicated in the
metabolic reprogramming of immune cells, in particular those
that regulate succinate levels, which, in turn, can influence HIF
signaling or other pathways (13, 25, 40, 41). Glutamine serves
as a major carbon source for succinate production in LPS-
activated macrophages via -ketoglutarate or, alternatively,
through the GABA shunt (9). A recent systems-based analysis
of macrophages under proinflammatory conditions described
key break points in TCA metabolism at isocitrate dehydroge-
FIGURE 4. Itaconate is not metabolized to succinate in RAW 264. 7 macrophages. a, carbon labeling indicating oxidative (black lines) and reductive (gray
lines) glutamine metabolism using [1-13C]glutamine. Labeled itaconate (M1) is only synthesized through reductive glutamine metabolism (gray), and if it is
metabolized to succinate, then it would result in succinate containing one labeled carbon (M1). b, mass isotopomer distribution of itaconate (black) and
succinate (white) of LPS-activated RAW 264.7 macrophages after 24-h exposure to [1-13C]glutamine tracer and 6-h exposure to 10 ngml1 LPS. The major
fraction of labeled itaconate contains one labeled carbon, whereas no labeling was found on succinate. Error bars represent the mean  S.E. of mass
isotopomer levels of three biological replicates. c, carbon labeling of TCA cycle intermediates using [U-13C6]glucose and [U-
13C5]glutamine tracers. If exoge-
nous, unlabeled itaconate ismetabolized to succinate, then labelingwould decrease but does not here. d, mass isotopomer distribution of succinate in resting
and LPS-activated RAW 264.7 macrophages after 6-h (black) and 24-h (gray) exposure to exogenous, unlabeled itaconate remains 90%, indicating that
itaconate is not metabolized to succinate. Cells were prelabeled with [U-13C6]glucose and [U-
13C5]glutamine over a period of three subcultures. Error bars
represent the mean S.E. of mass isotopomer levels of three biological replicates.
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FIGURE 5. Itaconate inhibits SDH. a and b, itaconate inhibits the OCR in (a) RAW 264. 7 macrophages and (b) BMDMs in a dose-dependent manner.
Shown are normalized OCRs of resting permeabilized cells exposed to increasing itaconate concentrations (0, 2.5, 5, 10, and 25 mM) with either 10 mM
(continuous line) or 2.5 mM (dashed line) succinate. Data represent the mean  S.E. of three repeated experiments. c, itaconate inhibits SDH of the
respiratory chain. Shown is the normalizedmaximal uncoupled OCR of permeabilized resting RAW 264.7 macrophages exposed to various substrates in
the presence of 0 mM (black) or 10 mM (white) itaconate. Data represent the mean S.E. of three repeated experiments normalized to conditions with
0 mM itaconate and 10 mM succinate.
FIGURE 6. Loss of Irg1decreases itaconate and succinate levels in Irg1KOBMDMs. a, Irg1 expression levels in LPS-activated (24 h, 10 ngml1 LPS) BMDMs
obtained from Irg1KOandWTmice. Error bars represent expression levels obtained from two independentmice (mean S.E.) relative to L27.b and c, itaconate
and succinate levels in BMDMs obtained from Irg1 KO and WT mice. Cells were activated for 6 h with 10 ngml1 LPS. Error bars represent mean  S.E. of
metabolite levels [mM] of six biological replicates obtained from two independent mice.
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nase and SDH (25). We have now identified a functional link
between these nodes of the TCA cycle, where itaconate pro-
duced by mammalian CAD at the first break-point regulates
SDH activity at the second break point.Within our analyses, we
did observe variability in succinate accumulation upon LPS
stimulation when comparing RAW 264.7 macrophages and
BMDMs. This variance is in the range of succinate accumula-
tion levels reported by others and is likely a function of cell,
medium formulation, and LPS variability (9). However, we con-
sistently observed increased succinate downstreamof itaconate
production or administration in a variety of cell types.
Succinate accumulation plays important roles during inflam-
mation so that it contributes to the induction of Il-1 expres-
sion via HIF-1 stabilization (9). Our results suggest that Irg1-
mediated itaconate production may influence downstream
inflammatory responses in macrophages (e.g. expression of
Il-1 or associated inflammatory genes). At present, it is not
known whether this inflammatory response is accomplished
directly by succinate or itaconate or mediated through other
mechanisms. Succinate inhibits HIF-1 signaling through inhi-
bition of PHD2 but can also impact the activity of numerous
-ketoglutarate-dependent dioxygenases (42, 43). As such,
itaconatemayhave pleiotropic effects on cells depending on the
expression,Ki, and compartment-specific impacts on succinate
concentrations. However, the physiological role of itaconate
and Irg1 require further investigations, particularly in the con-
text of macrophage development and differentiation. As noted
above, various other pathways (e.g. GABA shunt, glutaminoly-
sis) contribute to succinate synthesis inmacrophages and could
allow compensation (9, 13, 14). Intracellular signaling pathways
also play key roles inmacrophage polarization and likely sustain
inflammation to some degree in the absence of Irg1 (44).
Given the diverse effects of inflammation in human disease,
themechanistic interplay between itaconate and succinate is of
clinical interest. Itaconate was only recently identified as an
endogenous mammalian biochemical (19), and subsequent
studies demonstrated that this molecule was produced by
mammalian CAD activity on cis-aconitate (20). Itaconate
reprograms the metabolism of pathogens, such as Mycobacte-
rium tuberculosis, by inhibition of isocitrate lyase, a key enzyme
in the glyoxylate shunt (45); thus, macrophages produce the
antimicrobial metabolite itaconate to combat against invading
pathogens (20). Following these discoveries, it has recently been
speculated that itaconate might contribute to the function of
innate immune cells (2, 46). Importantly, IRG1 is induced by
various non-bacterial stimuli, including influenza A viral infec-
tion (47), Marek disease infection (48), during embryonic
implantation (49), neurotropic viral infections of neurons (50),
and in murine epidermal cells (51). Given the regulatory role of
itaconate in succinate accumulation described here, IRG1-me-
diated itaconate production may act as a signaling molecule in
other inflammatory situations or cellular states. Indeed, succi-
nate can inhibit various other -ketoglutarate-dependent
dioxygenases to impact diverse cellular processes (42, 43). On
the other hand, the mechanism outlined here for SDH inhibi-
tion could be used to mitigate pathogenic inflammation under
certain circumstances (e.g. via CAD inhibition). For example,
high levels of succinate have also been reported to occur under
ischemic conditions because of reverse SDH activity (40, 41).
The accumulated succinate is rapidly oxidized after reperfu-
FIGURE 7. Mechanism of LPS-induced succinate accumulation. Under inflammatory conditions, such as LPS stimulation, mammalian CAD catalyzes the
decarboxylation of the TCA cycle intermediate cis-aconitate to produce itaconate. This metabolite contributes to succinate accumulation in macrophages by
acting as an endogenous SDH inhibitor.
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sion, resulting in increased mitochondrial reactive oxygen spe-
cies production and damage. A similar mechanism has been
speculated to occur during sepsis (52). Notably, SDH inhibition
protected against brain injury after ischemia/reperfusion (40,
41), suggesting that inhibition of SDH by endogenously pro-
duced itaconate may buffer against potential oxidative damage
that can occur under such conditions.
Our findings provide critical new insights into the regulatory
machinery governing TCA cycle function, with mammalian
CAD-produced itaconate serving as a metabolic inhibitor to
cause succinate accumulation. Ultimately, these results may be
clinically important when drugs that target such metabolic
inflammatory signals are identified. The emerging role of itac-
onate as a regulatory molecule to reprogram immune cell
metabolism provides an intriguing link between innate immu-
nity, metabolism, and disease pathogenesis.
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116 results and publications
comparing and contrasting metabolism and cytokine ex-
pression during the early stages of inflammation in cell
lines and primary macrophages
Sapcariu SC, Wolf C, Delcambre S, Krämer L, Dong X, Schneider J,
Hiller, K To Be Submitted. 2016.
This study compares and contrasts cell lines and primary mouse macrophages,
in order to better understand their utility and limitations for scien-
tific studies into inflammatory processes. Metabolic and transcriptional
changes were looked at over the initial stage of an common inflamma-
tory stimulus. It was found that while both cell types are somewhat
comparable in terms of cytokine regulation and antimicrobial activ-
ity, basal metabolism is changed in the transformed cell line, and this
should be taken into account when looking at metabolic changes based
on inflammation in macrophage cell lines.
For this study, I conceived the idea and performed all experiments
(with the assistance of the other co-authors), as well as performed all
data analysis and wrote the manuscript.
Comparing and contrasting metabolism and
cytokine expression during the early stages of
inflammation in cell lines and primary
macrophages
Sean C. Sapcariu Cristina Wolf Sylvie Delcambre
Lisa Kra¨mer Xiangyi Dong Jochen Schneider
Karsten Hiller
Abstract
Inflammation is a cellular process designed to rid the body of pathogens
and repair damaged tissue, and requires a time-resolved set of steps in or-
der to facilitate this activity. One of the main cell types involved in the
inflammatory process are macrophages, and these cells are widely stud-
ied in laboratory settings using a variety of cell lines as well as primary
cells from both mice and humans. Macrophage research has uncovered
a wealth of important information about regulation of this process from
mRNA levels and metabolic changes. In this study, we compared one of
the most common mouse macrophage cell lines, RAW 264.7, with bone
marrow derived macrophages, using a series of time course experiments
to determine transcriptional and metabolic changes of these cells when
stimulated to a pro-inflammatory phenotype. While both cell types had
active pro-inflammatory pathways leading to cytokine expression and bac-
terial clearance, changes in the metabolic program (most likely due to
HIF-1α expression) could only be observed in the differentiated primary
macrophages. The results of this study illuminate two important factors
of macrophage research: 1) the appropriate cell type to use for a study
depends on the scientific question asked, and 2) there is a time-dependent
cascade of early-stage inflammation in macrophages, and this should be
taken into account when trying to understand the process.
1 Abstract
Introduction
The innate immune response in mammals acts as the first line of defense against
external pathogens, utilizing processes such as the inflammatory response in or-
der to remove infectious threats before they cause significant damage to the host.
Inflammation is a tightly controlled process that follows a time-resolved set of
actions in order to destroy pathogens and repair damaged tissue in an effective
and quick manner (Medzhitov, 2008). Improper regulation of the inflamma-
tory process has been implicated in a variety of diseases, including diabetes,
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neurodegenerative diseases, and cancer (Eizirik et al., 2009; Amor et al., 2010;
Coussens and Werb, 2002). One of the main cell types responsible for regulating
the inflammatory response are macrophages, a type of mononuclear cell that is
derived from bone marrow, but can both circulate through the body and na-
tively reside in all non-brain tissues (Murray and Wynn, 2011). During infection,
macrophages are recruited to the site of the inflammatory response to assist with
phagocytosis and bacterial removal, maintain homeostasis through the cleanup
of internal antigens, and act as the interface between the innate and adaptive
immune responses (Murray and Wynn, 2011). Macrophages recognize pathogen-
associated molecular patterns (PAMPs) and damage-associated molecular pat-
terns (DAMPs) through transmembrane Toll-like receptors (TLRs) (Seong and
Matzinger, 2004), activating signaling cascades that initiate the inflammatory
response and subsequent reprogramming of the cell (Zhang and Mosser, 2008).
In laboratory settings, the bacterial PAMP lipopolysaccharide (LPS) is often
used to stimulate macrophages to a pro-inflammatory state. LPS is a compo-
nent of the Gram-negative bacterial surface membrane and is recognized by
macrophage TLR4 and CD14 surface receptors, inducing a cascade that results
in the expression of cytokines (such as Il-1β, Tnfα, and Il-6 ) and a transforma-
tion into a pro-inflammatory phenotype (often called the M1 or M(LPS) state)
(Mosser and Edwards, 2008). Pro-inflammatory macrophages have increased
bactericidal activity and endocytosis, and it is these characteristics which aggres-
sively remove pathogens through processes that can also create tissue damage,
while anti-inflammatory macrophages (often called the M2 state) are involved in
wound healing and regulatory processes (Mosser and Edwards, 2008). The pro-
cess of inflammation is commonly thought to have different stages with regards
to macrophage activity, which would suggest that the activation and phenotype
of pro-inflammatory macrophages changes as inflammation proceeds. While
there has been a good deal of study about the transcriptional regulation of in-
flammation in macrophages (see review in Medzhitov and Horng (2009)), we
could find no study that looked at time-dependent regulation of inflammatory
cytokines.
Traditionally, pro-inflammatory macrophages are classified through their ac-
tivity and cytokine release profiles. However, it has recently been shown that
there are metabolic changes that occur in a pro-inflammatory macrophage which
are just as important to their activity, and are interconnected with cytokine
production. Succinic acid, a metabolite in the TCA cycle, is increased under
LPS stimulation, and has been shown to stabilize hypoxia-inducible factor 1-
alpha (HIF-1α), an important transcription factor and regulator of metabolic
activity and cytokine production, to enhance Il-1β production (Tannahill et al.,
2013). Another important metabolite which is produced in macrophages only
when stimulated to a pro-inflammatory state is itaconic acid. This metabolite is
produced in the mitochondria through the activity of cis-aconitate decarboxy-
lase (CAD, encoded by immunoresponsive gene 1 - Irg1 ) using cis-aconitate as
a substrate, and acts as a bacteriostatic antimicrobial by inhibiting isocitrate
lyase (Michelucci et al., 2013). Through the combined use of network analy-
sis and stable isotope labeling experiments, Jha et al identified two metabolic
breakpoints in the TCA cycle of pro-inflammatory macrophages, which lead to
the accumulation of succinic acid and itaconic acid (Jha et al., 2015). Fur-
thermore, itaconic acid was shown to inhibit succinate dehydrogenase activity,
leading to the buildup of succinic acid in LPS-stimulated macrophages. Indeed,
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metabolism is more than an endpoint of transcriptional changes arising from
macrophage activation, it instead is interwoven in the regulating of inflamma-
tory activity while at the same time producing the means to defend against
microbial invasion.
The study of pro-inflammatory macrophage activity in laboratory settings
requires access to macrophage cells that can be manipulated and experimented
upon. As in most areas of cellular biology, there exist both primary cells and im-
mortalized cell lines for this purpose. RAW 264.7 cells are a Abelson Leukaemia
Virus transformed mouse macrophage-like cell line which is widely used for in
vitro studies of macrophage response under inflammatory conditions (Tannahill
et al., 2013; Michelucci et al., 2013; Meiser et al., 2015). They have the advan-
tage of being easy to cultivate and handle in a laboratory setting, and are seen as
consistent and comparable between experiments and laboratories. Much of the
knowledge about pro-inflammatory macrophage activation has been obtained
using this cell line, and has proven to be transferable to in vivo systems. It
is important to note that these cells have been transformed to be continuously
proliferative, and this must be taken into account when making conclusions
about cellular processes for macrophages in general.
Bone marrow derived macrophages (BMDMs) are differentiated macrophages
obtained through the culture of mammalian bone marrow, typically from Mus
musculus. Cells from bone marrow are differentiated using either pure granu-
locyte macrophage colony-stimulating factor (GM-CSF), or supernatant from
the culture of the L929 mouse fibroblast cell line, which also produces GM-CSF
in combination with other factors which promote macrophage differentiation
Francke et al. (2011); Boltz-Nitulescu et al. (1987). As this cell model comes
directly from an individual animal without any transformations, it is considered
to be a more applicable model for translating experimental results to what is
actually occurring in nature. However, primary cells such as BMDMs can be
highly variable between animals, and are much more costly to obtain and work
with. It is thus important to understand both the similarities between the cell
line and the primary cell as well as the limitations of substituting one for the
other. Previous studies have compared RAW cells to BMDMs with regard to
cytokine expression, cell surface markers, and culture ability on different bio-
material surfaces, determining that cell lines respond differently to LPS than
BMDMs, with different cytokine response profiles and surface marker popula-
tions (Berghaus et al., 2010; Chamberlain et al., 2009). In addition, there has
been research into how cellular energy sources are taken up and metabolic prod-
ucts secreted over time in activated RAW cells and BMDMs, suggesting that
activated macrophages are glycolitic cells, with RAW cells utilizing glycolysis
to a greater extent than the BMDMs (Rodr´ıguez-Prados et al., 2010). However,
there have not been any studies directly comparing RAW cells and BMDMs with
regards to the timing of cytokine production or intracellular metabolic changes.
This work presents a targeted integration of metabolomics, stable isotope
labeled analysis, and RNA expression in order to profile metabolism in the
short-term response after LPS stimulation (as a model pro-inflammatory stim-
ulus). Concurrently, we want to highlight the benefits and weaknesses of using
RAW cells as a substitute model for primary mouse macrophages in the study of
inflammation. A clearly regulated short-term response to a pro-inflammatory
stimulation in terms of classical inflammatory transcriptional and metabolic
markers can be seen on in both RAW cells and BMDMs, and while the pat-
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terns of regulation are similar, the scale differs between the cell types. At the
same time, there are metabolic differences between primary cells and cell line
macrophages, as the transcriptional changes allowing RAW cells to act as an
immortalized cell line mask the metabolic changes that occur during the initial
inflammatory response in primary macrophages.
Materials and Methods
Cell culture and reagents
The mouse macrophage RAW 264.7 cell line was obtained from ATCC (ATCC
TIB-71, Manassas, VA, USA). Cells were cultured in Dulbecco’s Modified Ea-
gle’s Medium (DMEM) 5796 (Sigma Aldrich) with 10% Fetal Bovine Serum
(PAA or Invitrogen) and 1% penicillin/streptomycine (Gibco, Invitrogen), and
stored in an incubator with humidified atmosphere at 37◦C with 5% CO2. Cells
were grown and cultured in cell culture flasks (Thermo Fisher Scientific), and
split through scraping three times a week.
Bone marrow was extracted from femur and tibia of 8-weeks old C57BL/6
mice, and cultured for 7 days in the same conditions as above, using Roswell
Park Memorial Institute medium (RPMI) 1640 VLE (Merck Millipore) supple-
mented with 10% Fetal Bovine Serum and 20% L929 cell culture supernatant.
Cells were detached by scraping, and cell seeding and experiments were per-
formed using RPMI as defined without added L929 supernatant.
Escherichia coli purified LPS (Sigma Aldrich) was used to stimulate macrophages
into a pro-inflammatory state, using 10 ng/mL and 100 ng/mL for RAW cells
and BMDMs respectively. Concentrations for experiments follow commonly
used concentrations in the literature.
Stable isotope labeling experiments
For stable isotope labeling experiments, cells were cultured as above, but were
seeded in a labeled medium 24 hours before treatment.
RAW cells were seeded in Dulbecco’s Modified Eagle’s Medium (D5030,
Sigma Aldrich), supplemented with 3.7 g/L of sodium bicarbonate and 10%
dialyzed fetal bovine serum. 25 mmol/L glucose and 5 mmol/L glutamine were
also supplemented in the medium. For labeled glucose experiments, [U-13C6]-
Glucose (Cambridge Isotope Laboratories) was substituted, and for labeled glu-
tamine experiments, [U-13C5]-Glutamine (Campro Scientific) was substituted.
The pH of the finished medium was adjusted to 7.4, sterile filtered through a
0.22 µm Steriflip filter unit (Merck Millipore), and stored at 4◦C until use.
For BMDMs, RPMI 1640 was used, which contained either no glucose or
no glutamine. For labeled glucse experiments, 11 mmol/L of [U-13C6]-Glucose
(Cambridge Isotope Laboratories) was used, and for labeled glutamine exper-
iments, 2 mmol/L of [U-13C5]-Glutamine (Campro Scientific) was used. The
medium was pH adjusted and sterile filtered in the same manner as above.
Metabolite extraction protocol
The extraction protocol was performed as per Sapcariu et al. (2014). Briefly,
cells were washed with 0.9% NaCl, and immediately quenched with 200 µL
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Chromasolv R© Methanol (Sigma) at -20◦C and 200 µL Millipore H2O on ice.
Cell extracts were scraped and added to Eppendorf reaction tubes containing
200 µL Chromasolv R© chloroform at -20◦C. Tubes with extract were then vor-
texed in a 4◦C Thermomixer Eppendorf shaker at 1400 rpm for 20 minutes and
centrifuged at 4◦C for 5 minutes at 20,000 g. 200 µL of the polar phase was
transfered to a glass vial specific for GC-MS analysis (Chromatographie Zube-
hor Trott), dried in a rotary vacuum evaporator (Labconco) at -4◦C overnight,
and stored at -80◦C until analysis. The interphase was stored at -80◦C until
RNA extraction. As an internal standard, pentanedioic-d6 acid was added to
the extraction water at a concentration of 1 µg/mL.
GC-MS Analysis
Derivitization was performed with an Gerstel autosampler directly before mea-
surement on a gas chromotography-mass spectrometry instrument (GC-MS).
Dried metabolites were dissolved in 15 µL of 2% methoxyamine hydrochloride
in pyridine at a temperature of 40◦C for 90 minutes. 15 µL of 2,2,2-trifluoro-N-
methyl-N-trimethylsilyl-acetamide + 1% chloro-trimethyl-silane was added and
incubated at 55◦C for 60 minutes.
The metabolite extracts were measured on an Agilent 7890A GC containing
with a 30 m DB-35MS capillary column. The GC was connected to an Agilent
5975C MS operating in electron ionization (EI) at 70 eV.
1 µL of derivatized sample was hot injected into a split/splitless inlet at
270◦C in splitless mode. Helium was used as the carrier gas at a flow rate of 1
mL/min. The GC oven temperature was kept constant at 100◦C for 2 minutes
and then increased to 300◦C at 10◦C/min, where it was held for 4 minutes. The
total GC-MS run time of one sample was 26 minutes. For relative quantification
of metabolite levels, an alkane mix was run with the sequence in order to provide
retention index calibration for the experimental samples.
The MS source was kept at a constant temperature of 230◦C and the quadrupole
at 150◦C. For relative quantification of metabolite levels, the detector was oper-
ated in scan mode with an m/z range of 70 to 800. For analysis of stable isotope
labeling, the detector was operated in SIM mode with specific ions selected for
all compounds of interest.
mRNA extraction and Quantitative Real-Time PCR
Washed interphases were dried in a rotary vacuum evaporator (Labconco) at
4◦C until all liquid phase was evaporated, and then brought to room temper-
ature. RNA was extracted from the interphase of the samples using the Qi-
agen RNeasy minikit following manufacturer’s instructions, and RNA purity
was checked on a Thermo Scientific NanoDrop 2000C spectrophotometer. RNA
was reverse transcribed into cDNA using Invitrogen SuperScriptTM III reverse
transcriptase following manufacturer’s instructions, and stored at -20◦C until
qPCR analysis. All treatments were performed in experimental triplicates and
technical duplicates on the 96-well plate for statistical robustness.
Analysis of cDNA was performed on a Roche LightCycler 480 II, with iQTM
SYBR R© green supermix including the fluorescent pigment and the polymerase
required for the reactions. The program for the qPCR was as follows: activation
of the polymerase for 3 minutes at 95◦C, 40 amplification cycles (30 seconds
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denaturation at 95◦C, 30 seconds annealing at 60◦C, 30 seconds elongation
at 72◦C), melting curve analysis, and a cooling step at 40◦C. Comparative
quantification (using the ∆∆Ct method) was performed using LibreOffice Calc.
The primers used in qPCR analysis are shown in 1.
Table 1: Primers used for qPCR Analysis
Il-1b forward 5’-GCTTCAGGCAGGCAGTATC-3’
Il-1b reverse 5’-AGGATGGGCTCTTCTTCAAAG-3’
Tnfα forward 5’-GGTTCTGTCCCTTTCACTCAC-3’
Tnfα reverse 5’-TGCCTCTTCTGCCAGTTCC-3’
Il6 forward 5’-CGGCCTTCCCTACTTCACAA-3’
Il6 reverse 5’-TCTGCAAGTGCATCATCGTT-3’
Irg1 forward 5’-GCAACATGATGCTCAAGTCTG-3’
Irg1 reverse 5’-TGCTCCTCCGAATGATACCA-3’
Hif-1 forward 5’-TGACGGCGACATGGTTTACA-3’
Hif-1 reverse 5’-AATATGGCCCGTGCAGTGAA-3’
Pdk1 forward 5’-TGCAAAGTTGGTATATCCAAAGCC-3’
Pdk1 reverse 5’-ACCCCGAAGCTCTCCTTGTA-3’
Idh1 forward 5’-AAGGTTATGGCTCCCTTGGC-3’
Idh1 reverse 5’-TAGTGACGTGTGACAGTGCC-3’
Idh2 forward 5’-TTCCAAACCGTGACCAGACC-3’
Idh2 reverse 5’-GGATCGTTCCGTTAGGGCTC-3’
Idh3 forward 5’-GAGTACGCTCGGAACAACCA-3’
Idh3 reverse 5’-AGTTCTCCGCAACTTCCCTG-3’
L27 forward 5’-ACATTGACGATGGCACCTC-3’
L27 reverse 5’-GCTTGGCGATCTTCTTCTTG-3’
Metabolomics Data Analysis
Analysis of the raw peak data for both relative metabolite quantification and
mass isotopomer distribution (MID) analysis was performed using Metabolit-
eDetector (Hiller et al., 2009). This software provided chromatogram alignment,
peak matching, and automated compound identification (using an in-house li-
brary). Raw data was exported from MetaboliteDetector and processed using
either R statistical software (R Core Team, 2016) or LibreOffice Calc.
All metabolites identified with MetaboliteDetector were verified through
manual chromatogram analysis of characteristic fragment peaks.
Normalization of the metabolite raw data was performed using the follow-
ing methods: First, all metabolites were normalized to the internal standard
added to the extraction water in order to control for variations in extraction
amount and GC-MS measurements. Where applicable, normalized metabolite
signal intensity was further normalized to cell count as well as to the control
(or t=0) treatment, in order to provide a standard basis for comparison across
experiments.
MIDs were determined from samples cultured with labeled tracers using SIM
measurements. The data was corrected for natural isotope abundances using
MetaboliteDetector software.
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Weighted carbon contribution for labeled compounds was calculated using
the following formula:
1
n ∗
∑n
i=1Mi × i
where n is the number of carbons in the compound of interest, and Mi is
the ith mass isotopomer. Glucose and Glutamine contribution was calculated
with samples from the same experimental replicate, and contribution from other
sources was calculated by:
1− (CGlc + CGln)
where CGlc and CGln are the weighted carbon contributions from glucose
and glutamine, respectively.
Statistical Methodology
Experiments were performed in biological triplicates, either with different cell
passages (in the case of the RAW 264.7 cell line) or different mice (in the case
of the BMDMs). Within each experiment, each condition was repeated three
times in separate wells.
Statistically significant differences of metabolites or transcript level were
determined between specific treatments using an unpaired two-tailed Student’s
t-test. Error bars represent the standard error of the mean of the samples.
2 Results
2.1 Transcriptional regulation under short-term LPS stim-
ulation
2.1.1 Cytokine regulation
The two classical cytokines associated with pro-inflammatory macrophages, IL-
1β, and TNF-α were seen to be increased with LPS stimulation in both RAW
cells and BMDMs, as is known (Medzhitov and Horng, 2009). Interestingly, the
expression of these cytokines peaked at an early phase after stimulation, and
then behaved differently during the following phase (fig. 1). In both primary
cells and the cell line, levels of Tnf-α seem to be the first which increased,
followed by Il-1β expression. Then, levels of Tnf-α decreased back to almost
basal levels by 8 hours in both cell types, and this behavior was consistent with
Il-1β expression in RAW cells, while in BMDMs this decrease did not occur. In
addition, expression level increases for both cytokines appear to be much higher
in BMDMs compared to RAW cells.
The cytokine Il-6 plays a role in macrophages stimulated to a pro-inflammatory
state, but there is increasing evidence that it acts as well as an anti-inflammatory
cytokine (Xing et al., 1998). Il-6 expression followed the same trend as seen
with Tnf-α, having increased to a local maximum around 3 hours and then
having decreased steadily to the 8 hour timepoint (fig. 1). The transcriptional
regulation pattern of this cytokine was similar in both RAW cells and BMDMs,
but again at a higher expression level in BMDMs than in RAW cells.
Hif-1α plays an important role in pro-inflammatory macrophages, influenc-
ing the transcriptional regulation of many metabolic genes and cytokines (re-
viewed in Imtiyaz and Simon (2010)), and is known to be increased and stabi-
lized on a transcriptional and protein level, respectively (Nishi et al., 2008) in
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order to affect macrophage polarization (Galva´n-Pen˜a and O’Neill, 2015). In
RAW cells, Hif-1α showed no significant change with LPS stimulation, but ex-
pression levels steadily increased over the 8 hour stimulation period in BMDMs
(fig. 2).
2.1.2 Regulation of metabolic enzymes
Immunoresponsive gene 1 (Irg1 ), like the cytokines described above, showed
a transcriptional increase in both the RAW cells and the BMDMs from al-
most no expression to a relative peak around the 3 hour timepoint (fig. 2).
In both cell types, this was followed by a decrease in expression to the 8
hour timepoint, with expression levels higher in BMDMs compared to RAW
cells. The primary known function of Irg1 /CAD is the enzymatic function
of cis-aconitate decarboxylase (CAD), which catalyzes the production of ita-
conic acid from cis-aconitate, an antimicrobial compound associated with pro-
inflammatory macrophages (Michelucci et al., 2013).
In pro-inflammatory macrophages, it was thought that HIF-1α blocks pyru-
vate flux into the TCA cycle through transcription of pyruvate dehydrogenase
kinase 1 (Pdk1 ), which inhibits pyruvate dehydrogenase (PDH) activity (Kim
et al., 2006). Recently, we found that pyruvate oxidation into the TCA cycle is
maintained in pro-inflammatory macrophages; Pdk1 was seen to have reduced
transcript levels after 6 hours of LPS stimulation, and PDH was shown to be
active in transporting pyruvate into the TCA cycle (Meiser et al., 2015). In
the present work, expression levels of Pdk1 were found to decrease and stay
low under LPS stimulation in RAW cells, reaching a local minimum within 2-3
hours. In BMDMs, Pdk1 expression was increased at later time-points over the
8 hour stimulation, showing the opposite effect as in RAW cells (fig. 2).
The different isoforms of isocitrate dehydrogenase (IDH) catalyze the re-
versible conversion of isocitric acid to α-ketoglutaric acid, with IDH2 and IDH3
acting in the mitochondria, and IDH1 present in the cytosol. As these en-
zymes require either NADP(H) (in the case of IDH1 and IDH2) or NAD(H) (for
IDH3) as cofactors, they have a strong influence in the energy state of the cell
as well as dealing with reactive oxygen species (Maeng et al., 2004). In addition,
the IDH reaction was found to be a metabolic breakpoint in pro-inflammatory
macrophages (Jha et al., 2015). For Idh1 and Idh2, a gradual decrease in ex-
pression was seen over the 8 hour time period in both RAW cells and BMDMs,
reaching a local minimum only at around 6 hours (fig. 2). This decrease was
also seen with Idh3 in RAW cells, but expression increased in BMDMs, with
the upregulation of the Idh isoform seen beginning around 6 hours (fig. 2). Ex-
pression levels of Idh1 were higher in BMDMs, while the other two isoforms had
higher expression in RAW cells over the time period studied.
2.2 Changes in pro-inflammatory associated metabolite
pools under short-term LPS stimulation
Itaconic acid, an antimicrobial metabolite found in pro-inflammatory macrophages
(Michelucci et al., 2013), was present at a very low baseline in non-stimulated
cells, but production increased relatively quickly upon LPS stimulation (fig. 3a).
Following the same pattern as with Irg1 regulation (fig. 2), with an observed
delay most likely corresponding to the process of transcription and translation),
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a strong increase in itaconic acid started around 3 hours in both RAW cells and
BMDMs, and did not plateau for the entire period of time studied (fig. 3a).
Intracellular metabolite pools of itaconic acid were much higher in RAW cells
compared to BMDMs, but in both cell types increased to almost 100 times the
basal level.
The relative amount of succinic acid was increased under LPS stimulation,
and has been shown to be linked to increased Il-1β expression through HIF-1α
stabilization (Tannahill et al., 2013). This increase could be seen already occur-
ring as early as 3-4 hours, similar to the production of itaconic acid (fig. 3b).
2.3 Relative carbon contribution from glucose and glu-
tamine in central carbon metabolism
Through the replacement of normal carbon sources of cellular metabolism (glu-
cose and glutamine) with those having stable-isotope labeled carbons, it is
possible to measure the relative carbon contribution of glucose and glutamine
to metabolites in central metabolism from the overall labeling patterns of the
metabolites. This methodology complements normal measurement of metabo-
lite levels by adding information on how much of the overall metabolite pool
comes from which carbon source, and how this can change under different con-
ditions (such as LPS stimulation). To obtain a more comprehensive view of
how macrophage metabolism is affected under LPS stimulation, we applied this
technique to both RAW cells and BMDMs under the same conditions as the
above analyses. Glucose contribution was measured using [U-13C6]-Glucose,
and glutamine contribution was measured using [U-13C5]-Glutamine.
In RAW cells, the relative carbon contribution of glucose and glutamine to
most metabolites showed a short-term effect of perturbation, with a rapid return
to a stable contribution from both carbon sources. Between 5 and 15 minutes, a
small reduction of carbon contribution from glucose could be observed in pyruvic
acid and citric acid (figs. 4 and 4), while an corresponding increase could be seen
in itaconic acid (fig. 4); afterwards relative carbon contribution returned to a
stable level, albeit with itaconic acid taking more time to stabilize. The only
metabolite that we measured which did not follow this pattern is succinic acid,
showing increasing relative glutamine contribution with a longer stimulation
time, while carbon contribution from glucose remains stable over the 8 hours
(fig. 4).
BMDMs showed different patterns of time-dependent change in glucose and
glutamine carbon contribution to metabolites. Relative carbon contribution
from one or both of the measured carbon sources were seen to increase for many
metabolites after the LPS perturbation. A gradual increase accounting for a
20% change in carbon going from glucose to pyruvic acid could be seen over the
8 hours, with almost no supplementation from glutamine (fig. 4). Citric acid
carbon showed the same trend, with perturbation leading to a decrease and
gradual recovery of glutamine carbon (fig. 4). Carbon contribution to itaconic
acid remained relatively stable over the 8 hours of LPS stimulation in both RAW
cells and BMDMs, even as the metabolite pool increased rapidly; in BMDMs,
there was an increase of glucose carbon with longer stimulation, but only around
6% over 8 hours (fig. 4). An increasing relative carbon contribution from both
glutamine and glucose could be observed in succinic acid over the 8 hours, with
an increase of over 20% from glucose carbon (fig. 4).
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Other metabolites from both glycolysis and the TCA cycle which were mea-
sured (alanine, lactic acid, fumaric acid, and malic acid) show similar changes as
described above: RAW cells showed stable carbon contributions after an initial
change due to the LPS challenge, while BMDMs had a general increase of car-
bon contribution from one or both of the carbon sources measured (fig. 6). To
validate that glucose carbon entering the TCA cycle was done so through PDH
activity, the M2 isotopologue of certain TCA cycle metabolites were measured.
We found that PDH was indeed active in pro-inflammatory macrophages, as
a significant percentage of labeled TCA cycle metabolites came from glucose
carbon metabolized through PDH (fig. 7)
3 Discussion
The results of this study point to practical similarities as well as integral dif-
ferences between the RAW 264.7 macrophage cell line and BMDMs on both a
transcriptional level and a metabolic level. Interestingly, all cytokines measured
in this study show a similar trend of time-dependent regulation in both the cell
line and the primary cells, only differing in scale, as well as long term activity
(in the case of Il-1β - fig. 1. Cytokine expression is drastically increased in
primary cells compared to the cell line macrophages, an effect highlighting a
possible saturation effect or reduced sensitivity in RAW macrophages, which
could arise from the transformational process. In both cell types, expression
of Tnf-α reached a peak first, then followed by Il-1β around an hour later.
These data suggest that for the study of cytokine transciptional regulation in
pro-inflammatory macrophages, the RAW 264.7 cell line works as a comparable
substitute for primary mouse macrophages, as long as quantification of cytokine
expression is not being compared. The increased sensitivity to LPS of primary
cells compared to cell lines has also been observed in microglia, where differing
concentrations of LPS were used to achieve equivalent activation levels between
primary microglia and the MMGT12 cell line (Michelucci et al., 2009).
Although not a cytokine, Irg1 /CAD has been shown to be important for
the anti-bacterial activity of macrophages through the production of itaconic
acid (Michelucci et al., 2013). Indeed, Irg1 expression was seen to increase over
time, but decreases after an early peak in RAW cells (fig. 2). The data from
this work expands this previous study with more detailed short term regulatory
information. However, as the previous study did not look at BMDMs, it is
interesting to note that the scale and timing of regulation is different in the
primary cells compared to the cell line, similar to the cytokines described above.
Irg1 expression is higher in primary cells, again underlining the differences in
mRNA levels of pro-inflammatory related genes between BMDMs and RAW
cells.
In addition, itaconic acid production in both cell types continues to increase
even after expression of Irg1 has been reduced (fig. 3a). Michelucci et al. (2013)
show that in RAW cells, itaconic acid levels drop a few hours after Irg1 expres-
sion has been decreased (from 10 to 16 hours), and most likely the timepoints
we measured did not reach this point in either cell type. These results suggest
that the production of itaconic acid is an important part of the early-phase
macrophage response to inflammation, and is less important as part of the long-
term response. Michelucci et al. (2013) found a much lower increase of itaconic
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in primary human macrophages compared to the RAW cell line, and this trend
is the same in BMDMs. Itaconic acid levels therefore do not need to be very
high for cellular activities in primary cells, and the discordance in metabolite
levels can be attributed to metabolic differences in the TCA cycle between
immortalized cell lines and primary cells. Interestingly, much higher levels of
Irg1 are required in BMDMs in order to produce lower levels of itaconic acid,
and there could be other regulatory steps which control the production of this
antimicrobial metabolite, such as post-translational modification to CAD, the
enzyme catalyzing the reaction.
Previous work has shown that Irg1 has been seen to suppress production of
Il-1β and Tnf-α in LPS-tolerized macrophage (Li et al., 2013). Our data from
both RAW cells and BMDMs show Irg1 expression increase lagging behind the
expression increase of Tnf-α while peaking around the same time as Il-1β in
both cell types. The expression pattern of Irg1, with a delayed peak and less
pronounced decrease, represents a pattern that supports the concept of Irg1 -
mediated suppression of cytokine expression. Itaconic acid production then
follows after the peak of Irg1 expression is reached, illustrating the impact of
different time scales that connect transcriptional and metabolic regulation.
Expression changes of Hif-1α are not comparable between the different cell
types, which raises questions about connections between transciptional and
metabolic activity (fig. 2). HIF-1α is known to be a positive regulator of gly-
colysis in macrophages (through inducing transcription of genes encoding the
glucose transporter, GLUT1, and PDK, which inhibits oxidation of pyruvate
into acetyl-CoA), as well as implicated in an increased NAD+/NADH ratio in
monocytes (Cramer et al., 2003; Cheng et al., 2014). In addition, expression of
Hif-1α is known to be controlled by growth factors (DeBerardinis et al., 2008),
and stimulation of macrophages with LPS induces a cascade leading to Hif-1α
expression (Frede et al., 2006). Most likely, the metabolic differences between
the two cell types comes from the fact that RAW cells are virus transformed to be
immortalized, which makes significant changes to the transcriptional machinery
in order to allow the cells to continuously proliferate. This process of prolif-
eration requires a specific metabolic function, geared towards macromolecule
biosynthesis and energy production, which is not present in post-mitotic pri-
mary macrophages. The differences seen in metabolite levels is in alignment
with this hypothesis fig. 3, and point to a specialized regulation of central car-
bon metabolism, including under pro-inflammatory conditions in macrophages.
Consistent with how Hif-1α expression (and most likely the connected tran-
scriptional program) in RAW cells stays consistent with LPS stimulation while
increasing in BMDMs (fig. 2), the carbon contribution data shows strong dif-
ferences between the cell line and primary cells, as almost every metabolite
measured in RAW cells showed unchanging levels of relative carbon contribu-
tion from glucose and glutamine, in contrast to a mostly increasing utilization
of glucose and glutamine carbon for metabolites in pro-inflammatory BMDMs.
It has been shown previously that for both macrophages cell types, glucose
and glutamine consumption as well as glutamine and lactate secretion are in-
creased over time with LPS stimulation (Rodr´ıguez-Prados et al., 2010), so a
static carbon contribution to intracellular metabolites in RAW cells most likely
suggests that metabolic fluxes are not changing with stimulation, and simply
handle the increased carbon influx with normal proliferative activity. For future
macrophage cell line scientific studies, it should be noted that metabolism of
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RAW cells (and the modified associated transcriptional regulation) does not re-
act to pro-inflammatory perturbation in the same way as primary cells, and are
therefore not an adequate model for studies into normal metabolic machinery
under pro-inflammatory conditions.
As mentioned above, expression of Pdk1 is regulated by HIF-1α, and our
results confirm the link between them over the initial stage of macrophage re-
sponse to inflammation. In RAW cells, the expression level decrease seen in
Pdk1 (fig. 2), occurs while Hif-1α levels remain unchanged (fig. 2); this data in
combination with carbon contribution data from TCA cycle metabolites (fig. 4)
is consistent with our previous findings of PDH activity in LPS-stimulated RAW
cells (Meiser et al., 2015), and lends evidence to the idea that glucose carbon is
needed to fuel the TCA cycle of RAW macrophages at the beginning phase of
an inflammatory response. However, Pdk1 expression shows an overall increase
over the 8 hour stimulation in BMDMs (fig. 2), which parallels the increase
of Hif-1α expression in these primary cells (fig. 2),and reinforces the hypothe-
sis of metabolism being significantly different in RAW cells when compared to
BMDMs. Interestingly, there was increased glucose carbon entering the TCA
cycle through PDH, as evidenced by M2 isotopologues of TCA cycle metabolites
measured in cells cultured with uniformly labeled glucose (fig. 7), meaning that
PDH activity must be present in pro-inflammatory BMDMs. as regulation of
PDH by PDK happens on a protein level, it can not be confirmed by our data
whether the regulation of glucose carbon flux into the TCA cycle is governed
by this reaction.
As metabolites associated with the pro-inflammatory state of macrophages,
intracellular levels of both succinic acid and itaconic acid in macrophages are
increased upon LPS stimulation, regardless of the cell type (fig. 3). Succinic
acid is a key metabolite linked to signaling in pro-inflammatory macrophages,
which has been shown to be metabolized from glutamine and is thought to be
exported from the mitochondria to stabilize HIF-1α (Tannahill et al., 2013),
and thus propagate further inflammatory processes (Cramer et al., 2003). The
data found in this study support this key role for this key pro-inflammatory
metabolite. The importance of itaconic acid in pro-inflammatory macrophage
activity is only beginning to be understood, but it is seen as such an important
part of macrophage anti-bacterial defense, the normal TCA cycle activity is re-
structured just to produce this metabolite (Michelucci et al., 2013; Jha et al.,
2015). Recently, it has been shown that itaconic acid can act to inhibit suc-
cinate dehydrogenase activity, thus leading to an accumulation of intracellular
succinic acid (Cordes et al., 2016). The alignment of timing patterns between
the two metabolites adds evidence to this postulation, and this can be seen
independently of the differences in the metabolite levels between primary cells
and cell lines.
The increased relative carbon contribution from both glucose and glutamine
to succinic acid over the 8 hour stimulation time highlights the importance of
this metabolite in pro-inflammatory macrophages, showing increased utiliza-
tion of cellular carbon sources for its production (fig. 4). Even in RAW cells,
an increase in utilization of glutamine-derived carbon can be seen in succinic
acid (fig. 4), the only metabolite differing from the pattern of stable contribu-
tion levels. The accumulation of itaconic acid and succinic acid, as well as the
carbon contribution data, all support the growing body of evidence that these
are two key metabolites for pro-inflammatory macrophage activity, and all car-
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bon sources are utilized to rapidly synthesize them during the initial phase of
inflammatory stimulation in macrophages.
Jha et al. (2015) explained this phenomenon by uncovering that the bio-
chemical reactions catalyzed by IDH and SDH are the two reactions which are
classified as “metabolic breakpoints” in LPS-stimulated macrophages. These
breakpoints cause increased production of itaconic acid and succinate, respec-
tively, as major metabolic features of pro-inflammatory macrophage polariza-
tion. Our data supports and extends this idea on both an transcriptional and
metabolic level. In addition to the metabolite accumulation and labeling data,
expression levels of the three different Idh isoforms elucidate the timing of one
of these breakpoints, as well as differences between RAW cells and BMDMs.
Expression level changes in Idh isoforms show metabolic differences between
RAW cells and BMDMs at a transcriptional level. Idh1 and Idh2 show grad-
ual decreased expression over the 8 hour stimulation in both cell types, with a
stronger effect in BMDMs for Idh2 while having a lower expression level com-
pared to RAW cells fig. 2. The decreased expression levels of these Idh isoforms
suggest reduced enzyme production, and therefore less activity of this reaction,
with carbon being diverted to itaconic acid as described above. For Idh3, expres-
sion was seen to be decreased in RAW cells, while increased in BMDMs fig. 2.
For the cytosolic isoform, Idh1, expression was higher in BMDMs, while the mi-
tochondrial isoforms show increased expression levels in RAW cells, increasing
the metabolic differences between primary cells and cell lines. For each isoform
of Idh, expression level changes begin after TNFα, in the second phase of the
initial response (together with Il-1β and Irg1. IDH3 is a mitochondrial isoform
of the IDH protein, and requires NAD(H) as a cofactor, in contrast to IDH1 and
IDH2, which require NADP(H). For both cofactors, the forward reaction cre-
ates the reduced form, which can be used in other cellular processes. NADPH
is mostly required for ROS generation and detoxification, while NADH is used
in redox regulation and cellular energy production through the electron trans-
port chain, and its oxidized form is required for the activity of sirtuins, a class
of deacetylases which are known to have multiple targets in the mitochondria
(reviewed in Ying (2008)).
It is important to note that the changes shown in this data are only important
in the initial phase of macrophage-mediated inflammation. Time-dependent
regulation of most intracellular metabolites has not been clearly studied, only
itaconic acid levels over time have been shown to decrease at later timepoints
(Michelucci et al., 2013), and the change in succinic acid levels has not been
studied. Future work should go in the direction of how time-dependent expres-
sion level changes of cytokines and metabolic genes during inflammation are
connected to metabolite pool and metabolic flux changes, and how this regu-
lates the pro-inflammatory macrophage phenotype and inflammatory response.
4 Outlook
Through the comparison of the RAW 264.7 macrophage cell line to primary
mouse bone marrow derived macrophages, it can be seen that in the case of
macrophages, the validity of using a cell line model to make conclusions about
cellular activity in primary cells is dependent on the scope of the question.
Much of the transcriptional regulation patterns under inflammation was com-
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parable between RAW cells and BMDMs, including cytokine regulation and
pro-inflammatory phenotypic activity, which allows for valid comparisons and
is utilized to create useful insights into inflammatory regulation of macrophages
(Michelucci et al., 2013), however, the scale of response must be taken into
account, as there exist strong differences between primary macrophage mRNA
expression response and the corresponding changes in cell lines. In contrast,
metabolic changes are not consistent between the cell types, most likely due
to the proliferative nature of the RAW 264.7 cell line compared to the post-
differentiation phenotype of the BMDMs. However, metabolites which can be
linked to a pro-inflammatory phenotype (including itaconic acid and succinic
acid) act independently of these transcriptional differences, and can be studied.
The results of this study back up and complement previous work (Berghaus
et al., 2010; Chamberlain et al., 2009; Rodr´ıguez-Prados et al., 2010) showing
that while there are important differences between RAW 264.7 cells and pri-
mary BMDMs in terms of cytokine regulation and carbon metabolism, focused
questions in areas where there is known overlap between the responses of the
different cell types allow researchers to substitute cell lines for primary cells
without fear of inappropriate results.
On a transcriptional level in both cell line and primary macrophages, a phase
response of cytokine regulation in macrophages to LPS stimulation has been
shown. This is important to emphasize, as most studies choose one time point for
looking at the impact of inflammation on macrophage processes, and the activity
of the cell will be different depending on the time point chosen. Therefore, it
is necessary for studies on pro-inflammatory macrophages to determine which
phase of stimulation most directly is impacted by the question asked, as results
can be misleading.
A previous study has found that LPS stimulation leads to increase of cy-
tokine production, but too much LPS reduces cytokine expression, attributed
to the cytokine regulation by IRG1 and A20 (Li et al., 2013). Our results have
shown possible correlation between regulation of different cytokines (as well as
other genes implicated in pro-inflammatory macrophages). A tight regulation of
TNFα, Il-1β, and Irg1 is necessary to balance levels of different mediators and
activity of signaling pathways over time, as macrophages change roles during
the response to inflammation. More research is needed to determine what fac-
tors and processes are orchestrating this regulation, and what role metabolism
plays in these changes.
The timing patterns of the genes and metabolites studied in this work infer
that there is a cascading effect of regulation tying transcriptional and metabolic
regulation. Our hypothesis of the initial pro-inflammatory macrophage timeline
can be seen in fig. 5. LPS stimulation starts a two pronged cascade: cytokines
and Irg1 are activated to aid in the initial inflammatory signaling and bac-
terial clearance through itaconic acid production, while Hif-1α is induced in
order to prepare the transciptional and metabolic machinery necessary for a
pro-inflammatory macrophage phenotype. Succinic acid, which is accumulated
in part through itaconic acid activity, can stabilize HIF-1α to provide a posi-
tive feedback loop for maintaining the macrophage in this state. However, our
findings show that the Hif-1α side of regulation in RAW 264.7 macrophages is
not consistent with primary BMDMs, suggesting that for studying this aspect
of pro-inflammatory macrophages, a primary cell model is necessary.
Future studies in this field should investigate the different regulatory phases
14
of inflammation in macrophages, and response to pro-inflammatory stimulation
should be framed in terms of these phases as well as the current metabolic
and transcriptional state of the macrophage. Macrophages are a constantly
shifting regulator of the inflammatory process, and will most likely have different
regulatory control points depending on the current phenotypic phase of the cell.
Thinking about macrophages in this way can open up new ways of looking at
phenotypic switching, and help to find these control points in both time and
regulatory pathways which will allow for novel therapies and treatments for
diseases where macrophage regulation plays a role.
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Figure 1: Relative transcript levels of selected cytokines in LPS stim-
ulated macrophages unnormalized: (a) Tnf-α (b) Il-1β (c) Il-6 (d) Hif-1α
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Figure 2: Relative transcript levels of selected metabolic genes in LPS
stimulated macrophages unnormalized: (a) Irg1 (b) Pdk1 (c) Idh1 (d)
Idh2 (e) Idh3
(a) Itaconic Acid (b) Succinic Acid
Figure 3: Relative levels of pro-inflammatory associated metabolites
in LPS stimulated macrophages: (a) Itaconic Acid (b) Succinic Acid
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Figure 4: Relative carbon contribution from glucose and glutamine to
selected metabolites in LPS stimulated macrophages: (a) RAW cells and
(b) BMDMs Pyruvic acid carbon contribution (c) RAW cells and (d) BMDMs
Citric acid carbon contribution (e) RAW cells and (f) BMDMs Itaconic acid
carbon contribution (g) RAW cells and (h) BMDMs Succinic acid carbon con-
tribution
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Figure 5: Summary Figure - Cascading Response to LPS LPS stimula-
tion in macrophages leads to cytokine and Irg1 expression, both of which aid
the macrophage in bacterial clearance processes (through the use of antimicro-
bial compounds such as itaconic acid). Itaconic acid increases accumulation
of succinic acid, which stabilizes HIF-1α, modifying metabolic machinery. Hif-
1α expression is also increased through LPS stimulation (leading to the same
metabolic response), but this regulation under pro-inflammatory conditions can-
not be seen in a constituently proliferating cell line
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Figure 6: Supplemental Figure: Relative carbon contribution from
glucose and glutamine to selected metabolites in LPS stimulated
macrophages: (a) RAW cells and (b) BMDMs Alanine carbon contribution (c)
RAW cells and (d) BMDMs Lactic acid carbon contribution (e) RAW cells and
(f) BMDMs Fumaric acid carbon contribution (g) RAW cells and (h) BMDMs
Malic acid carbon contribution
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(a) BMDM - Citric Acid M2 (b) BMDM - Itaconic Acid M2
(c) BMDM - Succinic Acid M2 (d) BMDM - Fumaric Acid M2
Figure 7: Supplemental Figure: Mass isotopomer distributions from
glucose labeling in selected metabolites in LPS stimulated BMDMs:
(a) Citric acid M2 (b) Itaconic acid M2 (c) Succinic acid M2 (d) Fumaric acid
M2
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sirt3 decrease in pro-inflammatory macrophages regulates
polarization to an antimicrobial phenotype
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This manuscript comprises a series of experiments with the aim of
elucidating the effect of Sirt3 expression reduction in macrophages stim-
ulated to a pro-inflammatory state. By a combination of metabolomics
and other complementary analyses, we determine that SIRT3 reduction
in macrophages aids in the pro-inflammatory and antimicrobial pheno-
type, regulating cytokine secretion, inflammatory pathway regulation,
as well as bacterial clearance through what is most likely an itaconic
acid-dependent mechanism.
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1 Introduction
The sirtuin family was discovered as a conserved family of class III NAD+-
dependent histone lysine deacetylases, active in the regulation of proteins through
post-translational modification. (Michan and Sinclair, 2007). After years of
study, sirtuins are still known to be NAD+ dependent, but have been observed
to act on non-histone cellular proteins in multiple cellular compartments (He
et al., 2012), and to perform a wider variety of post-translational modifica-
tions including demalonylation and desuccinylation (Du et al., 2011; Peng et al.,
2011).
Most sirtuin targets that have been discovered control cellular metabolism,
and three sirtuin family members which are known to be active in the mitochon-
dria, SIRT3, SIRT4, and SIRT5. These mitochondrial sirtuins affect important
metabolic and regulatory pathways (including the TCA cycle, urea cycle, fatty
acid oxidation, ROS metabolism, and oxidative phosphorylation), with over 20
confirmed targets (He et al., 2012). SIRT3, a lysine deacetylase, is the most
studied mitochondrial sirtuin, with over 933 acetylation sites discovered in the
mitochondria, affecting oxidative phosphorylation, fatty acid metabolism, and
the TCA cycle (Sol et al., 2012). SIRT3 is the main sirtuin family member
responsible for mitochondrial protein deacetylation, since knockout of SIRT4
and SIRT5 were shown to produce no changes in the mitochondrial acetylome
(Lombard et al., 2007).
SIRT3 deacetylation activity in the mitochondria can target critical junc-
tions of energy metabolism and inflammatory response. Two subunits of the
succinate dehydrogenase (SDH) complex were found to be SIRT3 targets, show-
ing deacetylation affects TCA cycle metabolism and oxidative phosphorylation
(Cimen et al., 2009; Finley et al., 2011b). Isocitrate dehydrogenase 2 (IDH2),
which regulates levels of NADPH and glutathione, protecting against ROS-
mediated damage, has also been identifed as a SIRT3 target (Yu et al., 2012).
Activity of mitochondrial antioxidant manganese superoxide dismutase (Mn-
SOD) is directly regulated by SIRT3, impacting reactive oxygen species (ROS)
in the mitochondria (Tao et al., 2010).
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Macrophages are a phagocytic innate immune system cell, known to aid in
the coordination of inflammatory processes for the purpose of fighting off infec-
tions (Murray and Wynn, 2011). Through inflammatory cytokine production
(Duque and Descoteaux, 2015) as well as direct destruction of pathogenic bac-
teria (Jayaraman et al., 2013), macrophages are extremely important in tissue
defense. Cytokines expressed in pro-inflammatory macrophages include IL-1β,
IL-6, and TNFα, and production is triggered by cellular signaling cascades, in-
cluding nuclear factor kappa B (NF-kB) and mitogen-activated protein kinase
(MAPK) (Barton, 2008; Shi et al., 2009).
Salmonella enterica serovar Typhimimurium (S. Typhimuirum) is a gram-
negative facultative anaerobic bacterium characterized by strongly inducing the
secretion of pro-inflammatory cytokines in mouse models (Zhang et al., 2003).
Simultaneously, S. Typhimurium utilizes its virulence effector proteins to mod-
ulate host cell metabolism and induce pro-inflammatory cell death (Robinson
et al., 2012). Host cell defense mechanisms against S. Typhimurium infection
involve phagolysosomal degradation, ROS production (West et al., 2011) and
itaconic acid production (Cordes et al., 2015).
On a metabolic level, pro-inflammatory macrophages exhibit increased gly-
colytic activity and reduced oxidative phosphorylation (Galva´n-Pen˜a and O’Neill,
2015) Succinic acid, a metabolite in the TCA cycle, has been found to be in-
creased in pro-inflammatory macrophages through the metabolism of glutamine,
leading to increased IL-1β activity and increased glycolytic activity through
succinic acid-dependent increased HIF-1α stabilization (Tannahill et al., 2013).
Also, LPS stimulation leads to increased expression of Irg1 in macrophages,
which leads to the production of the antimicrobial metabolite itaconic acid, me-
tabolized from cis-aconitate (a TCA cycle intermediate) through CAD (Michelucci
et al., 2013). Glucose oxidized into the TCA cycle through PDH is one source of
carbon for itaconic acid, as HIF-1α-mediated inhibition of PDH activity through
transcription of Pdk1 is not active in LPS-activated macrophages (Meiser et al.,
2015).
These two metabolites have recently been found to be connected, with ita-
conic acid inhibiting succiniate dehydrogenase (SDH) in order to promote the
accumulation of succinic acid in LPS-stimulated macrophages (Cordes et al.,
2016). This regulation fits perfectly into the “metabolic breakpoints” found in
the TCA cycle by Jha et al. (2015), where network analysis shows the accu-
mulation of these two metabolites to be the main feature of pro-inflammatory
macrophage polarization.
While not yet directly implicated with metabolic changes, SIRT3 has been
seen to have an play a role in pro-inflammatory macrophage activity. IDH2 and
mnSOD have been shown to be a deacetylation target of SIRT3 in macrophages
for the purpose of mediating ROS regulation under inflammatory conditions
(Tao et al., 2010; Sheng et al., 2015). In LPS treated primary human macrophages,
SIRT1 and SIRT3 mRNA and protein expression is decreased (Storka et al.,
2013). Knockdown of Sirt3 also affects inflammatory cytokine expression, in-
creasing levels of iNOS and TNFα in RAW 264.7 macrophages (Xu et al., 2016).
These findings suggest a role for SIRT3 at the interface of metabolism and in-
flammation, able to regulate both processes in order to drive cellular processes
important for pro-inflammatory macrohpage activity.
However, previous studies have only used pathogen associated molecular
patterns, and the role of SIRT3 in the innate immune defense against invading
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pathogens is currently unknown. To expand upon these results, we further in-
vestigated the role of SIRT3 decrease in macrophages, and how SIRT3 regulates
the macrophage response to bacterial infection. Using primary macrophages, we
determined that a decrease in SIRT3 expression serves to regulate macrophage
pro-inflammatory and antimicrobial activity under both LPS stimulation and
bacterial infection. This regulation is mediated through the Irg1 -itaconic-acid-
SDH pathway, resulting in an increase of both itaconic acid for bacterial clear-
ance as well as succinate for pro-inflammatory cytokine stimulation.
2 Materials and Methods
2.1 BMDM differentiation
Bone marrow was extracted from femur and tibia of 8-weeks old WT and SIRT3
KO C57BL/6 mice, and cultured for 7 days in Roswell Park Memorial Institute
medium (RPMI) 1640 VLE (Merck Millipore) supplemented with 10% Fetal
Bovine Serum and 20% L929 cell culture supernatant. Cells were detached by
scraping, and all cell seeding and experiments were performed using RPMI as
defined without L929 supernatant.
2.2 Infection and stimulation
Infection with Salmonella enterica serovar Typhimurium SL1344 was performed
at a M.O.I. of 10 for all experiments. After addition of bacteria cells were
incubated for 10 min at RT and then for 30 min at 37◦C. Cells were then washed
with medium containing gentamycin 50 µg/mL and left in this same medium.
After two hours in medium with gentamycin 50 µg/mL, the concentration of
gentamycin was reduced to 10 µg/mL.
Escherichia coli and Salmonella enterica serovar Typhimimurium purified
LPS (Sigma Aldrich) was used, at a concentration of 100 ng/mL for all indicated
experiments. Cell medium was changed directly before stimulation.
2.3 Stable isotope labeling experiments
For stable isotope labeling experiments, cells were cultured as above, but were
seeded in a labeled medium 24 hours before treatment. RPMI 1640 was used
which contained either no glucose or no glutamine (Thermo Fisher). For labeled
glucse experiments, 11 mmol/L of U-13C6-Glucose (Cambridge Isotope Labo-
ratories) was added to the medium, and for labeled glutamine experiments, 2
mmol/L of U-13C5-Glutamine (Campro Scientific) was added. The pH of the
finished medium was adjusted to 7.4, sterile filtered through a 0.22 µm Steriflip
filter unit (Merck Millipore), and stored at 4◦C until use.
2.4 Metabolite and mRNA extraction protocol
The extraction protocol was performed as per Sapcariu et al. (2014). Briefly,
cells were washed with 0.9% NaCl, and immediately quenched with 200 µL
Chromasolv R© Methanol (Sigma) at -20◦C and 200 µL Millipore H2O on ice.
Cell extracts were scraped and added to eppendorf tubes containing 200 µL
Chromasolv R© chloroform at -20◦C. Tubes with extract were then vortexed in
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a 4◦C shaker at 1400 rpm for 20 minutes and centrifuged at 4◦C for 5 minutes
at 20,000 g. 200 µL of the polar phase was transfered to a glass vial specific for
GC-MS analysis (Chromatographie Zubehor Trott), dried in a rotary vacuum
evaporator (Labconco) at -4◦C overnight, and stored at -80◦C until analysis.
The interphase was stored at -80◦C until RNA extraction. As an internal stan-
dard, pentanedioic-d6 acid was added to the extraction water at a concentration
of 1 µg/mL.
2.5 GC-MS Analysis
Derivitization was performed with an Gerstel autosampler directly before mea-
surement on the GC-MS. Dried metabolites were dissolved in 15 µL of 2%
methoxyamine hydrochloride in pyridine at a temperature of 40◦C for 60 min-
utes. Then, 15 µL of 2,2,2-trifluoro-N-methyl-N-trimethylsilyl-acetamide + 1%
chloro-trimethyl-silane was added and incubated at 40◦C for 30 minutes.
The metabolite extracts were measured on an Agilent 7890A GC containing
with a 30 m DB-35MS capillary column. The GC was connected to an Agilent
5975C MS operating in electron ionization (EI) at 70 eV.
1 µL of derivatized sample was hot injected at 270◦C in splitless mode.
Helium was used as the carrier gas at a flow rate of 1 mL/min. The GC oven
temperature was kept constant at 100◦C for 2 minutes and then increased to
300◦C at 10◦C/min, where it was held for 4 minutes. The total GC-MS run
time of one sample was 26 minutes. For relative quantification of metabolite
levels, an alkane mix was run with the experimental sequence in order to provide
retention index calibration for the experimental samples.
The MS source was kept at a constant temperature of 230◦C and the quadrupole
at 150◦C. For relative quantification of metabolite levels, the detector was oper-
ated in scan mode with an m/z range of 70 to 800. For analysis of stable isotope
labeling, the detector was operated in SIM mode with specific ions selected for
all compounds of interest.
2.6 mRNA extraction and Quantitative Real-Time PCR
Washed interphases were dried in a rotary vacuum evaporator (Labconco) at
4◦C until all liquid phase was evaporated, and then brought to room tempera-
ture. RNA was extracted from the interphase of the samples using the Qiagen
RNeasy minikit, and RNA purity was checked on a Thermo Scientific NanoDrop
2000C spectrophotometer. RNA was reverse transcribed into cDNA using Invit-
rogen SuperScriptTM III reverse transcriptase, and stored at -20◦C until qPCR
analysis. All treatments were performed in technical triplicates on the 96-well
plate for statistical robustness.
Analysis of cDNA was performed on a Roche LightCycler 480 II, with iqTM
SYBR R© green supermix including the fluorescent pigment and the polymerase
required for the reactions. The program for the qPCR was as follows: activation
of the polymerase for 3 minutes at 95◦C, 40 amplification cycles (30 seconds
denaturation at 95◦C, 30 seconds annealing at 60◦C, 30 seconds elongation
at 72◦C), melting curve analysis, and a cooling step at 40◦C. Comparative
quantification (using the ∆∆Ct method) was performed using LibreOffice Calc.
The primers used in qPCR analysis are shown in 1.
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Il-1b forward 5’-GCTTCAGGCAGGCAGTATC-3’
Il-1b reverse 5’-AGGATGGGCTCTTCTTCAAAG-3’
Tnfα forward 5’-GGTTCTGTCCCTTTCACTCAC-3’
Tnfα reverse 5’-TGCCTCTTCTGCCAGTTCC-3’
Sirt3 forward 5’-TCACAACCCCAAGCCCTTTT-3’
Sirt3 reverse 5’-GTGGGCTTCAACCAGCTTTG-3’
Sirt4 forward 5’-TGAAAGAGGCGGACTCCCTA-3’
Sirt4 reverse 5’-CAACTCTCCACAGCGGGAAT-3’
Sirt5 forward 5’-CCTGGATCCTGCCATTCTGG-3’
Sirt5 reverse 5’-GGGTCCGGGAAAATGAAACC-3’
Il6 forward 5’-CGGCCTTCCCTACTTCACAA-3’
Il6 reverse 5’-TCTGCAAGTGCATCATCGTT-3’
Il10 forward 5’-GCTGCCTGCTCTTACTGACT-3’
Il10 reverse 5’-CCTGGGGCATCACTTCTACC-3’
Irg1 forward 5’-GCAACATGATGCTCAAGTCTG-3’
Irg1 reverse 5’-TGCTCCTCCGAATGATACCA-3’
Casp3 forward 5’-TCATCTCGCTCTGGTACGGA-3’
Casp3 reverse 5’-ACACACACAAAGCTGCTCCT-3’
L27 forward 5’-ACATTGACGATGGCACCTC-3’
L27 reverse 5’-GCTTGGCGATCTTCTTCTTG-3’
Table 1: Primers used for qPCR Analysis
2.7 Bacterial CFU quantification
BMDMs were infected with S. Typhimurium as above described. For the quan-
tification of colony forming units (CFU) cells were washed with cold PBS and
lysed with 1% Triton-X, 0.01% SDS in PBS. Several dilutions of the lysate
were plated in BHI plates and incubated over night at 37◦C. Next day, S.
Typhimurium CFU were counted.
2.8 Cytokine secretion quantification (ELISA)
Supernatants from S. Typhimurium (MOI 10) or LPS-treated BMDMs were
collected at 6h and 24h post-treatment. Analysis of secreted IL-6, TNFα, IL-
1β and IL-10 in the supernatants was performed using ELISA commercial kits
according to manufacturer instructions (R&D).
2.9 Cell viability assay
Cell viability of LPS-treated or S. Typhimurium-infected (MOI 10) BMDMs
was assessed using the commercial kit RealTime-Glo (Promega) according to
manufacturer instructions.
2.10 ROS measurement
The production of ROS in BMDMs upon LPS stimulation (100 ng/mL) or ST
infection (MOI 10) was assessed using a commercial kit (CellROX Green, Life
Technologies) according to manufacturer instructions.
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2.11 Metabolomics Data Analysis
Analysis of the raw peak data for both relative metabolite quantification and
MID analysis was performed using MetaboliteDetector (Hiller et al., 2009). This
software provided chromatogram alignment, peak matching, and automated
compound identification (using an in-house library). Raw data was exported
from MetaboliteDetector and processed using either R statistical software (R
Core Team, 2016) or LibreOffice Calc.
All metabolites identified with MetaboliteDetector were verified through
manual chromatogram analysis of characteristic fragement peaks.
Normalization of the metabolite raw data was performed using the follow-
ing methods: First, all metabolites were normalized to the internal standard
added to the extraction water in order to control for variations in extraction
amount and GC-MS measurements. Where applicable, normalized metabolite
signal intensity was further normalized to cell count as well as to the control
(or t=0) treatment, in order to provide a standard basis for comparison across
experiments.
MIDs were determined from samples cultured with labeled tracers using SIM
measurements. The data was corrected for natural isotope abundances using
MetaboliteDetector software.
2.12 Statistical Methodology
Experiments were performed in biological triplicates with different pairs of WT
and KO mice; within each experiment, each condition was repeated three times
in separate wells.
Statistically significant differences of metabolites or transcript level were
determined between specific treatments using an unpaired two-tailed Student’s
t-test. For explanation of significance in the figures, * denotes p < 0.05, **
denotes p < 0.01, and *** denotes p < 0.001. Error bars represent the standard
deviation of the samples.
3 Results
3.1 SIRT3 mRNA expression is decreased in LPS-stimulated
macrophages
In order to confirm the knowledge that Sirt3 expression is reduced in pro-
inflammatory macrophages, as well as to profile the expression changes in other
mitochondrial sirtuins, we looked at a time-dependent regulation of sirtuins
expression with LPS stimulation. Sirt3 expression was reduced very quickly,
reaching a local minimum after 3 hours, and stayed reduced until expression
levels start to increase at the 8 hour time point (fig. 1a). Levels of Sirt4 show
no drastic change in expression aside from a short increase within an hour of
LPS stimulation (fig. 1b). Expression of Sirt5 follows the pattern of Sirt3, with
a strong decrease by 3 hours; however, Sirt5 levels increase more rapidly than
Sirt3, already changing by 6 hours (fig. 1c).
SIRT3 has been seen to co-localize with SIRT5, suggesting a functional con-
nection (Nakamura et al., 2008), and both enzymes have been found to have
the same targets (Nakagawa and Guarente, 2014; Zhang et al., 2015). Thus, a
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similar expression pattern shows evidence for both enzymes working together
to control pro-inflammatory macrophage activity.
3.2 Knockout of Sirt3 leads to increased inflammatory
response with LPS stimulation
Using BMDMs from Sirt3 KO mice, we investigated the effects of LPS treatment
when SIRT3 was not present. SIRT3 mRNA and protein levels were measured
in the Sirt3 KO BMDMs in order to confirm that the knockout was present in
the BMDMs used (fig. 2).
Knockout of Sirt3 increased cell viability of BMDMs with LPS treatment
(fig. 3), suggesting SIRT3 contributes to the metabolic fitness of macrophages
upon pro-inflammatory insults. As this response is regulated in part by the
macrophage inflammatory process, we treated WT and Sirt3 KO BMDMs with
LPS and monitored changes in the secretion profile of inflammatory cytokines,
to study whether SIRT3 may play a role in the regulation of inflammation. We
found that in the Sirt3 KO BMDMs, the secretion of the inflammatory cytokines
IL-6, IL-1β and IL-10 were significantly enhanced upon LPS stimulation (fig. 4).
However, there was no change in the secretion levels of TNFα.
To look at central signaling pathways in inflammatory processes, protein ex-
pression and phosphorylation of p65, a major component of the NF-κB signaling
pathway, was analyzed by western blot, showing increased activation with Sirt3
knockout (fig. 5a). In addition, there was also an increase in the complementary
MAPK pathway, as evidenced through amplified phosphorylation of p38 protein
in Sirt3 KO BMDMs (fig. 5b).
3.3 Increased inflammatory response due to a combina-
tion of ROS production and metabolite regulation
In order to determine whether this increase in inflammatory activity was a result
of increased ROS production, we measured ROS levels through a fluorescense
assay, and found no significant reduction in ROS in Sirt3 KO compared to WT
BMDMs treated with LPS (fig. 6). However, differences in abundances of known
pro-inflammatory metabolites under LPS stimulation were found, with both
itaconic acid and succinic acid increased with knockout of Sirt3 (figs. 7a and 7b),
suggesting that metabolic changes were regulating inflammatory processes when
Sirt3 was knocked out.
As it is known that SIRT3 targets multiple enzymes in the mitochondria, we
investigated the effect of a knockout on intracellular metabolism. Using classical
metablolomics to measure the metabolite pool sizes, as well as stable isotope
assisted metabolomics techniques to determine relative carbon flux changes and
the relative carbon contribution of glucose and glutamine to different metabo-
lites.
Through incubating the macrophages with stable isotope labeled glucose and
glutamine, we were able to determine the utilization of these carbon sources in
LPS-stimulated macrophages, and how this changed when Sirt3 was knocked
out. While there was no significant difference between the carbon contribution
from glucose to itaconic acid between WT and Sirt3 KO BMDMs, there was a
slight decrease in the carbon contribution from glutamine when SIRT3 was not
active (fig. 8b). For succinic acid, there was a strong decrease in the contribution
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of carbon from both glucose and glutamine in the Sirt3 KO BMDMs (fig. 8c),
signifying a dilution of these carbons from other sources. It should be noted
that glutamine contribution to succinic acid continued to increase with Sirt3 KO
compared to the WT, suggesting that the inactivty of SIRT3 stops the control
of glutamine metabolized to succinic acid, which could influence the increased
succinic acid buildup (fig. 7b) and subsequent IL-1β secretion (fig. 4).
The labeled carbon sources also allowed us to determine how relative car-
bon flux to these two metabolites changed between WT and Sirt3 knockout
BMDMs stimulated with LPS. U-13C6-Glucose is metabolized to M1 isotopo-
logues of itaconic acid and M2 isotopologues of succinic acid. U-13C5-Glutamine
is metabolized to M4 isotopologues of succinic acid.
While relative glucose flux to the M1 isotopologues of itaconic acid did not
change after 6 hours of LPS stimulation (fig. 9c), succinic acid M2 isotopologues
increased over time with LPS stimulation (fig. 9d). Similarly to the carbon
contribution from glutamine, Sirt3 KO BMDMs show a more rapid increase of
M2 labeling than the WT cells, adding evidence to the hypothesis that SIRT3
activity helps control glutamine flux to succinic acid. Relative glutamine flux
was reduced to both M4 itaconic acid and M4 succinic acid in Sirt3 knockout
BMDMs for the first 6 hours of stimulation, compared to WT cells (fig. 10a),
with a stronger effect in succinic acid.
These results point to a role for SIRT3 in the regulation of succinic and
itaconic acid production under pro-inflammatory conditions, mostly through
affecting glutamine anaplerosis. As SIRT3 is known to target and activate
glutamate dehydrogenase (GDH) (Schlicker et al., 2008), knockout of the gene
would lead to a reduction of glutamate entering the TCA cycle through GDH.
3.4 Metabolic implications of Sirt3 knockout
To further investigate metabolic changes due to Sirt3 reduction in pro-inflammatory
macrophages, we looked at how SIRT3 activity could affect glycolysis. Previ-
ously, knockout of Sirt3 was seen in fibroblasts to reduce glycolytic activity
(Finley et al., 2011a), so we looked at how this pathway is regulated in in-
flammed macrophages. Two endpoints of glycolysis, pyruvic acid and lactic
acid, show an increase in pool size in Sirt3 KO BMDMs with LPS stimulation
(fig. 11). Previous studies have found that a reduction of SIRT3 activity slows
pyruvate dehydrogenase activity (Jing et al., 2013; Ozden et al., 2014), which
reduces the amount of pyruvic acid which is metabolized into the TCA cy-
cle. This, in turn, would lead to a buildup of the intracellular pyruvic acid pool.
Interestingly, knock out of SIRT3 activity resulted in an increase of pyruvate de-
hydrogenase kinase (PDHK) protein in S. Typhimurium infected macrophages
(fig. 17). PDHK inhibits pyruvate dehydrogenase activity, which causes the
buildup of pyruvic acid as well as the funneling of this metabolite to lactic acid
production.
Through glycolysis, U-13C6-Glucose metabolizes into M3 isotopologues of
both pyruvic acid and lactic acid, and these results are shown in fig. 9. Sirt3
knockout reduces the amount of M3 isotopologues of both metabolites, with
a stronger effect in pyruvic acid. With active SIRT3, labeling of pyruvic acid
reaches a plateau after 1 hour and remains stable, while an absence of SIRT3
causes a constant increase of relative glucose flux to pyruvate, suggesting a
more active glycolysis (fig. 9a). This effect is present in lactic acid as well, but
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to a lesser extent (fig. 9b). This hypothesis is reinforced through analysis of the
relative carbon contribution from glucose and glutamine to pyruvic acid (fig. 8a),
which shows the same trend as the M3 isotopologue from glucose (fig. 9a). The
similarity between the two illustrate how a large majority of the labeled carbon
from glucose is metabolized into an M3 lactate, with no other isotopologues
being formed.
3.5 Knockout of Sirt3 protects macrophages against Salmonella
Typhimurium infection
We then wanted to determine how SIRT3 affects pro-inflammatory macrophage
activity under an infection scenario, using Salmonella enterica serovar Typhim-
imurium as our model bacteria. First, sirtuin mRNA expression levels in in-
fected WT BMDMs were measured in order to validate that the reduction seen
in LPS-stimulated macrophages is also occurring under infection conditions. All
sirtuin family members except for Sirt1 showed reduced expression levels with
S. Typhimurium infection (fig. 12).
To measure pro-inflammatory activity of WT and Sirt3 KO BMDMs infected
with S. Typhimurium, secretion profiles of cytokines were measured. Levels of
secreted IL-6, IL-1β and IL-10 were enhanced in the Sirt3 KO BMDMs upon
infection (fig. 14). In contrast, levels of TNFα secretion were reduced. In
addition, activity of the NF-κB and MAPK pathways were analyzed as with
the LPS-stimulated BMDMs, with knockout of Sirt3 leading to increased p65
phosphorylation (fig. 15a) and no change in p38 phosphorylation (fig. 15b).
To gain further insight into the effect of SIRT3 in the innate immune defense
against bacterial infection we quantified the colony forming units (CFU) in WT
and Sirt3 KO BMDMs after 24h of infection with S. Typhimurium. We found a
decreased number of CFU in the Sirt3 KO BMDMs compared to WT, indicating
that the absence of SIRT3 enhances the clearance of intracellular pathogens
(fig. 13). Increased bacterial clearance correlated with decreased cell death in
the Sirt3 KO BMDMs (fig. 3), a similar result to LPS-stimulated macrophages.
The increased antimicrobial activity can be attributed to two known sources,
increased itaconic acid (Michelucci et al., 2013) and increased ROS (Tao et al.,
2010). Infection with S. Typhimurium increased ROS and itaconic acid produc-
tion in macrophages (fig. 6), showing a regulatory role for SIRT3 in antimicrobial
macrophage activities. SIRT3 has been shown to target IDH2 (Yu et al., 2012),
which is a proposed “metabolic breakpoint” leading to the buildup of itaconic
acid (Jha et al., 2015). We observed that knock out of SIRT3 activity causes
hyperacetylation of IDH2 (fig. 17), which in turn decreases its activity. This
reduction of IDH2 activity causes a shunting of carbon towards itaconic acid
production.
3.6 CAD is a potential target for SIRT3 deacetylation ac-
tivity
In order to understand how SIRT3 is able to regulate the metabolic activity of
itaconic acid, we investigated a possible link between SIRT3 and Irg1 /CAD.
Using both Sirt3 KO and Irg1 KO BMDMs, we measured the expression level
of the other gene, and found no dependence of mRNA level between the two
genes (fig. 16). In addition, the protein levels of IRG1/CAD were measured in S.
9
Typhimurium infected cells, with no discernible difference between the wild type
and the knockout (fig. 17). Fluroescence microscopy showed that SIRT3 and
CAD proteins co-localize outside of the nucleus after 6 hours of LPS stimulation
(fig. 18).
CAD acetylation results are in process. If CAD is acetylated, there is a
strong possibility that it is a SIRT3 target, thus regulating itaconic acid.
4 Discussion
While decreased expression of Sirt3 has been seen before in LPS-stimulated
macrophages, no further research has been performed to uncover the effects of
this downregulation. In this study, we investigated how a reduction of SIRT3
activity in macrophages can affect inflammatory cytokine and metabolic reg-
ulation. Our results uncover that the reduction of Sirt3 expression in pro-
inflammatory macrophages serves to increase the production of itaconic acid
and pro-inflammatory cytokines, therefore aiding in bacterial clearance and im-
proving the viability of macrophages under a pro-inflammatory challenge.
Both stimulation with LPS and infection with Salmonella Typhimurium in
Sirt3 knockout BMDMs induced an increase in pro-inflammatory cytokines, an
upregulation of NF-kB and MAPK signaling pathways, as well as an increase in
the pro-inflammatory metabolites itaconic and succinic acid. As a reduction of
SIRT3 activity would concurrently reduce the activity of IDH2, PDH, and GDH,
the amount of carbon from glucose and glutamine present in the production of
itaconic acid and succinic acid should decrease. Glutamine contribution to suc-
cinic acid continued to increase with Sirt3 KO compared to the WT (fig. 8c),
suggesting that the inactivty of SIRT3 stops the control of glutamine metabo-
lized to succinic acid, which could influence the increased succinic acid buildup
(fig. 7b) and subsequent IL-1β secretion (fig. 4). There was no significant de-
crease in contribution from either glucose or glutamine to itaconic acid (fig. 8b).
This highlights the metabolic importance of these two metabolites under pro-
inflammatory conditions, as the cell attempts to maximize production of both
metabolites when challenged.
Absence of Sirt3 in S. Typhimurium infected BMDMs led to increased clear-
ance of the bacteria and improved viability of the macrophages, most likely due
to the induction of the pro-inflammatory phenotype. However, this was not due
to SIRT3 induction of ROS in the cell (Tao et al., 2010), and is instead due to an
increase in itaconic acid production, a known antimicrobial (Michelucci et al.,
2013). The increase of itaconic acid through a reduction of Sirt3 could be due
to SIRT3 activity on CAD, the enzyme catalyzing the production of itaconic
acid. However, the link between SIRT3 and CAD is not yet confirmed, and
this should be followed up with further studies investigating direct interactions
between the two proteins.
Recently, it was found that itaconic acid can inhibit succinate dehydroge-
nase, leading to a buildup of succinic acid in the cell (Cordes et al., 2016). This,
in turn, will lead to increased expression of IL-1β (Tannahill et al., 2013), a
result found in our study. Upregulation of Irg1 has been found to inhibit pro-
duction of pro-inflammatory cytokines in LPS-tolerized macrophages (Li et al.,
2013), and Irg1 -mediated production of itaconic acid has been recently shown to
reduce both pro-inflammatory cytokine production as well as oxygen consump-
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tion in LPS-activated macrophages (Lampropoulou et al., 2016). The results
of our study point to SIRT3 activity being integrated into this process, partly
mediating the production of pro-inflammatory metabolites and the reduction in
pro-inflammatory cytokines (fig. 19).
It is known that SIRT3 can co-localize with SIRT5 (Nakamura et al., 2008),
and both sirtuin family members have been observed to have the same targets
in the mitochondria(Nakagawa and Guarente, 2014; Zhang et al., 2015). Our
results show the expression levels of both Sirt3 and Sirt5 decrease similarity,
which could lead to a combined regulation of the metabolic processes leading to
increased itaconic and succinic acid. Further research on the role of SIRT5 in
pro-inflammatory macrophages would be necessary to elucidate the role of this
enzyme.
Interestingly, reduction of SIRT3 activity leads to a buildup of pyruvic and
lactic acid (fig. 11), and possibly a more active glycolysis. These results mimic
those found previously in fibroblasts (Finley et al., 2011a), but as SIRT3 is
mainly located in the mitochondria, it is currently unclear as to why there
would be an effect on a cytosolic pathway. While SIRT3 is not known to be
active in the cytosol, there are other sirtuins which regulate activity there. This
could be an interesting point of study to understand currently unknown areas
of sirtuin research, such as how sirtuins act interact with each other, and any
possible signaling that may take place between them.
This study uncovers a new role for SIRT3 in the macrophage response to bac-
terial invasion, through a regulatory network combining SIRT3 with Irg1 /CAD
and SDH, as well as itaconic and succinic acid production. Our results add
SIRT3 as well to a list of targets that can be utilized as control points for
combating diseases where macrophage dysregulation and activity
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(a) Sirt3 (b) Sirt4
(c) Sirt5
Figure 1: mRNA expression of (a) Sirt3 (b) Sirt4 and (c) Sirt5 in LPS
treated macrophages
16
Figure 2: Protein expression of SIRT3 in ST infected Sirt3 WT and
KO macrophages
Figure 3: Cell viability in LPS treated and ST infected Sirt3 WT and
KO macrophages
17
Figure 4: ELISA analysis of protein activity in LPS treated Sirt3 WT
and KO macrophages
18
(a) p65 - NFkB signaling
(b) p38 - MAPK signaling
Figure 5: Protein expression of (a) p65 and (b) p38 in LPS treated
Sirt3 WT and KO macrophages
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Figure 6: ROS levels in LPS treated and ST infected Sirt3 WT and
KO macrophages
(a) Itaconic Acid (b) Succinic Acid
Figure 7: Metabolite levels in LPS treated Sirt3 WT and KO
macrophages (a) Itaconic acid (b) Succinic acid
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(a) Pyruvate (b) Itaconic acid
(c) Succinic acid
Figure 8: Relative carbon contribution for selected metabolites: (a)
Pyruvate (b) Itaconic acid (c) Succinic acid
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(a) Pyruvate (b) Lactate
(c) Itaconic acid (d) Succinic acid
Figure 9: Glucose derived MIDs for selected metabolites: (a) Pyruvate
(b) Lactate (c) Itaconic acid (d) Succinic acid
(a) Itaconic acid (b) Succinic acid
Figure 10: Glutamine derived MIDs for selected metabolites: (a) Ita-
conic acid (b) Succinic acid
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(a) Pyruvic acid (b) Lactic acid
Figure 11: Selected metabolite levels in LPS treated WT and Sirt3
KO BMDMs (a) Pyruvic acid and (b) Lactic acid
Figure 12: Expression levels of sirtuin mRNA in ST infected BMDMs
Figure 13: Bactrerial clearance in ST infected Sirt3 WT and KO
macrophages
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Figure 14: ELISA analysis of protein activity in ST infected Sirt3 WT
and KO macrophages
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(a) p65 - NFkB signaling
(b) p38 - MAPK signaling
Figure 15: Protein expression of (a) p65 and (b) p38 in ST infected
Sirt3 WT and KO macrophages
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(a) Sirt3 expression in Irg1 KO BMDMs (b) Irg1 expression in Sirt3 KO BMDMs
Figure 16: mRNA expression levels of (a) Sirt3 in Irg1 KO BMDMs
and (b) Irg1 in Sirt3 KO BMDMs
Figure 17: Protein expression of acetylated IDH2, IRG1, and PDHK
in LPS treated and ST infected Sirt3 WT and KO macrophages
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Figure 18: Fluorescence imagery of IRG1 and SIRT3 localization in
LPS stimulated WT macrophages
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Figure 19: Summary figure - Challenge with LPS or bacterial infection causes
a decrease in SIRT3, which promotes IRG1/CAD activity. This causes an in-
crease in the production of itaconic acid, which in turn inhibits succinate de-
hydrogenase, leading to a buildup of succinic acid. This increases the secretion
of IL-1β. Simultaneously, SIRT3 reduction causes an increase in other cytokine
production. The increase in cytokines along with the production of an an-
timicrobial metabolite itaconic acid lead to increased bacterial clearance in the
macrophage.
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4
D I S C U S S I O N A N D P E R S P E C T I V E S
Through multiple studies utilizing the combination of metabolomics ex-
periments with complementary analyses on other levels of cellular regu-
lation, the work in this thesis aimed to extend current knowledge about
macrophage metabolism under inflammatory conditions. Digging deeper
into the metabolic regulation of pro-inflammatory macrophages, a se-
ries of studies were performed in order to understand more about TCA
cycle metabolism, and how this is affected under inflammatory condi-
tions. The main scientific questions all corresponded to both itaconic
acid production and how cellular central carbon metabolism is reorga-
nized during the inflammatory process in macrophages, as well as the
role that the mitochondrial deacetylase SIRT3 plays in the regulation of
these changes.
It must be noted that for all of these studies, the joint omics extraction
method utilized by our lab was extremely important for obtaining exper-
imental data (Sapcariu et al., 2014) (see Chapter 3). This method allows
the maximal amount of data to be derived from individual samples, in-
creasing experimental efficiency, and minimizing variance through the
reduction of experiments required. Normally, a protocol is given in a
materials and methods section of an article. These descriptions are not
always fully detailed, and important steps may be omitted. Thus, it was
very important to share this specific protocol with the greater scientific
community, to make sure that as many laboratories as possible are able
to utilize this technique for their own studies. A standardized method-
ology can only improve data interpretation between experiments, and
is a good step towards more reproducible results from metabolomics
studies.
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4.1 pro-inflammatory effects of aerosols on multiple lev-
els of cellular regulation
Inflammatory effects are known to result from exhaust particle expo-
sure in lung cells (Schwarze et al., 2013), but there have been no studies
looking at omics level regulation of cells using an air-liquid interface
exposure system. Through studies carried out as a part of the HICE con-
sortium, we used an ALI system to conduct a multi-omics analysis of
lung epithelial cells exposed to diesel fuel and heavy fuel oil aerosols,
two common fuels used in transport shipping (Oeder et al., 2015) (see
Chapter 3). Heavy fuel oil is a sulfur containing shipping fuel used for
long distance high energy engine use, while diesel fuel is considered to
be cleaner, and used more in harbor regions in order to reduce sulfur
emissions near populated areas.
Figure 9: Particle effects on lung cells. (A) Histogram of regulated components in the
transcriptome, (B) Histogram of regulated components in the proteome. On
both levels of cellular regulation, heavy fuel oil shows a narrower range of
regulation than diesel fuel oil. HFO - heavy marine fuel oil, DF - diesel fuel.
From Oeder et al. (2015), figure created by J. Passig
4.1 pro-inflammatory effects of aerosols on multiple levels of cellular regulation 173
Unlike submerged experiments, which use particles dissolved in cell
culture medium, ALI experiments mimic the composition of lung tis-
sue in an experimental setup, leading to an exposure model which is a
much more biologically relevant model of how aerosols are entering the
lung. While heavy fuel oil particle exposure led to mRNA upregulation
of classical inflammatory pathways, diesel fuel showed a significantly
larger amount of regulation on the transcriptomic and proteomic level
compared to HFO, a surprising result for a “cleaner” fuel type (Fig-
ure 9).
In order to validate and extend these results, macrophages were ex-
posed to the same conditions in order to investigate a cell type directly
implicated in the inflammatory response, and we found striking differ-
ences between effects of the particle phase and the gas phase (Sapcariu
et al., 2016) (See Chapter 3). While particles in the aerosols elicited a
higher cytotoxic effect on the macrophages, the gas phase changed the
metabolic profile of the macrophages, and proteomic changes occurred
under heavy fuel oil aerosol exposure pointing to an activation of the im-
mune response (Figure 10). The importance of the gas phase in aerosol
exposure experiments are beginning to be acknowledged (Dilger et al.,
2016), and future studies should shift away from using submerged ex-
periments. In this way, gas phase effects can be measured, as well as
how the interaction between particle and gas phase modifies the impact
of the individual aerosol components.
One of the metabolic changes discovered in this study was that ita-
conic acid is produced in macrophages exposed to heavy fuel oil. Ita-
conic acid was discovered in 2011 to be produced in macrophages un-
der classical pro-inflammatory conditions (Strelko et al., 2011), but we
have found the first evidence of this metabolite being produced due to
anthropogenic pollutants.
Together, these two studies (Oeder et al., 2015; Sapcariu et al., 2016) val-
idate the idea that stricter regulations need to be in place for shipping-
based aerosol emissions, and further research needs to be done in order
to understand health effects of anthropogenic aerosols. In this way, we
can further our understanding of how pollution affects us, and environ-
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Figure 10: Aerosol effects on RAW 264.7 macrophages. For both heavy marine fuel oil
and diesel fuel, particles causes increased toxicity in macrophages, while
the gas phase was implicated in metabolic changes. For heavy marine fuel
oil, itaconic acid was found to be produced by exposed macrophages. From
Sapcariu et al. (2016)
mental policy can be built around data and evidence-based argumenta-
tion.
4.2 glucose flux into the tca cycle is vital for the in-
flammatory response
Studies on macrophage metabolism under inflammatory conditions show
decreased cellular oxygen consumption (Tannahill et al., 2013), which
suggest that there is less TCA cycle activity as oxidative phosphoryla-
tion is decreased, and this process is mainly driven by TCA cycle-derived
NADH. One of the reasons for this is the cascade initiated through
LPS-induced HIF-1α stabilization, suggesting a transcriptional activation
of PDK and thus a reduction of pyruvate dehydrogenase (PDH) com-
plex activity, catalyzing the oxidation of pyruvate into the TCA cycle.
However, we discovered that PDH activity is constitutively active in
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LPS-stimulated macrophages, and is necessary for pro-inflammatory cy-
tokine expression (Meiser et al., 2015) (see Chapter 3).
Figure 11: Metabolic network of pro-inflammatory macrophages. Glucose is utilized
macrophages for glycolysis as well as the TCA cycle, through the oxidation
of pyruvate through pyruvate dehydrogenase. This carbon is then used
to produce itaconic acid and acetyl-CoA (for fatty acid synthesis). Glu-
tamine anaplerosis is used to replenish the TCA cycle. Pkm - pyruvate kinase,
Alat - alanine transanimase, Ldh - lactate dehydrogenase, Hif1 - hypoxia-
inducible factor 1, Pdh - pyruvate dehydrogenase, Cs - citrate synthase,
Acly - ATP citrate lyase, Irg1 - immunoresponsive gene 1, Aco - aconitase,
Idh - isocitrate dehydrogenase, aKgdh - alpha-ketoglutarate dehydrogenase.
From Meiser et al. (2015), figure created by J. Meiser
Glucose oxidation into the TCA cycle is necessary to supply carbon for
the production of itaconic acid and other TCA cycle metabolites, as well
as fatty acids for morphological changes resulting from LPS stimula-
tion (Figure 11). Expression levels of Pdk1 were reduced, while PDK1
protein levels and their phosphorylation did not change, showing that
PDH-inhibiting activity was not increased with LPS stimulation. Trac-
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ing of [U-13C6]glucose to citric acid showed a basal level of 50% label-
ing and increased with LPS, showing not only that PDH activity was
active in resting macrophages, but that it was an important part of
the pro-inflammatory macrophage phenotype. In addition, macrophage
metabolic activity under hypoxia was investigated, and itaconic acid
was seen to be strongly decreased when macrophages were stimulated
with LPS in hypoxic conditions.
The results of this study refute the assumption long held in the macrophage
research community that since oxidative phosphorylation is reduced,
the TCA cycle is less active in pro-inflammatory macrophages. Instead,
this study adds to a growing body of evidence that the TCA cycle is vi-
tal to macrophage metabolism throughout the inflammatory process. In
addition, it is interesting to note how the central carbon metabolic net-
work dissociates during a pro-inflammatory challenge, with rerouting
of metabolic pathways in order to focus on the production of necessary
biomolecules for bacterial clearance. This theory has been suggested for
the TCA cycle specifically by Jha et al. (2015), and future studies should at-
tempt to understand how the concept of “metabolic breakpoints” could
be related to different cell types in disease states to determine important
regulatory points of disease metabolism.
4.3 increases in itaconic and succinic acid are linked
The antimicrobial activity of itaconic acid (Michelucci et al., 2013) and
the pro-inflammatory signaling properties of succinic acid (Tannahill
et al., 2013) have established these two metabolites as vital for the macrophage
response to infections and other inflammatory stimuli. While down-
stream succinic acid metabolism is known, what happens to itaconic
acid (aside from shutting down bacterial metabolism) is still being re-
searched. We found a link between the two metabolites, and were able
to show that itaconic acid is able to inhibit SDH activity to induce an
accumulation of succinic acid (Cordes et al., 2016) (see Chapter 3).
This regulation was shown to be present in both macrophages and
Irg1-overexpressing transformed lung cells, and to be attenuated with
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Figure 12: Itaconic acid inhibits succinate dehydrogenase. In pro-inflammatory
macrophages, the buildup of itaconic acid causes inhibition of succinate de-
hydrogenase, leading to a buildup of succinate in the mitochondria. From
Cordes et al. (2016), figure created by T. Cordes
knockout of Irg1 gene expression in BMDMs. While itaconic acid acts on
SDH, it is not metabolized into succinic acid, and downstream products
of its metabolism in macrophages still remain unidentified (Figure 12).
The results of this study point to a coordinated inflammatory response
on a metabolic level, one that plays a role in the regulation of both cy-
tokine activity and microbial defense. There has been some work on
determining how this process is regulated, with interferon regulatory
factor 1 (IRF1) identified as a transcription factor for Irg1 (Tallam et al.,
2016). However, as metabolism is able to react quickly to perturbations,
there might be more regulatory steps at non-transcriptional levels con-
tributing to the production of itaconic acid.
4.4 metabolic properties of cell lines differ from primary
macrophages
Cell lines are constantly used as biological models for a wide variety of
studies, in order to provide a cheaper and more readily accessible exper-
imental tool compared to primary cells. While it can be assumed that
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there are differences between primary cells and cell lines, we wanted to
judge how representative a cell line is of a primary cell model for the
study of the macrophage inflammatory process. This comparison was
performed through the identification of similarities and differences in
pro-inflammatory cytokine expression and metabolic changes. By com-
paring RAW 264.7 cells and BMDMs over the first 8 hours of the inflam-
matory response, we were able to determine that there are important
differences that need to be taken into account when substituting a cell
line for primary cells on both mRNA expression and metabolic levels
(see Chapter 3).
Pro-inflammatory cytokine expression is consistently higher in BMDMs,
even though the pattern of regulation is similar, showing that primary
cells have a stronger response to LPS stimulation (Figure 13). This is
also true for pro-inflammatory associated genes not typically classified
as cytokines, such as Irg1 or iNos.
Figure 13: Comparison of cytokines in early-stage macrophage LPS response. (a) Tnf-α
(b) Il-1β (c) Il-6 (d) Hif-1α
Metabolic changes due to pro-inflammatory stimulation are not com-
parable between the cell types, most likely because of transcriptional
changes necessary to have a proliferating cell line. This can immediately
be seen in Hif-1α expression (Figure 13), which is constant in RAW cells
while increasing over time in BMDMs. Pdk1 expression also has differ-
ent expression patterns in primary cells, showing an increase in expres-
sion similar to Hif-1α, possibly due to the transcriptional link between
the two (Figure 14). Expression of all three Idh isoforms decreased in
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RAW cells, while only Idh1 and Idh2 decreased in BMDMs (Figure 14),
reinforcing the idea of IDH as a metabolic breakpoint put forth by Jha
et al. (2015).
Figure 14: Comparison of metabolic genes in early-stage macrophage LPS response.
(a) Irg1 (b) Pdk1 (c) Idh1 (d) Idh2 (e) Idh3
Metabolic changes show a similar difference between the cell types as
with metabolic gene expression. Through the tracing of stable isotope
labeled glucose and glutamine in central carbon metabolism, we found
that over time, RAW cell carbon use from glucose and glutamine is not
significantly affected by a pro-inflammatory stimulus, while BMDMs
show increased use of glucose and glutamine for the production of
metabolites (Figure 15). In addition, relative metabolic flux of glucose
to metabolites in the TCA cycle (such as citric acid, fumaric acid, and
succinic acid) are not significantly affected by LPS in RAW cells, while
in BMDMs this flux increases over time. Metabolite pools of succinic
and itaconic acid, the two metabolites implicated in pro-inflammatory
macrophages, increased with the same trend in both cell types. Even
though the trends are similar, pool size of both metabolites were higher
in RAW 264.7 cells than BMDMs. In addition, the carbon use from glu-
cose and glutamine for these pro-inflammatory metabolites increases in
both RAW cells and BMDMs.
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Figure 15: Comparison of carbon contribution from glucose and glutamine in early-
stage macrophage LPS response. (a) RAW cells and (b) BMDMs - Pyruvic
acid, (c) RAW cells and (d) BMDMs - Citric acid, (e) RAW cells and (f)
BMDMs - Itaconic acid, (g) RAW cells and (h) BMDMs - Succinic acid.
4.5 sirt3 regulation promotes anti-bacterial activity in pro-inflammatory macrophages 181
LPS stimulation in macrophages thus leads to metabolic changes and
pro-inflammatory cascades, which have a specific order in the early
stage of the inflammatory response. Cytokine expression (as well as
Irg1) are increased early, followed by Hif-1α increase and decreases
in metabolic genes. This leads to an increase in the pro-inflammatory
metabolites itaconic acid and succinic acid, which lead to an antimicro-
bial response from the macrophage.
The results of this paper show important similarities and differences
between the RAW 264.7 macrophage cell line and primary BMDMs with
regard to pro-inflammatory cytokine expression and relative metabolic
flux changes. For the study of pro-inflammatory cytokines and metabo-
lites, RAW cells are a good substitute for primary BMDMs, since the tim-
ing of these effects after LPS stimulation is directly comparable. How-
ever, the fact that RAW cells have been transformed to be proliferative
and immortalized cause drastic changes to the metabolic machinery of
the cell, including Hif-1α expression. This means that for the study of
metabolic changes as a result of a pro-inflammatory stimulus, the re-
sults from RAW cells do not represent the metabolic activity in primary
BMDMs. In future studies, care should be taken to choose a correct ex-
perimental model during the design of a study in order to make sure
the model accurately can respond to the scientific question asked.
4.5 sirt3 regulation promotes anti-bacterial activity in
pro-inflammatory macrophages
After uncovering the flux of glucose complementary to that of glu-
tamine as a carbon source for itaconic acid production, and then deter-
mining a link between itaconic acid and succinic acid, the next step was
to understand how these metabolic changes are regulated in order to
identify regulatory points for possible drug targets. As it is known that
the mitochondrial sirtuin SIRT3 has reduced expression in LPS-treated
macrophages (Figure 16), we investigated how a reduction of SIRT3 in
macrophages can affect inflammatory cytokine and metabolic regula-
tion. In doing so, we uncovered that SIRT3 reduction serves to regulate
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the pro-inflammatory and anti-microbial phenotype in macrophages by
increasing production of itaconic acid and pro-inflammatory cytokines
(Manuscript in preparation - see Chapter 3).
Figure 16: Sirt3 expression decreases in LPS-treated BMDMs.
In Sirt3 knockout BMDMs, both stimulation with LPS and infection
with Salmonella typhimurium induced an increase in pro-inflammatory
cytokines, upregulation of NF-κB and MAPK signaling pathways, and in-
creased clearance of the bacterial infection, all of which led to improved
macrophage viability. This was not due to SIRT3 induction of ROS in the
cell, but instead from increased itaconic and succinic acid levels in the
Sirt3 knockout macrophages (Figure 18), possibly from SIRT3 deacety-
lation of CAD, the enzyme catalyzing the production of itaconic acid.
However, the link between SIRT3 and CAD could not be confirmed,
and this should be followed up with further studies investigating direct
interactions between the two proteins.
Irg1 upregulation has been found to reduce pro-inflammatory cy-
tokine production in LPS-tolerized macrophages (Li et al., 2013), and a
paper published very recently suggests that Irg1-mediated production
of itaconic acid can reduce both pro-inflammatory cytokine production
as well as oxygen consumption in LPS-activated macrophages (Lam-
propoulou et al., 2016). Our results show that this reduction could be
partly mediated by SIRT3 activity. Thus, in the macrophage response
to pathogens, the activity of SIRT3 can be implicated in the regulatory
network of Irg1/CAD, itaconic acid, SDH, and succinic acid determined
through these studies.
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Figure 17: Cell viability and bacterial clearance of Sirt3 KO BMDMs. (a) Cell viability
of WT and Sirt3 KO macrophages infected with S. Typhimuirum, (b) Cell vi-
ability of WT and Sirt3 KO macrophages stimulated with LPS, (c) Bacterial
clearance of WT and Sirt3 KO macrophages infected with S. Typhimuirum
Figure by S. Gutiérrez
Figure 18: Metabolite levels in LPS treated WT Sirt3 and KO BMDMs. (a) Itaconic acid
(b) Succinic acid
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4.6 outlook
Throughout this work, I have looked at pro-inflammatory macrophages
stimulated with different cellular agonists, including ship engine ex-
haust aerosols, LPS, and Salmonella typhimurium. Interestingly, while
the sources of inflammation can be varied, the production of itaconic
acid by macrophages seems to be conserved with most pro-inflammatory
stimulations, suggesting that itaconic acid accumulation is important to
the general macrophage inflammatory response.
In addition, glucose and glutamine both supply carbons into the TCA cycle,
where they are funneled towards production of itaconic and succinic
acid in pro-inflammatory macrophages. The combination of constant
PDH activity independent of HIF-1α stabilization and repression of SDH
allow for glucose and glutamine influx to increase metabolite levels of
itaconic and succinic acid, consistent with the hypothesized “metabolic
breakpoints” put forth by Jha et al. (2015).
The role of itaconic acid as an antimicrobial is known, but to discover
other roles of this metabolite is vital for determining human health ap-
plications (as well as implications of its use). Itaconic acid’s ability to
inhibit SDH and promote the buildup of succinic acid shows that this
antimicrobial metabolite can also affect TCA cycle activity. As SDH is also
complex II of the ETC, there is also the possibility that inhibition due
to itaconic acid is linked to the reduction in oxidative phosphorylation
and the redox state of the cell. Further research should be performed on
itaconic acid to determine other possible biochemical reactions it can af-
fect, in order to understand the potential of this metabolite with regards
to artificially regulating metabolic activity in diseases where metabolic
dysregulation plays a role.
Just as itaconic acid has been found to have multiple roles in the cell,
the same is likely for Irg1, the gene implicated in its production. Studies
link Irg1 with ROS production and cytokine secretion (Li et al., 2013; Ren
et al., 2016), and it is starting to look like Irg1 is a main regulator of
inflammatory processes in macrophages. Understanding the transcrip-
tional regulation of Irg1 is the next step, and recently it was discovered
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that Irf1 serves to affect mRNA and protein expression of Irg1/CAD
(Tallam et al., 2016).
In addition to transcriptional regulation of itaconic acid production,
we have uncovered additional regulation of this process through the
SIRT3 deacetylase, which most likely affects CAD activity and thus reg-
ulates itaconic acid production. In addition, SIRT3 activity regulates pro-
inflammatory cytokine production as well as the NF-κB and MAPK sig-
naling pathways. This regulation helps to promote a pro-inflammatory
macrophage phenotype as well as aiding in clearance of pathogenic bac-
teria and thus cellular survival under infections.
As SIRT3 is implicated (and decreased to serve cellular needs) in clas-
sical inflammation, this protein (as well as other sirtuin family members)
could be exploited as therapeutic targets, in order to modulate uncon-
trolled inflammation in diseases with a metabolic aspect. One further
avenue of research is probing whether CAD is a target of SIRT3, and
how this regulation affects itaconic acid levels. The results in this the-
sis suggest that CAD is acetylated, and deacetylation activity of SIRT3
could regulate the production of itaconic acid levels, but this must be
confirmed. The consequence of SIRT3 involvement in macrophage in-
flammation is that metabolic regulation plays an important role in in-
flammatory processes, as well as confirming SIRT3 as a promising drug
target in metabolically linked diseases.
The combined results of the study point to a tightly linked network
of pro-inflammatory metabolic regulation for the purpose of promoting
antimicrobial and increased cytokine activity through the interplay of
SIRT3, Irg1, succinic acid (as well as SDH), and itaconic acid. In addi-
tion, the work in this thesis adds evidence to the idea that the TCA cycle
is extremely important for both pro-inflammatory metabolite produc-
tion as well as regulation of cytokine expression in active macrophages,
separating its role from that of glycolysis and showing a decoupling of
central carbon metabolism under inflammatory conditions.
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